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The intracellular transduction of interferon signals from the plasma membrane to the nucleus 
is mediated by signal transducer and activator of transcription 1 (STAT1) which acts in 
tetrameric form as a transcription factor in immune responses. In this project, the protomer 
exchange between STAT1 dimers was studied under kinetic aspects and this process was 
identified as a potential rate-limiting step in the STAT1 activation/inactivation cycle. The data 
support an alternative mechanism for the transition between the parallel and anti-parallel 
conformation of STAT1 dimers based on the dissociation and subsequent reassociation of 
protomers which does not require reciprocal interactions within the N-terminal domain dimer 
to stabilize an intermediate conformational state. However, binding to high-affinity STAT-
specific target sequences, termed gamma-activated sites (GAS), critically interfered with the 
exchange dynamics. A tandem GAS element in the promoter of the human gene coding for 
the cytoskeletal protein ezrin was identified in silico as a putative STAT1 target sequence, and 
was confirmed to bind dimeric STAT1 on each motif to moderately induce gene transcription. 
However, mice carrying either an N-terminal substitution mutation of STAT1 affecting 
cooperative DNA binding or a complete functional knockout of the Stat1 gene did not present 
with altered expression of ezrin and moesin in bone marrow cells compared with mice 
expressing the wildtype molecule. In a model of myocardial infarction performed by ligation 
of the left anterior descending coronary artery, male mice expressing the IFNγ-irresponsive 
STAT1 mutant displayed higher survival rates, whereas females were protected from adverse 
cardiac remodelling in the early remodelling phase. The inflammatory infiltrate showed a 
mild increase in tyrosine-phosphorylated STAT1, while the pool of total STAT1 was 
significantly reduced in the infarcted areas of knockin animals as compared to their wildtype 
littermates. In experimental autoimmune encephalomyelitis used as a model for a T helper 
cell-induced autoimmune disease, cells obtained from lymphatic organs of STAT1-deficient 
animals at the time of disease onset were hyperproliferative and secreted high amounts of 
IFNγ and IL-17A. Injection of these mice with lipopolysaccharide during the induction phase 
of experimental autoimmune encephalomyelitis completely abolished this proliferative 
phenotype. In summary, the findings demonstrate the role of cooperative DNA binding and 
tetramer formation of STAT1 in orchestrating complex immunological processes, even in the 
absence of infectious agents and, furthermore, highlight the function of tyrosine-





STAT1-vermittelte zelluläre Antworten in murinen entzündlichen 
Erkrankungen 
Die intrazelluläre Weiterleitung von Interferonsignalen von der Zytoplasmamembran zum 
Zellkern wird vermittelt über den Signaltransduktor und Aktivator der Transkription 1 
(STAT1), welcher in seiner tetrameren Form als Transkriptionsfaktor an Immunantworten 
beteiligt ist. In diesem Projekt wurde der Protomerenaustausch zwischen STAT1-Dimeren 
unter kinetischen Gesichtspunkten untersucht und dabei dieser Prozess als ein potentiell 
geschwindigkeitsbestimmender Schritt des Aktivierungs-/Inaktivierungs-Zyklus von STAT1 
identifiziert. Die Daten unterstützen einen alternativen Mechanismus für den Wechsel 
zwischen der parallelen und antiparallelen Konformation von STAT1-Dimeren basierend auf 
der Dissoziation und nachfolgenden Reassoziation von Protomeren, bei dem reziproke 
Interaktionen innerhalb des N-terminalen Domänendimers zur Stabilisierung eines 
intermediären Konformationsübergangs nicht benötigt werden. Durch Bindung an spezifische 
DNA-Zielbereiche, als Gamma-aktivierte Sequenzen (GAS) bezeichnet, wird die Dynamik 
des Protomerenaustauschs wesentlich beeinträchtigt. In der Sequenz des für das zytoskelettale 
Strukturprotein Ezrin kodierenden humanen EZR-Gens wurde mittels in silico Analyse ein 
doppeltes GAS-Motiv als mögliche STAT1-Zielsequenz identifiziert und die Bindung von 
STAT1-Dimeren an jedes der beiden Elemente sowie eine moderate Geninduktion bestätigt. 
Allerdings zeigen Mäuse mit einer N-terminalen Substitutionsmutation von STAT1, welche 
die kooperative DNA-Bindung beeinträchtigt, sowie auch ein kompletter funktioneller 
Knockout des Stat1-Gens keine veränderte Expression von Ezrin und Moesin in 
Knochenmarkszellen verglichen mit Mäusen, die das Wildtyp-Molekül exprimieren. In einem 
Myokardinfarktmodell durch Ligatur des Ramus interventricularis anterior zeigen männliche 
Mäuse mit Expression der Interferon-γ-irresponsiven STAT1-Mutante höhere 
Überlebensraten, während weibliche Tiere vor den nachteiligen Effekten des kardialen 
Remodellings in der frühen Phase geschützt sind. In entzündlichen myokardialen Infiltraten 
dieser Tiere wurde ein geringfügig höheres Expressionsniveau an tyrosinphosphoryliertem 
STAT1 nachgewiesen, während die Gesamtproteinmenge an STAT1 gegenüber dem Wildtyp 
reduziert war. Zellen aus lymphatischen Organen STAT1-defizienter Tiere mit 
experimenteller autoimmuner Enzephalomyelitis, die als Modell einer T-Helfer-Zell-
vermittelten Autoimmunerkrankung verwendet wurde, zeigten einen hyperproliferativen 
Phänotyp und sezernierten größere Mengen an IFNγ und IL-17A. Injektion dieser Mäuse mit 




Enzephalomyelitis hob den hyperproliferativen Phänotyp vollständig auf. Zusammenfassend 
demonstrieren die Ergebnisse aus dieser Arbeit die Bedeutung einer kooperativen DNA-
Bindung und Tetramerstabilisierung von STAT1 im Zusammenspiel komplexer 
immunologischer Prozesse auch in Abwesenheit infektiöser Pathogene und unterstreichen 
zudem die Schlüsselrolle von tyrosinphosphoryliertem STAT1 bei der Verknüpfung zwischen 
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1.1  STAT1 – A key transcription factor in immunity and inflammation 
Signal transducer and activator of transcription 1 (STAT1) belongs to a family of latent 
signal-dependent transcription factors that is highly conserved among mammals and is 
involved in a plethora of cellular processes including immunity, cell growth, differentiation 
and apoptosis (Levy and Darnell, 2002). The protein was first described in the early 1990s as 
part of a complex that was phosphorylated in response to interferon-α (IFNα) and IFNγ (Fu, 
1992; Shuai et al., 1992).  
STAT family proteins are thought to have evolved with the development of the first 
multicellular organisms. They were reported to be present in Dictyostelium discoideum and 
Drosophila melanogaster but were not found in Saccharomyces cerevisiae (Yan et al., 1996; 
Kawata et al., 1997). In mammals, there are seven different forms of STAT proteins, namely 
STAT1, STAT2, STAT3, STAT4, STAT5a, STAT5b and STAT6. In mice, the genes for 
these proteins cluster in three regions: Stat1 and Stat4 at the proximal region of chromosome 
1, Stat2 and Stat6 at the distal region of chromosome 10 and Stat3, Stat5a and Stat5b at the 
distal region of chromosome 11 (Copeland et al., 1995). In humans, the genes encoding 
STAT1 and STAT4 are localised in a head to tail tandem orientation to the long arm of 
chromosome 2, STAT3, STAT5a and STAT5b are localized to chromosome 17, and STAT2 and 
STAT6 are both found on chromosome 12 (Darnell, 1997). 
Upon activation by extracellular signalling ligands at the plasma membrane, STAT 
proteins exert their roles as transcription factors in the nucleus and modulate cytokine-
dependent gene expression (Darnell, 1997). Among the signalling molecules are a variety of 
cytokines including interferons, interleukins, growth factors, and hormones (Abroun et al., 
2015). 
The characteristic structure of members of the STAT protein family is a modular set-up of 
an amino-terminal, a coiled-coil, a DNA-binding, a Src-homology (SH2), and a 
transactivation domain (from amino- to carboxy-terminus). The molecular weight of 
mammalian STAT proteins ranges between 80 kDa and 113 kDa (Darnell, 1997; Levy and 
Darnell, 2002). Conserved among the STAT transactivation domains is a tyrosine residue that 
is phosphorylated by Janus kinases (JAKs) upon activation. In STAT1, this residue is located 




(Shuai et al., 1993a; Kaptein, 1996). By differential splicing or proteolysis, all STAT proteins 
except for STAT2 have been found to be expressed with different isoforms of different 
protein size and slightly different regulation. In the case of STAT1 and STAT3, a full-length 
α- and a truncated β-isoform are expressed. Both β-isoforms lack a serine residue which is 
conserved among full-length STAT1, STAT3, STAT5a and STAT5b. Phosphorylation of this 
serine residue has been shown to boost STAT1 transcriptional activity rendering the β-
isoforms less active (Schindler et al., 1992a; Schaefer et al., 1995; Wang et al., 1996; Decker 
and Kovarik, 2000; Horvath, 2000; Lödige et al., 2005). 
The three-dimensional structures of STAT1 and STAT3 dimers bound to DNA were 
determined using crystallographic analyses. The data revealed the nature of STAT-DNA 
binding including the dimerization of the two protomers via reciprocal interactions of their 
SH2 domains and the binding interface interacting with the DNA (Becker et al., 1998; Chen et 
al., 1998). However, these structural analyses failed to determine the structure of the N-
terminal domain and parts of the transactivation domain. Combination of the models of 
STAT1 and STAT4 for which crystallography of the N-terminus had been successful led to a 
model that predicted interactions of the N-termini within a dimer (Baden et al., 1998; 
Vinkemeier et al., 1998; Chen et al., 2003b). Crystallographic analysis of unphosphorylated 
STAT1 confirmed these predictions based on the hybrid model and showed that 
unphosphorylated cytosolic STAT1 forms tetrameric complexes as dimers of dimers. These 
studies identified two different conformational states of STAT1 dimers that would both be 
supported by N-terminal interactions and showed that phosphorylated STAT1 favoured the 
more open parallel alignment, while unphosphorylated STAT1 was more likely to acquire the 
more condensed antiparallel state (Mao et al., 2005; Wenta et al., 2008). STAT1 dimers in the 
parallel conformation were assumed to interact with the receptor and shown to bind to DNA.  
The main role in stabilizing this conformational state was attributed to the SH2 domain. 
Stabilization of the antiparallel state is mainly achieved through a combination of N-terminal 
domain interactions and interactions of the coiled-coil domain with the DNA-binding domain 
of the partner protomer. It was proposed that phosphorylated STAT1 dimers in the parallel 
conformation are a poor substrate for phosphatases and cannot leave the nucleus unless they 
are dephosphorylated (Meyer et al., 2003). This suggests that a conformational shift is a main 
constituent of the STAT1 activation-inactivation cycle. It was predicted that interactions of 




that the phenylalanine at position 77 plays a major role (Mao et al., 2005; Zhong et al., 2005; 
Mertens et al., 2006; Wenta et al., 2008).  
Second to the SH2 domain, the amino-terminal domain is the most highly conserved 
domain among the STAT proteins. However, domain exchange experiments have shown that 
it is not interchangeable. In STAT1, the amino-terminal domain spans the first 135 amino 
acids (Strehlow and Schindler, 1998; Murphy et al., 2000) and through this domain, protein-
protein interactions between two STAT1 molecules are facilitated. Based on structural data 
and targeted mutagenesis, a conserved phenylalanine residue was identified at position 77 in 
STAT1 and at position 81 in STAT5 that is essential for the formation of tetramers (John et 
al., 1999; Meyer et al., 2004). Mutation of this residue in STAT1 to alanine resulted in 
severely impaired cooperative DNA binding and reduced expression of some but not all 
STAT1 target genes. Furthermore, the STAT1 N-terminus provides a surface to interact with 
other modulating factors such as the CREB-binding protein (CBP/p300) and protein inhibitor 
of activated STAT1 (PIAS1) (Leung et al., 1996; Darnell, 1997; Horvath, 2000; Shuai, 2000). 
In summary, DNA-bound tetramers and higher-order oligomers of STAT1 are formed by 
reciprocal amino-terminal interactions. 
 
 
Figure 1: Model of tetramer stabilization of STAT1 binding to DNA. Shown are STAT1 dimers in 
parallel alignment (blue and green) bound to the DNA double helix (red). The N-termini (N) of two 
dimers interact to facilitate cooperative DNA binding. 
 
The coiled-coil domain of STAT1 consists of 181 amino acids and forms a structure of 




activation cycle (Begitt et al., 2000). In addition, the coiled-coil domain forms an interface for 
interactions with the DNA-binding domain of a partner molecule in order to stabilize the anti-
parallel dimer conformation. Targeted mutagenesis of the residues Q340, G384, Q408 of the 
DNA-binding domain and residue F172 disrupts these interactions and led to the 
destabilization of the antiparallel conformational state and prolonged tyrosine phosphorylation 
(Begitt et al., 2000; Mao et al., 2005; Mertens et al., 2006). 
The DNA-binding domain contains the interface for the interaction of STAT1 with target 
sequences on DNA. Through several distinct residues, STAT1 interacts with the major as well 
as the minor groove of the DNA-double helix (Chen et al., 1998). Besides the DNA binding 
activity, this domain also provides the nuclear localisation sequence needed for the interaction 
with importin-α-5 to facilitate nuclear import of the phosphorylated STAT1 dimer (Fagerlund 
et al., 2002; McBride et al., 2002; Meyer et al., 2002). 
The STAT1 linker domain spans the amino acids 488 to 575 (Chen et al., 1998). A variety 
of residues have been identified in the linker domain of STAT1 as well as of STAT3 which 
upon mutation, alter DNA-binding kinetics and affect gene transcription. It is believed that by 
interactions of the linker domain with the SH2 domain and the DNA-binding domain, the 
process of association to and release from DNA is regulated (Yang et al., 2002; Hüntelmann 
et al., 2014; Mertens et al., 2015). Furthermore, the measles virus phosphoprotein was found 
to interact with the STAT1 linker domain, thereby, preventing JAK1-induced activating 
phosphorylation, indicating that the linker domain is a target of viral pathogens during 
immune evasion (Devaux et al., 2013). 
The SH2 domain is highly conserved among the STAT family members and provides the 
surface for the dimerization of tyrosine-phosphorylated STAT1 molecules. For this 
interaction, the arginine residue at position 602 is most critical since it interacts with the 
phosphorylated tyrosine residue 701 of the partner protomer to form a parallel STAT1 dimer 
(Shuai et al., 1993b; Chen et al., 1998; Wenta et al., 2008). 
The transactivation domain of STAT1 spans a region of 67 amino acids and holds the 
critical phosphorylation site at position 701 as well as the serine residue at position 727 that 
can be phosphorylated to enhance transcription. The truncated STAT1β isoform lacks 
transcriptional activation, despite the fact that this isoform is able to dimerize, become 
tyrosine-phosphorylated and bind to DNA. Due to its low levels of conservation among the 




specificity (Shuai et al., 1992; Schindler et al., 1992b; Darnell, 1997; Decker and Kovarik, 
2000). 
STAT1 is activated mainly by interferon signalling. Interferons are classified into three 
different subgroups. The type I interferons (IFNα, IFNβ and some related molecules) are 
known to be essential in orchestrating an antiviral defence. The only mammalian type II 
interferon is IFNγ. It has been identified as a main actor in antibacterial, -fungal and -parasite 
immunity but plays only a limited role in antiviral activity. Type III interferons classified as 
different isoforms of IFNλ were discovered in 2003. They were found to carry out their main 
tasks in supporting epithelial barrier function and in immunity against some RNA viruses 
(Kotenko et al., 2003; Sheppard et al., 2003; Zhang et al., 2008; Lazear et al., 2015). 
Interferon signalling is initiated by binding of the cytokine to the extracellular domain of 
its cognate receptor. Type I interferons bind to the interferon-α receptor (IFNAR) which is 
comprised of two subunits, IFNAR1 and IFNAR2 (Novick et al., 1994; Platanias, 2005). 
Extracellular IFNγ is detected by the interferon-γ receptor (IFNGR) (Langer and Pestka, 
1988). IFNAR and IFNGR are both class-II cytokine receptors. They contain an extracellular 
ligand-binding domain and a transmembrane domain which spans the membrane once. 
Proteins with tyrosine-kinase activity are bound to the intracellular carboxy-terminal domain 
of interferon receptors (Bach et al., 1997). Upon binding of the ligand to its receptor, the two 
receptor subunits dimerize. Janus kinases become activated which enables them to recruit and 
phosphorylate STAT proteins at a conserved tyrosine residue near the carboxy-terminus to 
induce activation. The Janus kinases are a relatively small family of tyrosine kinases 
consisting of only four members, namely JAK1, JAK2, JAK3 and TYK2 (tyrosine kinase 2). 
They are non-covalently bound to cytokine receptors via a four-point-one, ezrin, radixin, 
moesin (FERM) domain (Yamaoka et al., 2004). To facilitate differential regulation of type I 
and type II interferon signalling, IFNAR recruits STAT1 as well as STAT2, while IFNGR 
exclusively recruits STAT1 (Shuai et al., 1993b; Darnell, 1997). In the case of STAT1, the 
transcription factor is recruited from a pool of monomers and unphosphorylated dimers 
located in the cytosolic and nuclear compartment of the resting cell (Yang and Stark, 2008).  
Following phosphorylation of STAT1 and STAT2, two different complexes are formed. 
The STAT1 homodimer is formed by interactions of the SH2 domains of two phosphorylated 
STAT1 monomers. The interferon-stimulated gene factor 3 (ISGF-3), a complex formed of 
phosphorylated STAT1 and STAT2 together with interferon-regulatory factor 9 (IRF9), is 




importin-α5 and readily accumulate in the nucleus within minutes after activation (Fagerlund 
et al., 2002). Once inside the nucleus, the imported complexes facilitate transcription of 
interferon-responsive genes by association to target sequences in promoter and enhancer 
regions. STAT1 homodimers bind with high affinity to a palindromic sequence, the so-called 
interferon-gamma-activated site (GAS). The ISGF-3 complex binds to a different sequence, 
termed IFNα-stimulated response element (ISRE) (Darnell et al., 1994; Horvath, 2000). 
STAT inactivation is catalysed by phosphatases located in the cytosol and in the nucleus. 
In the cytosol, the most prominent tyrosine phosphatases are SH2-containing phosphatase 1 
(SHP-1), SHP-2, and protein tyrosine phosphatase 1B (PTP1B). In the case of STAT1 and 
STAT3, an important mechanism of inactivation is dephosphorylation in the nucleus by the 
T cell protein tyrosine phosphatase TC-45 (Hoeve et al., 2002; Levy and Darnell, 2002; 
Rawlings et al., 2004). 
The most well-studied inhibitory mechanism to counteract JAK/STAT signalling is by the 
expression of suppressor of cytokine signalling (SOCS) proteins. These proteins are 
components in a negative feedback loop since most SOCS protein encoding genes are known 
targets of STAT-regulated gene transcription (Starr and Hilton, 1999; Levy and Darnell, 
2002). Eight members of the SOCS protein family have been characterized and termed 
SOCS1-SOCS7 and cytokine-inducible SH2-domain containing protein (CIS). Some SOCS 
proteins execute their action of JAK/STAT signal inhibition by binding to the catalytic 
subunit of the receptor-bound JAKs, thereby hindering the autophosphorylation of the 
kinases. CIS has a different mode of action in competing with STAT proteins for the receptor 
binding site. The best studied of the SOCS protein family are SOCS1 and SOCS3 since the 
genetic knockout of these factors in mice results in complex and distinct impairments of 
immune regulation (Alexander, 2002; Rawlings et al., 2004; Linossi and Nicholson, 2015). 
Another system of JAK/STAT signal inhibition functions through the expression of PIAS. 
This class of proteins has been shown to interact with numerous signalling pathways, the 
JAK/STAT and nuclear factor κB (NFκB) pathway being the best studied. They are thought 
to interact with dimeric STAT complexes by blocking the DNA-binding activity to prevent 
STATs from binding to promoters and, additionally, by the recruitment of co-repressors to 
stop the initiation of transcription. PIAS regulation does not affect all STAT-inducible genes 
to the same extent, indicating a mechanism of differential regulation. While some genes have 
been shown to be upregulated in PIAS1 knockdown, other genes remain unaffected (Liu et al., 




To study the function of STAT proteins in more detail, several different genetic knockout 
models for members of the STAT protein family have been generated. Since STAT1 mediates 
the intracellular signal transduction of both type I and type II interferons, the complete 
functional knockout of this transcription factor results in a complete absence of the typical 
response to IFNα, IFNβ and IFNγ. These mice show a high susceptibility to a large variety of 
microbial pathogens while remaining otherwise healthy and indistinguishable from wildtype 
littermates when kept under pathogen-free conditions (Durbin et al., 1996; Meraz et al., 
1996). Using an ex vivo ischemia/reperfusion model of Langendorff perfusion of the heart, it 
was demonstrated that STAT1-deficient mice displayed reduced infarct size. Cardiomyocytes 
of the STAT1-knockout mouse line favoured autophagy over apoptosis signalling, resulting in 
higher cell survival rates in the peri-infarct region (McCormick et al., 2012).  
The STAT1-F77A knockin mouse lacks the critical phenylalanine residue located in the N-
terminus which is needed to facilitate tetramer stabilization. Owing to the exchange of this 
amino acid residue to alanine, cooperative DNA binding is rendered impossible. The F77A 
point mutation leaves type I interferon signal transduction mostly unaffected, but results in 
severely impaired transcriptional activation upon IFNγ signalling. Mice lacking N-domain-
mediated tetramer stabilization are protected from viral infection and have a lower mortality 
under treatment with lipopolysaccharide (LPS). However, the transgenic mouse line showed 
higher rates of mortality when infected with Listeria monocytogenes, indicating impairments 
in antibacterial but not antiviral response (Begitt et al., 2014). 
For some STAT proteins, especially for STAT1, it has been shown that they upregulate 
their own expression in a self-inducing manner. Upon IFNγ stimulation, the intracellular 
levels of unphosphorylated STAT1 are increased and remain elevated for more than one day. 
During this time, a set of immunomodulatory genes, among them several genes important in 
antiviral immune regulation, are overexpressed, as shown in fibroblasts and mammary gland 
epithelial cells (Cheon and Stark, 2009). A genetic knockin of Stat1 which is constitutively 
unphosphorylated at this critical tyrosine residue was generated. The resulting mutant 
displayed a reduced and delayed response to type I and type II interferons. Furthermore, mice 
expressing tyrosine-phosphorylation-dead STAT1 were more susceptible to infection with 
Legionella pneumophila but not to Listeria monocytogenes compared with the complete 
functional knockout of STAT1 (Majoros et al., 2016). 
As a component of the ISGF-3 complex, STAT2 is needed to transduce type I interferon 




immunological phenotype in being more susceptible to a broad range of viral pathogens (Park 
et al., 2000). 
The physiological role of STAT3 cannot be evaluated using a complete functional 
knockout in mice, since this factor contributes to embryonal development, and STAT3-
deficiency is lethal between embryonic day 6.5 and 7.5 (Takeda et al., 1997b). Using a 
conditional knockout in Mx-Cre mice, 90 % knockdown efficiency in the liver and 70 % 
knockdown efficiency in the bone marrow were achieved. These mice showed a markedly 
reduced production of liver acute phase proteins in response to lipopolysaccharide (LPS) 
while overall cytokine signalling – pro- as well as anti-inflammatory – was prolonged (Alonzi 
et al., 2001). A cardiomyocyte-specific deletion of Stat3 resulted in an increased susceptibility 
to cardiac damage, higher rates of apoptosis in response to inflammation, and the 
development of cardiac fibrosis and dysfunction in old age (Jacoby et al., 2003; Hilfiker-
Kleiner et al., 2004). 
STAT4 is the main transducer of interleukin-12 (IL-12) signalling – a strong inducer of 
differentiation towards the Th1 lineage in CD4
+
 T cells. While developing normally and being 
fertile, STAT4 knockout mice display increased numbers of Th2 cells accompanied by a 
blockade of the development of Th1 cells (Kaplan et al., 1996b; Takeda and Akira, 2000; 
Wurster et al., 2000). 
Genetic knockout of Stat5a has led to the identification of its role as a signal transducer in 
mammopoiesis and lactogenesis. While being indistinguishable from wildtype littermates, 
homozygous STAT5a-deficient mice did not lactate, indicating that, in the process of 
mammary gland development, STAT5a has a non-redundant role that STAT5b cannot 
compensate for despite its high sequence homology (Liu et al., 1997). Functional knockout of 
STAT5b led to a resistance to growth hormone (GH) pulses resulting in dwarfism, elevated 
plasma GH, low plasma insulin-like growth factor 1 (IGF1), and obesity (Udy et al., 1997). A 
redundant role for STAT5a and STAT5b in T cells was identified using a double mutant. 
Peripheral T cells failed to proliferate in response to IL-2 signalling (Moriggl et al., 1999). 
Using STAT5a-STAT5b double knockin N-domain mutant mice in which STAT5 proteins 
form dimers but not tetrameric complexes, Lin and coworkers identified a set of cytokine-
regulated genes whose expression required STAT5 tetramers (Lin et al., 2012). Moreover, the 
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resulting in impaired cytokine-mediated proliferation. These findings demonstrated that 
tetramerization of STAT5 is critical for cytokine responses and normal immune function. 
STAT6 is activated by IL-4 and IL-13 signalling, stimuli that induce the differentiation of 
Th2 cells. A mouse model of a complete functional knockout of STAT6 resulted in severely 
impaired humoral immune responses caused by altered T-helper cell differentiation (Kaplan et 
al., 1996a; Shimoda et al., 1996; Takeda et al., 1997a). 
IL-10 deficiency in mice is associated with increased expression of IFNγ, C-X-C motif 
chemokine ligand 9 (CXCL9) and CXCL10 upon central nervous system (CNS) infection 
with murine cytomegalovirus. Surprisingly, infiltration of the brain by natural killer (NK) 
cells and CD8
+
 T cells was decreased. Expression of L-selectin/CD62L was elevated on CD8
+
 
T cells obtained from murine cytomegalovirus-infected animals, and migration along a 
CXCL10 gradient was impaired (Cheeran et al., 2009).  
Knockout of the PIAS1 gene was described as a transgenic model for impaired JAK/STAT 
inhibition (Liu et al., 2004). Mice deficient in PIAS1 expression displayed a set of STAT1-
regulated genes that were constitutively upregulated (guanylate binding protein 1 [Gbp1], 
Cxcl9, Cxcl10), while others remained unaffected (Irf1, nitric oxide synthase 2 [Nos2], 
Socs1). Genetic knockout of Pias1 was partly embryonically lethal, and homozygous pups 
were smaller than wildtype littermates, while being protected from bacterial infection and 
showing a stronger antiviral response. 
The phenotypes of the above-mentioned transgenic mouse models with impaired 
JAK/STAT signalling underscore that this signalling pathway plays a major role in innate and 
adaptive immunity. In summary, type I interferon signalling is known to activate the ISGF-3 
complex which induces the transcription of several genes involved in antiviral immunity. 
Studies using mutants with defective type I interferon signalling have shown that the 
formation of ISGF-3 is required for protection against a variety of viral pathogens (Horvath, 
2000; Levy and Darnell, 2002; Jouanguy et al., 2007). The type II interferon IFNγ was 
identified to be involved in a variety of immunity- and inflammation-related processes 
including macrophage and T cell activation. The list of IFNγ-target genes includes genes 
coding for antiviral and microbicidal molecules, such as major histocompatibility complex 
(MHC) molecules, cytokines, chemokines, and phagocytic receptors (Stark, 2007; Hu and 
Ivashkiv, 2009). In innate immunity, IFNγ not only directly activates macrophages but low-




STAT1-dependent response to type II interferon and to inflammatory signals acting through 
toll-like receptor 4 (TLR4) (Hu et al., 2002). 
Signal transduction via STAT3 often acts as a counterbalance to STAT1 signalling. The 
activation of STAT3 signalling is induced by a variety of factors, among others IL-6, IL-10, 
epidermal growth factor EGF, and leukemia-inhibitory factor LIF (Wegenka et al., 1993; 
Riley et al., 1999; Abroun et al., 2015). STAT3 has been attributed a role in several 
immunological processes, such as autoimmune disease, cancer, and anti-fungal immunity. 
Dominant negative STAT3 mutations lead to a disease termed hyper-IgE syndrome, which is 
accompanied by chronic mucocutaneous candidiasis (Nefedova et al., 2004; Frisullo et al., 
2006; Harada et al., 2007; Cypowyj et al., 2012). 
Within the context of adaptive immunity, STAT1- and STAT3-dependent signal pathways 
are both important in the lineage decision of CD4
+
 T helper (Th) cells. IFNγ, IL-12, STAT1 
and STAT4 form a positive feed-forward loop to induce the master transcription factor of the 
Th1 cell fate, T-box transcription factor 21 (TBX21/T-bet) (Afkarian et al., 2002). 
Differentiation towards the Th17 lineage is induced by a combination of IL-6 and 
transforming growth factor β (TGFβ) signalling which leads to the induction of the master 
regulator of the Th17 program, RAR-related orphan receptor γ t (RORγt) in a STAT3-
dependent manner (Bettelli et al., 2006; Ivanov et al., 2006; Korn et al., 2007; Yang et al., 
2007). In contrast, regulatory T cells counteract the pro-inflammatory responses executed by 
Th1, Th2 and Th17 cells. This CD4
+
 T cell lineage is induced by a combination of TGFβ, IL-
2 and IL-10 (Chen et al., 2003a; Zheng et al., 2004; Fontenot et al., 2005). IFNγ- or STAT1-
deficient CD4
+
 T cells are more prone to develop towards the regulatory T cell fate (Caretto et 
al., 2010). 
Although STAT1- and STAT3-dependent signal pathways induce different and often 
opposing reactions, stimulation of cells with IFNγ can induce STAT3 phosphorylation, and, 
vice versa, IL-6 - among other activators of STAT3 signalling - also induces STAT1 
activation. This effect is especially pronounced in the absence of either of the two STAT 
proteins (Stark, 2007). Some activators of STAT signalling display a cell type-specific 
differential regulation of STAT gene induction, e.g. IFNβ is a strong inducer of STAT1 
phosphorylation in monocytes and CD8
+
 T cells but a poor inducer in CD4
+
 T cells and 
B cells. In all four cell types, IFNβ also induces a pronounced STAT3 and STAT5 activation, 
suggesting that canonical STAT signalling cascades are not applicable to all cell types (van 




recently shown for other cytokines, including IL-21 and IL-27 (Peters et al., 2015; Wan et al., 
2015). 
 
1.2 JAK/STAT signalling, the actin cytoskeleton and the ERM-proteins 
Numerous studies have reported that interferons are engaged in the regulation of cell shape 
via the actin cytoskeleton. In intestinal epithelial cells, IFNγ reduces the expression of the 
zona occludens protein ZO-1 and induces rearrangements of the apical actin cytoskeleton 
which results in increased paracellular permeability of the monolayer (Youakim and Ahdieh, 
1999). During embryonic development, transient IFNγ production accompanied 
reorganization and re-gain of polarity of trophectoderm cells which had been treated with a 
protein kinase C agonist  (Marcelo and Lefèvre, 2002). Rearrangements of the cytoskeleton 
have been of interest within the context of activation of different subsets of leukocytes. IL-2, 
as well as, type I interferons were shown to increase mobility of MHC-I and Ly49A at the cell 
membrane of NK cells (Bagawath-Singh et al., 2016). 
Recruitment to the site of inflammation strongly depends on well-orchestrated cytoskeletal 
rearrangements. In experiments using a Boyden chamber, it has been demonstrated that 
complement C3 isoform a (C3a) in combination with IFNα and IFNγ was more potent in 
inducing F-actin-mediated migration than C3a alone (Gutzmer et al., 2004). Activation of T 
cells by antigen-presenting cells (APCs) involves rearrangements of the actin cytoskeleton 
(Valitutti et al., 1995). Migration in response to a chemotactic stimulus is strongly dependent 
on the correct distribution of signalling molecules and specific proteins to the correct location 
of the polarized cell (Niggli, 2014). T cells derived from mice deficient for the actin-bundling 
protein leukocyte plastin did not form proper immunological synapses with antigen-
presenting cells resulting in reduced activation, proliferation and cytokine production and less 
severe symptoms in experimental autoimmune encephalomyelitis (EAE). This shows that 
proper lamellipodia formation is necessary for T cell activation (Wang et al., 2010). 
Not only activation and recruitment of leukocytes are impaired in this context but also the 
process of migration within the tissue strongly depends on the formation of cellular 
protrusions that interact with matrix proteins. IFNβ and IFNγ but not IFNα are known to alter 
actin and paxillin cytoskeletal arrangement, thereby, inhibiting the contact of cell protrusions 
to fibronectin in U937 cells which hinders migration (Surin et al., 2000). Immature B cells 




IFNγ/PI3K/PKCα-dependent mechanism which induced actin-cytoskeleton rearrangements 
that impaired migration (Flaishon et al., 2001). The cytokines C-C motif chemokine ligand 2 
(CCL2), CXCL9, CCL5, IL-8 and CXCL10 induce microglial migration towards sites of 
brain inflammation. This migratory process is accompanied by reorganization of F-actin 
(Cross and Woodroofe, 1999). 
In the context of infection with intracellular bacteria, the actin cytoskeleton is often 
exploited by the pathogen to facilitate bacterial movement. In fighting infection of the 
intracellular bacterium L. monocytogenes, IL-6 was shown to impair the recruitment of actin 
by the bacterium, while IL-6 and IFNγ both increased the expression of inducible nitric oxide 
synthase (iNOS) which helps in the defence against intracellular bacteria via production of 
reactive nitrogen species (Ouadrhiri et al., 1999). The enzyme iNOS was found to be 
sequestered near the cell membrane to the actin cortex in macrophages where it acts as a first 
line of defence against intracellular bacteria (Webb et al., 2001). 
One mechanism of signalling mediated by the actin cytoskeleton is through the ERM 
proteins ezrin, radixin and moesin. This class of proteins forms the link between several 
transmembrane factors and the actin cytoskeleton and is an evolutionary conserved class of 
cytoskeletal proteins. They are associated with the cytoskeleton and form the link between 
actin filaments and the intracellular domain of cell surface membrane-spanning proteins. They 
are involved in a diverse set of cellular processes such being the assembly of the mitotic 
spindle and stability of filopodia, lamellipodia, microvilli and adhesion sites. Besides 
facilitating structural integrity of the cell, they perform scaffolding functions which aid signal 
transduction in response to extracellular stimuli (Takeuchi et al., 1994; Lamb et al., 1997; 
Furutani et al., 2007; Fehon et al., 2010; Vilmos et al., 2016). 
Structurally, ERM proteins contain a highly conserved FERM domain at the N-terminus, 
an α-helical domain at the centre which is predicted to form coiled coils and an actin-binding 
domain at the carboxy-terminus. The FERM domain consists of three subunits - a ubiquitin-
like fold, a four-helix bundle and a phosphotyrosine-binding-like domain – which assemble in 
a cloverleaf-like structure and facilitate binding to membrane-associated proteins. The C-
terminal and α-helical domain can fold over the FERM domain in order to cover the 
interaction sites (Hamada et al., 2000; Bretscher et al., 2002; Pore and Gupta, 2015). 
ERM proteins have been attributed several roles in immune mediation such as B and T cell 




as intracellular signal transmission (Pore and Gupta, 2015). Ezrin, moesin and radixin bind to 
filamentous but not to globular actin. In most leukocyte subsets, only ezrin and moesin were 
identified while radixin was not detected (Pestonjamasp et al., 1995; Ivetic and Ridley, 2004). 
In T cell activation, the ERM proteins are known to have a role in sequestering membrane 
proteins that are not directly associated with T cell receptor (TCR) signalling to the distal pole 
complex (Chauhan and Moore, 2011). During the process of leukocyte extravasation, an 
accumulation of intercellular adhesion molecule 1 (ICAM1), vascular cell adhesion molecule 
1 (VCAM1), ezrin and moesin regulated by Rho/p160 ROCK signalling was needed at the 
apical pole of the endothelial cells to allow for leukocyte adhesion and transmigration 
(Barreiro et al., 2002). During the process of diapedesis, Thr567-phosphorylated ezrin is 
involved in uropod formation and the sequestration of CD44 to the polar cap at the rear end of 
transmigrating lymphocytes (Lee et al., 2004). T cells derived from patients with systemic 
lupus erythematosus exhibit higher adhesion and migration capacity, while overexpressing 
CD44 and Thr567-phosphorylated ezrin. Transfection of healthy donor T cells with a 
constitutively active form of ezrin resulted in increased adhesion and migration (Li et al., 
2007). However, recent experiments using CD4
+
 T cells that lacked ezrin and moesin showed 
that ERM proteins were mostly dispensable for migration and diapedesis but severely 
impaired the interaction with β1-integrin and homing to the lymph nodes (Chen et al., 2013).  
In the context of innate immunity, moesin was shown to co-precipitate with toll-like 
receptor 4, lymphocyte antigen 96 (LY96) and CD14 in macrophages. Blockade of moesin 
using a neutralizing antibody resulted in reduction of TLR4 signal transduction via myeloid 
differentiation primary response protein 88 (MyD88), interleukin-1 receptor-associated kinase 
1 (IRAK1) and TNF receptor-associated factor 6 (TRAF6) (Zawawi et al., 2010). Treatment 
of peripheral blood monocyte-derived macrophages with IFNγ was associated with increased 
expression of P-glycoprotein and induced a polar redistribution of P-glycoprotein co-localized 
with ezrin and actin on cell pseudopodia. These results were shown exclusively for 
macrophages and could not be confirmed for monocytes and lymphocytes (Puddu et al., 
1999). 
Although expression of the ERM genes is tissue specific, some redundancy has been 
shown in their function. Mice with a global genetic knockout of moesin developed normally, 
were fertile and did not show impairments in processes relying on ERM signalling such as 
platelet aggregation or the formation of stress fibres (Doi et al., 1999). However, moesin 




recruitment in a peritonitis model (Matsumoto and Hirata, 2016). Mutations in the moesin 
gene in humans have been linked to primary immunodeficiency (Lagresle-Peyrou et al., 
2016). Genetic knockout of radixin in mice led to the birth of healthy appearing pups. 
However, in these mice, the secretion of bilirubin was hindered leading to high serum 
concentrations of conjugated bilirubin and liver injury (Kikuchi et al., 2002). Ezrin deficiency 
in mice results in severe defects in the development of the gastrointestinal system. Usually, 
these mice die within the first two weeks post-natal (Tamura et al., 2005). Knockdown of 
ezrin in trophoblast giant cells identified a non-redundant role of ezrin in an immunological 
context and was shown to be required for sequestering heat-shock protein 70 (HSP70) and 
facilitating phagocytosis of bacterial pathogens (Watanabe et al., 2009). 
Overexpression and increased activity of ezrin have been implicated in the context of 
cancer. Increased ezrin protein expression in solid tumours has been associated with poor 
prognosis and increased formation of metastasis (Elzagheid et al., 2008; Leiphrakpam et al., 
2014; Cetin et al., 2015). Using hepatocellular carcinoma cell lines, it was shown that its 
overexpression was associated with an increased ability to migrate, suggesting a role in the 
formation of metastases (Zhang et al., 2006). In Epstein-Barr virus-associated nasopharyngeal 
carcinoma, ezrin overexpression was linked to increased motility and invasiveness (Endo et 
al., 2009). In non-small cell lung cancer cells, interactions of phosphorylated ezrin with the 
EGF receptor were shown to boost transcription of oncogenic target genes of EGF signalling 
(Saygideğer-Kont et al., 2016). 
ERM phosphorylation is regulated by small GTPases. Deletion of the small GTPase Ras-
associated protein 1 (Rap1) in T cells resulted in reduced homing to lymph nodes and 
increased invasion of the intestinal mucosa by an ERM phosphorylation-dependent 
mechanism (Ishihara et al., 2015). Interactions of the Ras homolog (Rho) family GTPases and 
the ERM proteins have been implicated in the regulation of several factors involved in 
migration and cell adhesion such as CD44 and solute carrier family 9 member A1 (SLC9A1) 
(Okamoto et al., 1999; Denker and Barber, 2002). Besides Ras-related C3 botulinum toxin 
substrate 1 (Rac1), also RhoA was shown to be involved in endothelia interaction with 
extracellular matrix proteins in an ERM-dependent manner (Menager et al., 1999). Transient 
signalling via the TCR results in reduced ERM phosphorylation in a Rac-dependent manner 
which affects polarity and motility of T cells. This mechanism stalls T cells in their current 
position and might allow for the establishment of a proper immunological synapse (Cernuda-




1.3 Objectives of this project 
STAT1 displays a variety of ways of facilitating signalling: the tyrosine-phosphorylated 
molecule binds to STAT2 and IRF9 to mediate IFNα signalling, while in IFNγ signalling 
homodimers of STAT1 are formed. The un-phosphorylated homodimer has recently been 
shown to be transcriptionally active and, in addition, STAT1 exerts also non-transcriptional 
effects. The STAT1-F77A knockin mouse is a useful tool to distinguish signalling mediated 
by the homo-tetramer from other types of signalling. Up to now, this mouse model has been 
studied mainly within the context of infectious disease. In this project, the focus is shifted 
from the context of infectious disease where the immune system is activated in order to fight a 
pathogen towards non-infectious inflammatory diseases. The mouse models of myocardial 
infarction and EAE are well-established procedures that will be focused on in this 
investigation. The aim of this study is to increase our understanding of the role of STAT1 in 
these immunological processes. 
This project will assess the role of the N-terminal domain in the transition between the two 
STAT1 conformational states. Thereafter, the contribution of interferon-activated STAT1 
signalling on the expression of the ERM proteins will be studied. In order to evaluate the 
recruitment of immune cells to sites of myocardial inflammation in vivo, experimental ligation 
of the left anterior descending artery will be performed in STAT1-F77A knockin mice and the 
effect will be compared to their wildtype littermates. In addition, the role of STAT1 
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2 Materials and methods 
 
2.1 Materials 
2.1.1 Chemicals and reagents 
Table 1: List of chemicals and reagents 
Name Company 
Agarose Carl Roth, Karlsruhe, Germany 
Ampicillin Sigma-Aldrich, Taufkirchen, Germany 
APS (ammonium persulphate) Carl Roth 
Bromophenol blue Fisher Bioreagents, Pittsburgh, USA 
BSA (bovine serum albumin) Fraction V Carl Roth 
Complete Mini proteinase inhibitor cocktail Roche, Rotkreuz, Switzerland 
Concanavalin A Sigma-Aldrich  
DAB (3,3’-diaminobenzidine) Sigma-Aldrich 




Hartmann Analytic, Braunschweig, Germany 
DMSO (dimethyl sulphoxide) Applichem, Darmstadt, Germany 
dNTP (deoxynucleotide triphosphates) Carl Roth  
DTT (dithiothreitol) Applichem 
EDTA (ethylenediaminetetraacetic acid) Sigma-Aldrich  
EGTA (ethylene glycol-bis(β-amimoethyl 
ether)-N,N,N’,N’-tetraacetic acid) 
Carl Roth 
Entellan Merck Millipore, Darmstadt, Germany 
Eosin Y Merck Millipore 
Ethanol, 99.8 % Carl Roth 
Ethidium bromide solution 0.625 g/ml VWR Life Science, Erlangen, Germany 
FBS (fetal bovine serum) Superior Biochrom, Berlin, Germany 
Ficoll Amersham Bioscience, Freiburg, Germany 
Fluoromount G Southern Biotech, Birmingham, USA 
Formaldehyde solution, 37 % Carl Roth 
Glycerol, ROTIPURAN® ≥99,5 %, p. a. Carl Roth 
Glycine Carl Roth 
H2O2 (hydrogen peroxide) solution (30 %) Carl Roth 
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H2SO4 (sulphuric acid) Carl Roth 
[
3
H]-Thymidine (tritiated thymidine) (37 
MBq/ml) 
MP Biomedicals, Eschwege, Germany 
HEPES (4-(2-hydroxyethyl)-1-
piperazineethanesulphonic acid), Pufferan 
≥99,5 %, p. a. 
Carl Roth  
HEPES, cell culture grade Carl Roth  
Hoechst 33258 Sigma-Aldrich 
Igepal CA-630 Sigma-Aldrich  
Isopropanol Carl Roth  
Kanamycin Sigma-Aldrich  
KCl (potassium chloride) Merck Millipore 
L-glutamine Thermo Fisher 
LiCl (lithium chloride) Carl Roth 
LPS Sigma-Aldrich  
Lymphocyte separation medium PAA, Pasching, Austria 
Mayer’s haemalum Merck Millipore 
MegaTran 1.0 Origene, Rockville, USA 
Mercaptoethanol Sigma-Aldrich  
Methanol Merck Millipore 
MgCl2 (magnesium chloride) Sigma-Aldrich 
Na3C6H5O7 (trisodium citrate) Carl Roth  
NaCl (sodium chloride) Carl Roth  
NaCl, 0.9 % B. Braun, Melsungen, Germany 
NaHCO3 (sodium bicarbonate) Carl Roth 
NaN3 (sodium azide) Thermo Fisher 
Na-Pyruvate (sodium pyruvate) Thermo Fisher 
Na3VO4 (sodium orthovanadate) Acros Organics, Geel, Belgium 
NEAA (non-essential amino acids) Thermo Fisher 
PBS (phosphate buffered saline) Life Technologies, Carlsbad, USA 
Pefabloc Roche 
Penicillin/streptomycin Biochrom 
Pertussis toxin List Biological Laboratories, Campbell, USA 
Phenol/chloroform/isoamylalcohol (25:24:1) Carl Roth  






Protein A Agarose/Salmon Sperm DNA Merck, Darmstadt, Germany 
Puromycin Sigma-Aldrich  
RIPA (radioimmunoprecipitation assay) 
buffer, 10 x 
Merck 
Rotiphorese Gel 30 (Acrylamid/Bisacrylamid 
(37.5:1)-solution) 
Carl Roth  
Rotiphorese Gel 40 (Acrylamid/Bisacrylamid 
(29:1)-solution) 
Carl Roth 
Roti-Plast Paraffin Carl Roth  
SDS (sodium dodecyl sulphate) Carl Roth  
SDS PAGE (polyacrylamide gel 
electrophoresis) running buffer, 10x 
Carl Roth  
Sodium acetate Carl Roth  
Sodium deoxycholate Applichem 
TEMED (tetramethylethylenediamine) Carl Roth  
Tris-base  Carl Roth  
Tris-HCl Carl Roth  
Triton X-100 Carl Roth  
Tween-20 Carl Roth  
Xylene Merck Millipore 
 
2.1.2 Culture media 
Table 2: List of media 
Name Company 
DMEM (Dulbecco’s modified Eagle’s 
medium) (Glucose 4.5 g/l, 580 mg/l L-
Glutamin, 110 mg/l Na-pyruvate) 
Biochrom 
DMEM (Glucose 4.5 g/l, without L-
Glutamin, 110 mg/l Na-pyruvate) 
Biochrom 
LB medium (Luria/Miller) Carl Roth 
RPMI (Roswell Park Memorial Institute 
medium) 1640 
Lonza, Basel, Switzerland 




Table 3: List of drugs 
Name Company 
Cepetor (medetomidine, 1 mg/ml) Cp-pharma, Burgdorf, Germany 
CFA (complete Freund’s adjuvant) Difco Laboratories, Detroit, USA 
Fentanyl (0.05 mg/ml) Rotexmedica, Trittau, Germany 
Flumazenil (0.5 mg/ml) Inresa Arzneimittel, Freiburg im Breisgau, 
Germany 
Isoflurane Abbvie, Chicago, USA 
Ketamine Medistar, Ascheberg, Germany 
Midazolam (5 mg/ml) Rotexmedica 
Novalminsulfon (metamizol, 500 mg/ml) Zentiva Pharma, Berlin, Germany 
Revertor (atipamezole hydrochloride (5 
mg/ml) 
Cp-pharma 
Temgesic (buprenorphine hydrochloride 
0.324 mg/ml) 
Reckitt Benckiser, Slough, UK 
Xylariem (xylazine hydrochloride) Ecuphar, Greifswald, Germany 
 
2.1.4 Kits 
Table 4: List of kits 
Name Company 
ABsolute Blue QPCR SYBR Green Mix Thermo Fisher, Waltham, USA 
Bio-Rad Protein Assay Kit II Bio-Rad, Hercules, USA 
Mouse IFNγ Enzyme-linked immunosorbent 
assay (ELISA) MAX Deluxe 
Biolegend, San Diego, USA 
Mouse IL-17 ELISA MAX Deluxe Biolegend 
PE anti-mouse/rat/human FOXP3 Flow kit Biolegend 
PeqGold total RNA Kit VWR Life Science 
Qiagen Plasmid Maxi Kit Qiagen, Hilden, Germany 









Table 5: List of equipment 
Name Company 
Bandelin Sonopuls Bandelin electronic, Berlin, Germany 
BioBeam 8000, gamma irradiation device STS, Braunschweig, Germany 
Biological safety cabinet class II, Herasafe 
KS 9 
Thermo Fisher Scientific, Langenselbold, 
Germany 
BioPhotometer plus Eppendorf, Hamburg, Germany 
Cell harvester Filter Mate Perkin Elmer, Waltham, USA 
Centrifuge 5804 R Eppendorf 
Embedding machine EG1160 Leica, Wetzlar, Germany 
Filter mate cell harvester Perkin Elmer 
FLA-5100 scanner Fuji, Düsseldorf, Germany 
Flow cytometer FACSCalibur BD, Heidelberg, Germany 
Freezing container  Nalgene, Rochester, USA 
Incubator B 5061 EC-CO2 Heraeus, Hanau, Germany 
Speedmill tissue homogenizer Analytic Jena, Jena, Germany 
Luminescence counter MicroBeta TriLux Perkin Elmer, Waltham, USA 
Microcentrifuge 5415 R Eppendorf 
Microscope, fluorescent, Axiovert 200M Zeiss Oberkochen, Germany 
Microscope, inverted, Axiovert 40 CFL Zeiss 
Microscope, BX51 Olympus, Tokyo, Japan 
Microtome SM 2000 R Leica 
Mini Vent type 845 FMI GmbH, Seeheim-Jungenheim, Germany 
Multifuge 1S-R Heraeus 
Neubauer-modified counting chamber Paul Marienfeld, Königshofen, Germany 
Odyssey CLx imaging system LI-COR, Bad Homburg, Germany 
Orbital shaker VWR Life Science 
Pipettes, Type Research (P1000, P200, P100, 
P10, P2.5)  
Eppendorf 
Power supply unit Biometra, Göttingen, Germany 
Real-time cycler Mastercycler epgradient S Eppendorf 
Rocker Duomax 1030 Heidolph, Schwabach, Germany 
Semi-dry blotting cell Peqlab Biotechnologie, Erlangen, Germany 
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SDS PAGE gel running system Biometra 
Steel Mesh, pore size 40 µm  UMG factory, Göttingen, Germany 
Sonicator UW 2070 Bandelin electronic 
Sunrise ELISA Reader Tecan, Männedorf, Switzerland 
Surgical forceps Fine Science Tools, Heidelberg, Germany 
Surgical scissors Fine Science Tools 
Thermo shaker TS1 Biometra 
Tissue Dehydration System TP1028 Leica 
Tuberculin metal/glass syringe Hartenstein, Würzburg, Germany 
UVsolo TS imaging system Analytic Jena 
Vevo® 2100 System Visualsonics, Toronto, Canada 
Waterbath GFL Schuett biotec GmBH, Göttingen, Germany 
 
2.1.6 Disposables 
Table 6: List of disposable materials 
Name Company 
Cell culture flasks, T75 Sarstedt, Nümbrecht, Germany 
Cell culture plates, 6-well, 24-well, 96-well Sarstedt 
Cell Scraper 25 cm Sarstedt 
Cryovials Nunc, Roskilde, Denmark 
Ethilon 9-0 BV-4 5.0 mm 3/8c EH7448G 
surgical silk 
Ethicon, Norderstedt, Germany 
FACS tubes BD 
Falcon tubes, 15 ml, 50 ml Sarstedt 
Filter mat A Perkin Elmer, Waltham, USA 
Glass capillary intraEND 100 µl Brand, Wertheim, Germany 
Glass cover slip Thermo Fisher 
Glass microscope slide Thermo Fisher 
Illustra-MicroSpin-G-25 column GE Healthcare, Little Chalfont, UK 
Injection needles B. Braun, Melsungen, Germany 
InnuSpeed lysis tubes A Analytic Jena 
Insulin Syringe, 29 G B. Braun, Melsungen, Germany 
MaxiSorp ELISA plates, 96-well, flat bottom Nunc 
MeltiLex A scintillator sheets Perkin Elmer 
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Microreaction tube, 0.2 ml, 1.5 ml, 2 ml Eppendorf 
Petri Dishes, 10 cm Corning, New York, USA 
Pipette Tips (P1000, P100, P10) Sarstedt 
Prolene 6-0 C-1 13 mm 3/8c 8889H surgical 
silk 
Ethicon, Norderstedt, Germany 
PVDF (polyvinylidene fluoride) membrane 
Immobilon-P 
Merck Millipore 
Round bottom tubes, 14 ml BD 
Serological pipettes, 5 ml, 10 ml Sarstedt, Nümbrecht, Germany 
Syringe, 20 ml, 10 ml BD, Heidelberg, Germany 
 
2.1.7 Water 
Most solutions referred to in this study were produced using double-distilled H2O. This 
quality was reached using the PURELAB Plus purification system (Elga Labwater, Celle, 
Germany). Water with a resistivity of 18.2 MΩ*cm was produced.  
If DNase-, RNase- and proteinase-free water was specifically recommended for the 
application, Molecular Biology Grade Water (5 Prime, Hilden, Germany) was used. 
 
2.1.8 Sterilization of material 
Laboratory equipment and solutions used in cell culture or other highly sensitive settings were 
sterilized using the 5075 ELV autoclave (Tuttnauer Europe B.V., Breda, the Netherlands). 
If heat sterilization was not recommended for a solution, filter-sterilization was performed 
using a Minisart NY 25 syringe filter (Sartorius, Göttingen, Germany). 
 
2.1.9 Oligonucleotides and primers 
All oligonucleotide primers were purchased from Sigma-Aldrich. The online platforms 
primer3plus and NCBI blast were used to design primers. For the genotyping of the STAT1 
knockout mouse line, sequences were taken from (Meraz et al., 1996)). All oligonucleotides 
were reconstituted in DNase-, RNase-, proteinase-free water and stored at -20°C. 
 
2.1.9.1 Hybridised oligonucleotides 
Nucleotides were reconstituted at a concentration of 200 µmol/l. Hybridization was achieved 
through mixing equal parts of complementary oligos, heating to 95°C for 5 min and slow 
cooling to room temperature. 
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Table 7: List of hybridised oligonucleotides 
Name  Sequence 
2xGAS Sense 5’-TTT TCG TTT CCC CGA AAT TGA CGG ATT TCC CCG 
AAA C-3’ 
 Antisense 5’-TTT TGT TTC GGG GAA ATC CGT CAA TTT CGG GGA 
AAC G-3’ 
EZR long Sense 5’-TTT TCA AAC AAA AAA ACT TAA TTC CTA GAA TTT 
CAG AGA AAT CCC ATG GAG CTT TTT-3’ 
 Antisense 5’-TTT AAA AAG CTC CAT GGG ATT TCT CTG AAA TTC 
TAG GAA TTA AGT TTT TTT GTT TG-3’ 
EZR short Sense 5’-TTT TTA ATT CCT AGA ATT TCA GAG AAT C-3’ 
 Antisense 5’TTT TGA TTT CTC TGA AAT TCT AGG AAT TA-3’ 
EZR M1 Sense 5’-TTT TTA ATA GCT ACT ATT TCA GAG AAT C-3’ 
 Antisense 5’-TTT TGA TTT CTC TGA AAT AGT AGC TAT TA-3’ 
EZR M2 Sense 5’-TTT TTA ATT CCT AGA ATT AGA GAC TAA TC-3’ 
 Antisense 5’-TTT TGA TTA GTC TCT AAT TCT AGG AAT TA-3’ 
EZR M3 Sense 5’-TTT TTA ATA GCT ACT ATT AGA GAC TAA TC-3’ 
 Antisense 5’-TTT TGA TTA GTC TCT AAT AGT AGC TAT TA-3’ 
EZR M4 Sense 5’-TTT TTA ATT CCT AGT ATT ACA GAG AAA TC-3’ 
 Antisense 5’-TTT TGA TTT TC TGT AAT ACT AGG AAT TA-3’ 
M67 Sense 5’-TTT TCG ACA TTT CCC GTA AAT CTG-3’ 
 Antisense 5’-TTT TCA GAT TTA CGG GAA ATG TCG-3’ 
Grade of purification: Desalted 
 
2.1.9.2 Oligonucleotide primers 
Primers used for genotyping and chromatin immunoprecipitation (ChIP) were reconstituted to 
a concentration of 100 µmol/l. Primers used in quantitative real-time polymerase-chain 
reaction (qRT-PCR) were reconstituted to the concentration of 50 µmol/l. 
Table 8: List of oligonucleotide primers for genotyping 
Gene  Sequence 
Stat1-F77A Forward 5’-CGC GAA TTG CTA ATA AAA CAA G-3’ 
 Reverse 5’-TGC TGC TGA GTC CAA ATA AAG-3’ 
Stat1 wt Forward 5’-GGC TGA CCT TGG AAC TTG TG-3’ 
 Reverse 5’-AAG AGT CAG CAG GGG TCT GA-3’ 
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neomycin  5’-AGC GCA TCG CCT TCT ATC-3’ 
Grade of purification: Desalted 
 
Table 9: List of oligonucleotide primers for ChIP 
Gene  Sequence 
EZR Forward 5’-GAA GCC AGA CGT TGA GAA CC-3’ 
 Reverse 5’-CCG AAG CTC TGG TTA AGT GG-3’ 
IRF1 Forward 5’-CTT  CGC CGC TAG CTC TAC AAC AG-3’ 
 Reverse 5’-GCT CCG GGT GGC CTCGGT TCG-3’ 
Grade of purification: Desalted 
 
Table 10: List of oligonucleotide primers for quantitative PCR (qPCR) 
Gene  Sequence 
ccl2 Forward 5’-CCA GTC ACC TGC TGT TAT AAC-3’ 
 Reverse 5’-TGG AAT CCT GAA CCC ACT TCT-3’ 
cxcl10 Forward 5’-ATT CTG AGC CTA CAG CAG AG-3’ 
 Reverse 5’-GCT TGC AGG AAT AAT TTC AA-3’ 
ezr Forward 5’-CAG AGA GAG AGC TCT CGG AG-3’ 
 Reverse 5’-TGG CAG TGT ATT CTG CAA GC-3’ 
gapdh Forward 5’-GAA GGT GAA GGT CGG AGT C-3’ 
 Reverse 5’-GAA GAT GGT GAT GGG ATT TC-3’ 
ifit1 Forward 5’-CAG AAG CCC AGA CTT ACC TG-3’ 
 Reverse 5’ATA GGC AGA GAT CGC ATA CC-3’ 
irf1 Forward 5’-AGC TA GCT GTG CGA GTG TA-3’ 
 Reverse 5’-TAG CTG CTG TGG TCA TCA GG-3’ 
stat1 Forward 5’-CCG TTT TCA TGA CCT CCT GT-3’ 
 Reverse 5’-TGA ATA TTC CCC GAC TGA GC-3’ 
Grade of purification: HPLC 
 
2.1.10 Enzymes and recombinant proteins 
Table 11: List of enzymes 
Name Company 
ExtrAvidin (streptavidin-peroxidase) Sigma-Aldrich 
InnuTaq DNA polymerase Analytic Jena 
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InnuTaq HOT-A DNA polymerase Analytic Jena 
Klenow fragment New England Biolabs, Ipswich, USA 
Proteinase K Carl Roth 
Taq polymerase Ares Bioscience GmbH, Cologne, Germany 
Trypsin PAA, Pasching, Austria 
Tsp509I Thermo Fisher 
 
Table 12: List of recombinant proteins 
Name Company 
IFN-α, human, recombinant from E. coli Biomol, Hamburg, Germany 
IFN-α, murine, recombinant from E. coli Abcam, Cambridge, Germany 
IFN-γ, human, recombinant from E. coli Biomol 
IFN-γ, murine, recombinant from E. coli Biomol 
Myelin oligodendrocyte glycoprotein peptide 
amino acids 35-55 (MOG35-55) 
Institute for Medical Immunology Charité 
Berlin, Berlin, Germany 
 
2.1.11 Antibodies 
Table 13: List of primary antibodies 
Name Company Cat-No. 
Acetyl-histone H3 Merck-Millipore, Darmstadt, Germany 17-10112 
CCR2 AF700, clone 475301 R&D Systems, Wiesbaden, Germany FAB 5538N 
CD3 Bio-Rad, Hercules, USA MCA 1477 
CD4 PE, clone GK1.5 BD Pharmingen, Erembodegem, 
Belgium 
557308 
CD4 PE/Cy5, clone H129.19 Biolegend, San Diego, USA 130312 
CD4 PE e610, clone RM4-5 eBioscience, Frankfurt a. M.,Germany 61-0042-80 
CD8α PE/Cy7, clone 53-6.7 Biolegend 100722 
CD11b FITC, clone M1/70 Biolegend 101206 
CD25 FITC, clone 7D4 BD Pharmingen 553070 
CD44 PE, clone IM7 BD Pharmingen 553134 
CD62L FITC, clone MEL-14 Biolegend 104405 
CD68 Bio-Rad MCA 1957T 
Ezrin Cell Signaling Technology, Cambridge, 
UK 
3145 
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Ezrin/radixin/moesin Cell Signaling Technology 3142 
Glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH), 
clone 14C10 rabbit mAB 
Cell Signaling Technology 2118 
Ly-6C APC/Cy7,  clone 
HK1.4 
Biolegend, San Diego, USA 128025 
Ly-6G PE, clone RB6-8C5 BD Pharmingen 553128 
Myeloperoxidase Thermo Fisher PA5-16672 
NK-1.1 APC/Cy7, clone 
PK136 
Biolegend 108723 




Cell Signaling Technology 3141 
p-STAT1, clone 58D6 Cell Signaling Technology 9167 
p-STAT3 Cell Signaling Technology 9131 
STAT1, (C-24) Santa Cruz, Dallas, USA sc-345 
STAT1α p91, (M-23) Santa Cruz sc-591 
STAT3, (H-190) Santa Cruz sc-7179 
TCRβ FITC, clone H57-597 BD Pharmingen 553171 
 
Table 14: List of secondary antibodies 
Name Company Cat-No. 
Biotinylated anti-rabbit IgG (H+L) 
derived from goat 
Vector Laboratories Inc, 
Burlingame, USA 
BA-1000 
Biotinylated anti-rat IgG (H+L) derived 
from rabbit 
Vector Laboratories Inc, 
Burlingame, USA 
BA-4001 
Goat anti-rat secondary antibody, Alexa-
Fluor 647 conjugated 
Thermo Fisher A-21247 
Donkey anti-rabbit secondary antibody, 
IRDye 800CW conjugated 
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2.1.12 Plasmids and constructs 
Table 15: List of plasmids and constructs 
Name Description Reference 
pSTAT1 Full-length human STAT1 cloned into the 
pcDNA3.1 mammalian expression vector 
(Thermo Fisher) 
(Begitt et al., 2000) 
pSTAT1-DE92/96RR pSTAT1 double missense mutation with 
exchange of aspartate 92 and glutamate 96 to 
arginine 
(Staab et al., 2015) 
pSTAT1-F77A pSTAT1 point mutation with exchange of 
phenylalanine 77 to alanine 
(Meyer et al., 
2004) 
pSTAT1-GFP Recombinant human STAT1α (aa 1-746) 
protein fused to green fluorescent protein 
(GFP) at the carboxy-terminus cloned into the 
pEGFP-N1 vector (Clontech Laboratories Inc, 
Mountain View, USA) 
(Begitt et al., 2000) 
pSTAT1-GFP-F77A pSTAT1-GFP encoding the F77A point 
mutation as a STAT1 GFP fusion protein 
(Meyer et al., 
2004) 
 
2.1.13 Cell lines 
Table 16: List of cell lines 
Name Characteristics Origin 
HeLa Human adherent epitheloid cervix carcinoma 
cell line; positive for HPV16 
(Scherer et al., 1953) 
Kind gift from Professor Uwe 
Vinkemeier, Nottingham 
HL-60 Human suspension cell line derived from 
peripheral blood promyeloblast leukemia 
(Collins et al., 1977)  
Kind gift from Professor 
Matthias Dobbelstein, Göttingen 
Jurkat Human suspension cell line derived from 
T lymphocyte leukemia 
 
(Gillis and Watson, 1980) 
Kind gift from Professor 
Matthias Dobbelstein, Göttingen 
U3A Human adherent epitheloid fibrosarcoma line; 
deficient in STAT1 expression 
 
(McKendry et al., 1991)  
Kind gift from Professor Uwe 
Vinkemeier, Nottingham 
 




Some of the experiments in this project were performed in mice as a model organism. Mice 
were kept in individually ventilated cages in the animal facilities of the University Medical 
Centre, Göttingen. All experiments performed were in line with the current law and approved 
by the Lower Saxony State Office for Consumer Protection and Food Safety 
(Niedersächsisches Landesamt für Verbraucherschutz und Lebensmittelsicherheit, LAVES). 
 
Table 17: List of mouse lines 
Name Characteristics Origin 
STAT1-F77A 
knockin 
Mouse line carrying a point mutation 
resulting in a substitution of alanine 
in position 77 for phenylalanine on a 
C57Bl6/N background (Charles 
Rivers, Sulzfeld, Germany) 
(Begitt et al., 2014) 
 
STAT1 knockout Mouse line with deletion of several 
exons of STAT1 resulting in a 
complete functional knockout; 
obtained on an 129/Sv background 
and backcrossed for more than six 
generations onto a C57BL6/N 
(Charles Rivers, Sulzfeld, Germany) 
genetic background 
(Meraz et al., 1996) 
Purchased from Taconic 
Farms, Cologne, Germany 
 
2.1.15 Software 
Table 18: List of software 
Name Description Distributor 






Operating and analysis 
software for cell sorter 
 
BD 
CorelDRAW 12 Vector Graphics editor Corel Corporation, Ottawa, 
Canada 




Fiji Add-on to the ImageJ 
software with focus on 
biological-image analysis 
Public domain; add-on to 
ImageJ (Schindelin et al., 
2012) 
 
IBM SPSS, Version 23 
 
Statistics software IBM, Armonk, USA 
ImageJ Java-based image processing 
program 
Public domain; developed at 
NIH by Wayne Rasband 




Operating and analysis 









Operating software for 
Eppendorf real-time cycler 
 
Eppendorf 
SigmaPlot Statistics software Systat Software GmbH, 
Erkrath, Germany 
 
TINA v 2.0 
 





Vevo® 2100 Software Operating and analysis 










2.2.1 Cell culture 
2.2.1.1 Unfreezing of established tumour cell lines 
To unfreeze established tumour cell lines (namely U3A, HeLa, Jurkat and HL-60), a cryovial 
containing 1.5 x 10
6
 cells was taken from the -80°C freezer and quickly thawed in a water 
bath at 37°C. As soon as most of the cell suspension was liquid, the content of the tube was 
transferred to 10 ml pre-warmed culture medium. This diluted suspension was centrifuged for 
5 min at 65 x g at room temperature. The supernatant was discarded, the pellet was re-
suspended in 10 ml pre-warmed culture medium and transferred to a T75 culture flask to 
allow the cells to attach and grow. The following culture media were used: for U3A cells 
DMEM (with L-glutamine) with 10 % FBS, 1 % penicillin/streptomycin, and 0.008 % 
puromycin and for HeLa, HL-60, and Jurkat cells RPMI 1640, supplemented with 10 % FBS 
and 1 % penicillin/streptomycin. Commercially obtained PBS (Gibco) was used for all cell-
culture applications. 
 
2.2.1.2 Freezing of established tumour cell lines 
To freeze cells from an established tumour cell line, the cells were harvested by digestion of 
cell-cell junctions using trypsin after washing the cells with PBS for adherent cells or direct 
centrifugation of suspension culture cells. The incubation time with trypsin was 2 min for 
U3A cells and 4 min for HeLa cells. The cells were collected and spun down at 65 x g for 
5 min. The supernatant was discarded, the pellet was resuspended in the respective freezing 
medium and aliquots of 1.5 x 10
6
 cells in 1 ml freezing medium were transferred to cryotubes. 
The tubes were transferred to a freezing container to allow gradual cooling to -80°C and 
stored at -80°C. Culture medium supplemented with 20 % FBS and 10 % DMSO was used for 
freezing HeLa, HL60, Jurkat, and U3A cells. 
 
2.2.1.3 Maintenance, passaging and seeding of established tumour cell lines 
The established tumour cell lines were cultured in a humidified atmosphere at 37°C and 5 % 
CO2 (HeLa, HL-60, Jurkat, and U3A cells). The cells were passaged every 2 to 3 days. For 
this, the suspension cells were pelleted by centrifugation at 65 x g for 5 min. The supernatant 
was discarded, and the pellet resuspended in culture medium. An aliquot was inoculated with 
fresh culture media in a new T75 flask (typical passage as 1:8 or 1:10 dilution). Adherent cells 
were washed with PBS and trypsinized. Trypsin activity was stopped by addition of twice the 
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amount of complete culture medium. An aliquot from this suspension was used to start a new 
passage in a T75 flask (typical passage as 1:8 or 1:10 dilution). For the plating, cells were 
counted before being seeded. For protein and RNA analysis, 250,000 cells were seeded in 
each well of a 6-well culture plate. This corresponds to a density of approximately 
1.56 x 10
5




2.2.1.4 Routine check for mycoplasma infection in established tumour cell lines 
To check for infection with mycoplasma, cells were stained with Hoechst dye. Suspension 
cells were spun down at 100 x g and resuspended in methanol for a 15 min fixation. After 
having been spun down again, the cells were resuspended in Hoechst dye diluted 1:5,000 in 
methanol and incubated at 37°C for 15 min. Cells were spun down yet again, washed with 
PBS and resuspended in PBS. For the analysis, 50 µl of the cell suspension were placed on a 
glass microscope slide and covered with a cover slip. Adherent cells were fixed with 4 % 
formaldehyde in PBS for 15 min at room temperature. Cells were washed twice with PBS and 
once with H2O and stained with Hoechst dye diluted 1:5,000 in PBS. Again, cells were 
washed twice with PBS, once with H2O, and mounted using Fluoromount G mounting 
medium. Cells were routinely analysed for Hoechst staining in the cytoplasm to detect 
mycoplasma infection using the Axiovert 200M fluorescent microscope at 340 nm and a 
magnification of 40x. 
 
2.2.1.5 Treatment of cultured cells with different stimuli 
Prior to protein or RNA extraction, cultured cells were treated with different stimuli. To this 
end, the respective stimulus (e.g. IFNγ) was diluted in pre-warmed culture medium at the 
desired concentration for adherent cells or at five times the concentrations used for suspension 
cells. For adherent cells, the culture medium was replaced by the medium containing the 
stimulus. In the case of suspension cells, 25 % of the culture volume was added from the 
cytokine-containing medium. For the RNA extraction, culture medium was replaced with 
culture medium containing only 0.5 % FBS 16 h prior to the beginning of the stimulation, and 
stimulation with cytokines was also performed in low serum-culture medium. If not stated 
differently, treatment concentrations were as follows: human IFNγ; 50 ng/ml, human IFNα; 
50 ng/ml, murine IFNγ; 5 ng/ml, and murine IFNα; 5 ng/ml. Treatment with vanadate was 
carried out using 0.8 mmol/l sodium vanadate and 0.2 mmol/l H2O2. 
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2.2.1.6 Transfection of cultured cells with plasmid DNA 
Cultured eukaryotic cells were transfected with different vectors using MegaTran 1.0 
according to the manufacturer’s recommendation. For the 6-well plate scale, 160 µl of 
150 mM NaCl solution were mixed with 1.6 µg of DNA and 4.8 µl of MegaTran 1.0 per well 
using a vortex and incubated at room temperature for 10 min. For each well, 160 µl of this 
solution was added to eukaryotic cells that had grown to 50-70 % confluence and blended 
with the culture supernatant by gentle agitation. Cells were cultured for a further 24 h before 
stimulation to allow for uptake and expression of the vector. 
 
2.2.2 Protein biochemistry 
2.2.2.1 Fractionated protein extraction 
For protein extraction, cells grown in 6-well-culture plates or a single cell suspension were 
used. For suspension cells, the cells were collected and harvested by centrifugation for 4 min 
at 1,500 x g. They were washed with PBS and spun down again. The pellet was resuspended 
in 50 µl complete cytosolic protein lysis buffer (20 mM HEPES, 10 mM KCl, 1 mM EDTA, 
100 µM Na3VO4, 10 % glycerol, 0.1 % IGEPAL CA-630, pH 7.4, supplemented with 1 % 
Complete proteinase inhibitor cocktail (reconstituted), 3 mM DTT, 0.4 mM Pefabloc) and 
incubated on ice for 5 min. In order to harvest adherent cells, they were washed twice with 
PBS, and 50 µl of complete cytosolic protein lysis buffer were added to the culture dish. The 
cells were incubated with the lysis buffer for 5 min, harvested using a cell scraper and then 
transferred to a 1.5 ml microreaction tube. The cells in complete cytosolic lysis buffer were 
spun down for 15 sec at 4°C and 16,100 x g. The supernatant was transferred to a fresh 
microreaction tube and centrifuged again for 5 min at 4°C and 16,100 x g. The resulting 
cleared supernatant was collected as cytosolic protein extract. The pellet from the initial 
centrifugation step was resuspended in 50 µl complete nucleic protein lysis buffer (20 mM 
HEPES, 420 mM KCl, 1 mM EDTA, 100 µM Na3VO4, 20 % glycerol, pH 7.4, supplemented 
with 1 % Complete proteinase inhibitor cocktail, 3 mM DTT, and 0.4 mM Pefabloc) and 
incubated on ice for 30 min. The lysate was centrifuged for 15 min at 4°C and 16,100 x g. The 
supernatant was collected as nucleic extract. Finally, the cytosolic and nucleic extracts were 
pooled. If the protein extracts were to be used in electrophoretic mobility shift assay (EMSA) 
analysis, they were stored without any further processing at -80°C. If the protein extracts were 
to be used in Western blotting analysis, 14.4 µl of 6x Laemmli buffer (350 mM Tris-HCl, 8 % 
SDS, 30 % glycerol, 10 % mercaptoethanol, 0.04 % bromophenol, pH 7.4) were added to the 
80 µl pooled protein sample. The extracts were boiled at 95°C for 3 min and stored at -20°C. 
Materials and Methods 
33 
 
2.2.2.2 Direct protein extraction from bone marrow cells 
Proteins from treated murine bone marrow were obtained using a direct approach: Following 
isolation of the bone marrow and production of a single cell suspension, cells were collected 
by centrifugation for 4 min at 100 x g at 4°C. The cells were washed once with ice-cold PBS 
and collected using a second centrifugation step. The pellet was resuspended in 100 µl 2x 
Laemmli buffer (produced by diluting 6x Laemmli buffer in double-distilled H2O) using a 
29 G insulin syringe. The extracts were boiled at 95°C for 3 min and stored at -20°C until use. 
Before being loaded, these samples were diluted 1:1 in SDS-running buffer and again boiled 
for 3 min at 95°C. 
 
2.2.2.3 Protein extraction from murine heart 
In order to extract protein from murine heart, cardiac tissue was snap-frozen in liquid N2 after 
removal of the heart from the mouse and separation of the lower third of the left ventricle 
(main infarcted area) from the rest of the organ. Protein extraction was achieved by splitting 
the acquired pieces of tissue in a mortar with liquid N2. Roughly 40 mg of tissue were used 
for protein extraction. The tissue was placed in 800 µl complete RIPA buffer supplemented 
with  1 % complete protease inhibitor cocktail, 1 % PMSF (100 µM in isopropanol), and 1 
mM Na3VO4 and homogenized using the Speedmill tissue homogenizer with innuSpeed lysis 
tubes A for 4 x 45 sec. The homogenized sample was incubated on ice for 30 min and 
transferred to a fresh reaction tube before sonication at 50 % amplitude, 70 % time for 3 x 30 
sec. After sonication, debris was spun down at 12,000 x g for 20 min at 4°C. Supernatants 
were collected as protein extracts and stored at -80°C until use. When used for Western 
blotting experiments, 40 µg of protein were diluted in PBS (150 mM NaCl, 100 mM 
Na2HPO4, 15 mM K2HPO4, 30 mM KCl, pH 7.4) and 6x Laemmli buffer was added. These 
samples were boiled for 5 min at 95°C before being loaded. 
 
2.2.2.4 Protein quantification using Bradford assay 
To quantify protein concentrations in samples obtained from whole tissue, the Bradford 
method was used (Bradford, 1976). Briefly, protein samples were diluted in PBS to reach a 
total volume of 800 µl. Two hundred µl of the Bio-Rad protein assay dye reagent was added 
and incubated with the protein solution for 5 min. The solution was transferred to a semi-
micro cuvette for spectrometric analysis at 595 nm using the BioPhotometer plus. The 
photometer was calibrated for concentrations ranging from 1-25 µg/ml using the BSA 
standard provided with the Bio-Rad Protein Assay Kit II. 
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2.2.2.5 Western blotting analysis 
For Western blotting analysis, protein samples containing Laemmli buffer were loaded onto a 
two-phase 10 % SDS-PAGE gel. Polymerisation of the stacking gel was achieved by adding 
25 % stacking gel buffer (500 mM Tris-HCl, 0.4 % SDS, pH 6.8), 16 % Rotiphorese Gel 30, 
0.6 % APS, and 0.2 % TEMED in double-distilled H2O. The separating gel was polymerised 
by mixing 25 % separating gel buffer (1.5 mM Tris-HCl, 0.2 % SDS, pH 8.8), 33.1  % 
Rotiphorese Gel 30, 0.03 % APS, and 0.16 % TEMED (in double-distilled H2O). The samples 
were run at 11 mA using 1x SDS PAGE running buffer (25 mM Tris-Base, 192 mM glycine, 
0.1% SDS, pH 8.6) and transferred onto a PVDF membrane using a semidry blotting 
technique at 80 mA for 90 min with transfer buffer (25 mM Tris-base, 150 mM glycine, 10 % 
methanol, pH 8.0). The resulting blot was blocked using 4 % BSA in Tris-buffered saline 
(TBS) (137 mM NaCl, 10 mM Tris-HCl, pH 7.4) supplemented with 0.1 % Tween-20 (TBST) 
and incubated overnight at 4°C with the primary antibody diluted in 4 % BSA in TBST. Then, 
the blot was washed five times for 5 min with TBST before being incubated with the diluted 
secondary antibody for 1 h in the dark at room temperature. It was washed 5 times with 
TBST, once with TBS and scanned using the LI-COR Odyssey CLx imaging system. For 
reblotting, the membrane was washed three times for 5 min and three times for 15 min in 
TBST. Thereafter, it was incubated overnight with a new primary antibody and developed the 
next day, as described above. If the first and second antigen to be detected were similar in 
molecular size, the blot was stripped from its first set of primary and secondary antibodies 
before analysis. To this end, the blot was incubated with stripping buffer (62.5 mM Tris-HCl, 
2 % SDS, 0.7 % mercaptoethanol, pH 6.8) at 60°C for 60 min. Subsequently, it was 
thoroughly washed with tap water, then four times for 15 min in TBST, blocked again with 
4 % BSA in TBST and incubated overnight with a different primary antibody. 
The dilutions of primary antibodies were as follows: anti-ERM 1:1,000; anti-ezrin 1:2,000; 
anti-GAPDH 1:5,000; anti-phospho-ERM 1:1,000; anti-phosphotyrosine-STAT1 1:1,000; 
anti-phosphotyrosine-STAT3 1:1,000; anti-STAT1 1:1,000 and anti-STAT3 1:750. Dilution 
of the IRDye 800CW-conjugated donkey-anti-rabbit secondary antibody was 1:10,000. 
 
2.2.2.6 Electrophoretic mobility shift assay 
DNA binding of STAT1 was assessed using electrophoretic mobility shift assay (EMSA). For 
this technique, purified samples of native protein were incubated with radioactively labelled 
DNA probes in the presence of a non-specific competitor (poly-dIdC), and the reactions were 
run on a native polyacrylamide gel. The DNA probe (0.2 µl) was mixed with 1 µl poly-dIdC 
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(2 mg/ml), 1.3 µl DTT (100 mM), 3.5 µl H2O and 2.5 µl 5x EMSA loading buffer (100 mM 
HEPES, 200 mM KCl, 5 mM MgCl2, 2.5 mM EDTA, 0.5 mM EGTA, 20 % Ficoll) and 
incubated with 4.5 µl or adjusted amounts of protein extracts for the times indicated. The 
STAT1 C-24 antibody was used in a supershift reaction, while the STAT3 H-190 antibody 
was used as a negative control. This mixture was loaded onto an equilibrated non-denaturing 
4.8 % TBE-polyacrylamide gel (12 % Rotiphorese Gel 40, 2.4 % TBE (89 mM Tris-base, 
89 mM boric acid, 2 mM EDTA), 2 % APS, 0.1 % TEMED) and run at 400 V using 
0.25x TBE. The gel was then pressed against Whatman blotting paper and vacuum-dried. The 
radioactive signals were detected using transfer of the signal to a phospho-imager film and 
read by the FLA-5100 scanner. For this reading, the software TINA v 2.0 was used. 
 
2.2.2.7 Radioactive labelling of EMSA probes 
Oligonucleotides intended for use in EMSA were annealed by mixing them at a concentration 
of 100 mmol/l in DNase-, RNase- and proteinase-free H2O and heating the mixture to 95°C in 
a water bath. This was left to slowly cool to room temperature overnight to allow proper 
annealing and was then stored at -20°C until further use. Radioactive labelling was performed 
by an end-filling reaction using the Klenow fragment. Five units of the Klenow fragment 
derived from DNA polymerase I from E. coli were mixed with 5 µl 10x Eco-Pol buffer, 
0.1 ng annealed oligonucleotides and 8 µl [
33
P]-labelled ATP and incubated for 25 min at 
room temperature. Finally, an excess of non-radioactive dNTPs (6.5 mM of each dNTP) was 
added for a further 5 min, and the reaction was stopped by addition of 1 µl of 0.5 mM EDTA 




In order to quantify IL-17 and IFNγ production, culture supernatants of cells isolated from 
lymph node and spleen were collected after 72 h incubation in restimulation medium (ReMed) 
(5 % FBS, 0.0002 % mercaptoethanol in R0 medium supplemented with 1 % NEAA, 1 % Na-
pyruvate, 1 % L-glutamine, and 1 % penicillin/streptomycin) and analysed using ELISA 
technique. Cells isolated as described above were seeded in U-bottom 96-well plates at a 
density of 3 x 10
5
 cells per well for the analysis of lymph node isolates and 6 x 10
5
 cells per 
well for spleen cells, respectively. MOG35-55 at a final concentration of 20 µg/ml was used as a 
specific stimulus, while concanavalin A at a concentration of 1.25 µg/ml was used as control. 
Cells were incubated with the reagents at 37°C and 5 % CO2. Each condition was analysed in 
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triplicate individually for every animal. After 72 h, supernatants were collected and stored 
at -80°C until analysis. Measurements were performed using the Mouse ELISA MAX Deluxe 
kits for IL-17A and IFNγ following the manufacturer’s recommendations. Briefly, MaxiSorp 
ELISA plates were coated with 100 µl of the capture antibody provided, diluted 1:200 in 
coating buffer for 16 h at 4°C. Unspecific binding sites of the capture antibodies were blocked 
with Assay Diluent A for 1 h at room temperature. One hundred µl of diluted supernatants 
were added to the wells of the plate and incubated for 2 h at room temperature under mild 
agitation, each sample was applied in triplicate. Samples were diluted in Assay Diluent A in 
order to give values within the dynamic range of the assay. Standard curves were generated 
by inclusion of diluted IL-17A or IFNγ at concentrations of 15.6 pg/ml, 31.25 pg/ml, 62.5 
pg/ml, 125 pg/ml, 250 pg/ml, 500 pg/ml and 1,000 pg/ml. Background values were acquired 
by measurement of pure Assay Diluent A. 100 µl of diluted detection antibody was added to 
each well and incubated for 1 h. Thereafter, the wells were incubated with the avidin-
conjugated horseradish peroxidase for 30 min. Finally, 100 µl of freshly prepared TMB 
substrate solution was added and incubated with the plate in the dark for 20 min. The 
chromatic reaction was terminated by adding 100 µl 2 N H2SO4 to each well. A thorough 
rinse using PBS-Tween was performed between each of the steps. Absorbance at 450 nm and 
570 nm was determined using the Sunrise ELISA plate reader. Difference values used for 
further analysis were calculated as the absorbance at 570 nm subtracted from the absorbance 
at 450 nm. Quantitative assessment of the data was performed using the standard curve. 
 
2.2.3 DNA analysis 
2.2.3.1 DNA extraction from tail biopsies 
To extract DNA from mouse tissue samples (e.g. tail biopsy), the tissue sample was lysed in 
500 µl tail extraction buffer (100 mM Tris, 5 mM EDTA, 200 mM NaCl, 0.2 % SDS, pH 8.5) 
and 10 µl proteinase K (20 mg/ml) overnight at 56°C and 250 rpm in a thermo-shaker. 
Proteinase K was inactivated by a 5 min incubation at 90°C. The lysate was centrifuged at 
16,100 x g and 10°C for 15 min, 350 µl of the supernatant was collected, and the DNA was 
precipitated by adding 500 µl isopropanol. The sample was mixed thoroughly by vortexing 
and centrifuged for 5 min at 16,100 x g. The supernatant was discarded, the pellet was washed 
twice with 70 % ethanol, air-dried and finally resuspended in 50 µl TE buffer (10 mM Tris-
base, 1 mM EDTA, pH 7.5). The DNA was heated to 48°C for 30 min and stored at 4°C 
overnight before analysis to allow complete resuspension. 
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2.2.3.2 Genotyping of STAT1-F77A knockin mice 
Genotyping of STAT1-F77A knockin mice was achieved by PCR amplification and 
subsequent analysis of a restriction-fragment size polymorphism. The respective fragment 
was amplified using the primer pair stat1 F77A at a final concentration of 0.4 µmol/l, 2.5 µl 
of 10x reaction buffer, 0.5 µl of 50 mM MgCl2 solution, 1 µl of dNTP mix (10 µmol/l), 
17.25 µl of DNase-, RNase- and proteinase-free water and 0.25 µl of Taq polymerase for each 
sample. 1.5 µl of purified DNA solution was added. The reaction was transferred to a 
thermocycler and run with the following program: 95°C for 3 min, followed by 41 cycles of 
denaturation at 95°C for 15 s, annealing at 61°C for 15 s, and extension at 72°C for 15 sec 
with a final elongation at 72°C for 7 min. The resulting PCR product was run on a 1 % 
agarose gel at 85 mA for 45 min and analysed using the UVsolo TS imaging system to check 
for proper product amplification. A total of 5 µl of the product were incubated with 0.3 µl of 
Tsp509I, 1.5 µl of reaction buffer B and 7.2 µl of DNase, RNase- and proteinase-free water 
overnight at 65°C. The digested PCR product was tested using a 3 % agarose gel run at 
85 mA for 60 min. Since the F77A mutation eliminates a Tsp509I-restriction site, fragment-
length polymorphism was exploited for genotype analysis. Due to the loss of a Tsp509I site 
caused by mutation F77A, the STAT1F77A-derived PCR product showed an additional 
234 bp fragment, which was cleaved into two fragments of similar size in the case of 
wildtype-derived DNA.  
 
2.2.3.3 Genotyping of STAT1-KO mice 
Genotyping of STAT1-KO mice was achieved by a PCR setup resulting in the amplification 
of a native or neomycin cassette-related fragment of the KO allele or both with a common 
upstream primer and a reverse primer located either in the deleted sequence or in the 
neomycin-resistance gene. For this purpose, the DNA was prepared and purified as described 
above. The PCR reaction included 2.5 µl of 10x buffer containing MgCl2, 1 µl each of stat1 
wildtype forward and reverse and neomycin primer, 0.625 µl of dNTP, 0.15 µl of innuTaq 
Hot A polymerase, 1 µl of DNA and 17.7 µl of DNase- RNase- and proteinase-free water. 
The PCR conditions were 95°C for 4 min, followed by 40 cycles of denaturation at 95°C for 
45 s, annealing at 60°C for 45 s, and extension at 72°C for 210 sec with a final elongation at 
72°C for 10 min. The resulting PCR product was run on a 1 % agarose gel at 85 mA for 
45 min and visualized using the UVsolo TS imaging system. The PCR product from the 
native gene was 1.7 kb, while the corresponding product length of the transgene was 1.3 kb.  
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2.2.3.4 Plasmid amplification  
For plasmid amplification, chemically competent bacteria of the E. coli strain DH5α were 
transformed using the heat-shock method (Cohen et al., 1972). Briefly, 100 µl of DH5α cells 
were slowly unfrozen and incubated on ice with 1 µg of the desired plasmid DNA. The 
bacteria were then exposed to a 30 sec heat shock at 42°C with a subsequent 2 min-incubation 
on ice. The reaction was transferred to 1 ml of antibiotic-free LB medium and incubated for 
1 h at 37°C with 225 rpm of orbital agitation before being spread on a pre-warmed agarose 
plate containing either ampicillin (for the plasmids derived from pcDNA3.1) or kanamycin 
(for the plasmids derived from pEGFP-N1). After incubation lasting 16 h, a colony was 
picked and inoculated with 2 ml of LB medium containing the respective antibiotic and grown 
for 8 h, before 1 ml of this pre-culture was transferred to 100 ml of LB medium with 
antibiotic and incubated overnight. The bacteria grown in this culture were centrifuged at 
6,000 x g for 15 min. For the isolation of plasmid DNA, the Qiagen Plasmid Maxi kit was 
used according to the manufacturers’ instructions. The DNA was resuspended in DNAse-, 
RNAse- and proteinase-free water. The concentration was adjusted to 1 µg/µl after 
determination by UV spectrophotometry. Plasmid DNA was stored at -20°C. 
 
2.2.3.5 ChIP analysis 
For chromatin immunoprecipitation (ChIP), Jurkat cells were grown in 10 ml suspension 
culture until they reached 80 % confluence and treated with 50 ng/ml IFNγ for 45 min or left 
untreated. Cells were harvested, washed twice with PBS and resuspended in 1.5 % 
formaldehyde in PBS. Cells were fixed for 15 min before the reaction was stopped by adding 
11 % of the volume of 2 M glycine solution. After 5 min incubation, the cells were washed 
twice with ice-cold PBS and resuspended in 750 µl FA-lysis buffer (50 mM HEPES, 140 mM 
NaCl, 1 mM EDTA, 1 % Triton X-100, 0.1 % sodium deoxycholate, 0.1 % SDS, pH 7.5). 
Cells were lysed for 20 min on ice. Subsequently, sonication was performed 20 times for 
25 sec at 70 % time and 55 % amplitude. A total of 6.75 ml RIPA buffer (50 mM Tris-HCl, 
150 mM NaCl, 2 mM EDTA, 1 % IGEPAL CA-630, 0.5 % sodium deoxycholate 0.1 % SDS, 
1 % complete protease inhibitor cocktail (reconstituted), pH 8.0) and 60 µl of protein-A 
agarose/salmon sperm DNA were added for a preclearing step of 30 min with slow rotation. 
Agarose beads were removed by centrifugation at 700 x g for 1 min. Four hundred µl of each 
sample were collected as reference input and stored at -20°C until further analysis. Overnight 
incubation with the antibodies for pull-down was performed in a volume of 1.6 ml each at 
4°C with constant rotation. The following primary and secondary antibodies were used with 
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their corresponding dilutions: anti-STAT1αp91 (M-23); 1:640, anti-acetyl histone; 1:320, and 
anti-rabbit immunoglobulin (IgG); 1:320. Incubation with 5 µl H2O was included as a 
negative control. After 16 h of incubation, 40 µl of protein-A agarose/salmon sperm DNA 
was diluted 1:2 in TE-buffer and added to the sample. Incubation lasted 1.5 h at 4°C with 
constant rotation. Beads were centrifuged at 4°C and 700 x g for 1 min. The beads were 
washed in five consecutive steps with low salt buffer (20 mM Tris-HCl, 150 mM NaCl, 2 mM 
EDTA, 1 % Triton X-100, 0.1 % SDS, pH 8.1), high salt buffer (20 mM Tris-HCl, 500 mM 
NaCl, 2 mM EDTA, 1 % Triton X-100, 0.1 % SDS, pH 8.1), LiCl buffer (10 mM Tris-HCl, 
250 mM LiCl, 1 mM EDTA, 1 % sodium deoxycholate, 1 % IGEPAL CA-630, pH 8.1), and 
TE buffer twice. The DNA/protein complex was eluted with a 1:1 mix of 2 % SDS solution 
and 200 mM NaHCO3 solution in two consecutive steps in a total volume of 400 µl. 
Afterwards, 14 µl of 5 M NaCl solution were added and incubated at 65°C overnight with 
constant agitation. To each reaction, 7 µl of 0.5 M EDTA solution, 14 µl of 1 M Tris-HCl 
solution and 1 µl of proteinase K solution (20 mg/ml) were added and incubated with the 
sample for 1 h at 37°C. The enzyme was heat-inactivated for 20 min at 75°C. DNA was 
isolated using 360 µl phenol/chloroform/isoamyl alcohol (25:24:1). The phases were 
separated at 10,000 x g for 2 min. The aqueous phase was collected and supplemented with 
35 µl of 3 M sodium acetate solution and DNA was precipitated by incubation with 800 µl 
isopropanol at -20°C for 1 h. The DNA was collected by centrifugation for 15 min at 
16,100 x g and 4°C. The pellet was washed once in 70 % ethanol and left to air-dry before 
being dissolved in DNase-, RNase- and proteinase-free water. ChIP samples were stored 
at -20°C. 
 
2.2.3.6 ChIP-analysis PCR 
ChIP analysis was performed using classical PCR. For the reaction, innuTaq HOT-A DNA 
polymerase was used according to the manufacturer’s recommendations. The reaction 
included 2.5 µl of 10x buffer containing MgCl2, 1 µl of 10 mM forward and reverse primer 
each, 0.625 µl of dNTPs (10 mM), 0.15 µl of polymerase, 1.5 µl of DNA and 18.225 of µl 
DNase-, RNase- and proteinase-free water. The reaction was transferred to a thermocycler 
and run using the following protocol: 95°C for 4 min, followed by 38 cycles of denaturation at 
95°C for 45 s, annealing at 61°C for 45 s, and extension at 72°C for 120 sec with a final 
elongation at 72°C for 10 min. The resulting PCR product was run on a 1 % agarose gel at 
85 mA for 45 min and analysed using the UVsolo TS gel imaging system. 
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2.2.4 RNA analysis 
2.2.4.1 RNA extraction from cell culture 
For the extraction of RNA, the PeqGold total RNA kit was used according to the 
manufacturer’s recommendation. Briefly, cells were cultured in starvation medium for 16 h 
and subsequently treated for the respective duration of time with the indicated cytokine. At 
the end of the incubation time, the cells were washed with PBS. Four hundred µl of lysis 
buffer T were added to each well. The lysed cells were transferred to the DNA-removing 
column and centrifuged at 12,000 x g for 1 min. The eluate was mixed with an equal volume 
of 70 % ethanol and transferred to an RNA-binding column. The column was centrifuged for 
1 min at 10,000 x g, washed once with wash buffer 1 and twice with ethanol-supplemented 
wash buffer 2. The column was then centrifuged for 1 min to dry at 10,000 x g and 50 µl of 
DNase-, RNase- and proteinase-free water were added and incubated with the column for 
3 min. The RNA was eluted during a 1 min centrifugation at 5,000 x g. The resulting RNA 
was used directly for cDNA synthesis or stored at -80 C. 
 
2.2.4.2 Reverse transcription of RNA isolated using the PeqGold total RNA kit 
To obtain cDNA from the isolated RNA samples, the RNA was reversely transcribed using 
the Verso cDNA Synthesis Kit from Thermo Fisher according to the manufacturer’s 
instructions. For each sample, 4 µl of 5x cDNA synthesis buffer, 2 µl of dNTP mix, 1 µl of 
RNA primer (anchored Oligo dT), 1 µl of RT Enhancer, 1 µl of Verso Enzyme Mix and 3 µl 
of DNase-, RNase- and proteinase-free H2O were mixed and added to 8 µl of the purified 
RNA. The amount of RNA necessary for sufficient yield of the cDNA synthesis had been 
determined empirically. The mix was transferred to the thermocycler and incubated for 
30 min at 42°C. The reaction was stopped by heating the sample to 95°C for the duration of 
2 min. The synthesised cDNA was stored at -20°C until use. 
 
2.2.4.3 Real-time PCR 
Endogenous gene transcription was analysed using quantitative PCR (qPCR) technique. The 
reactions were performed at 95°C for 4 min, followed by 38 cycles of denaturation at 95°C 
for 45 s, annealing at 61°C for 45 s, and extension at 72°C for 120 sec with a final elongation 
at 72°C for 10 min and the epgradient S real-time cycler. All primers used in qPCR were 
diluted to a working concentration of 5 µmol/l. A mastermix was prepared containing 10 µl of 
SYBR green, 0.28 µl of each primer and 9.44 µl of H2O for each sample and 19 µl of this mix 
were added to each cavity of a ThermoFast semi-skirted 96-well-plate. One µl of the cDNA 
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solution was added to the reaction mix. Each reaction was performed in duplicate. The 
reaction was run with settings adjusted to Filter 520 nm ‘SYBR’, Filter 550 nm ‘X’, Sample 
Vol. ’20 µl’, Probe ‘SYBR Green’. The following program was used: 95°C for 15 min, 
followed by 45 cycles of denaturation at 95°C for 15 sec, annealing at 55°C for 30 sec, and 
extension at 72°C for 30 sec. GAPDH was used as reference housekeeping gene. The program 
realplex ep was used to operate and adjust the settings of the real-time cycler. Data analysis 
was performed using the 2
-ΔΔCT method (Livak and Schmittgen, 2001).  
 
2.2.5 Primary cell isolation 
2.2.5.1 Isolation of bone marrow cells 
Primary murine bone marrow cells were isolated from mouse femur and tibia. The mice were 
sacrificed by CO2 inhalation. The fur, skin, muscle and fat were removed from the leg. The 
leg was cut at the hip joint, the femur separated from the hip bone through dislocation. The 
foot was removed, femur and tibia were separated from each other using a scalpel cut at the 
patella. The bones were washed in PBS, and potentially remaining tissue was removed using 
gauze drenched in PBS. The femurs and tibias were transferred to a cell-culture hood and 
sterilized for 15 sec in 70 % ethanol. Samples were then rinsed in PBS and transferred to 
DMEM supplemented with 10 % FBS and 1 % penicillin/streptomycin for short-time storage. 
The ends of the bones were cut using sterile surgical scissors. A syringe filled with medium 
carrying a 21 G needle was inserted into the bone and used to flush the bone marrow into a 
50 ml falcon tube. The bone marrow was dispersed using a 23 G needle, passed through a 
40 µm cell strainer and centrifuged for 5 min at 100 x g. The supernatant was discarded, and 
the cells were resuspended in medium at the desired density. 
 
2.2.5.2 Isolation of splenocytes and T cells  
Primary cells from spleen and lymph nodes were obtained from mice which had been 
immunized with MOG35-55, in order to assess proliferation and production of cytokines. The 
mice were euthanized using CO2, and the spleen as well as the inguinal and mesenteric lymph 
nodes were collected in ice-cold preservation medium (EH medium) (DMEM supplemented 
with glutamine and 25 mM HEPES). The organs were pressed trough a steel mesh to separate 
the cells and eliminate connective tissue. The resuspended cells were centrifuged at 100 x g 
for 6 min at 4°C, and the pellet was washed once using EH medium. The cells were 
resuspended in ReMed. Cell numbers were counted using a Neubauer chamber and the cell 
suspension diluted for seeding in proliferation and cytokine production assays. 
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2.2.5.3 Isolation of leukocytes from blood 
To analyse the composition of leukocyte subsets in circulation, 100 µl of blood were taken 
from the retro-orbital sinus of mice using a glass capillary. The blood-filled capillary was 
transferred to a 1.5 ml reaction tube containing 400 µl of PBS/EDTA (1 mM EDTA in PBS) 
solution. Lymphocyte separation medium was carefully added as a sublayer and the samples 
were centrifuged for 20 min at 300 x g. The resulting buffy coat (~200 µl) was collected, 
transferred to 3 ml FACS buffer (2 % BSA, 308 mM NaN3 in PBS) and used for further 
analysis. 
 
2.2.5.4 Assessment of proliferation capacity 
To evaluate whether primary cells derived from spleen and lymph nodes of 
MOG35-55-immunized animals were able to proliferate upon an antigen stimulus, a 
proliferation assay was performed. The proliferation rate was assessed based on detection of 
[
3
H]-thymidine incorporated into the DNA. To this end, cells isolated from treated mice as 
described above were seeded in U-bottom 96-well plates in 100 µl ReMed per well. Cell 
numbers were 3 x 10
5
 for cells obtained from lymph nodes and 6 x 10
5
 for spleenocytes. 
MOG35-55 at a concentration of 20 µg/ml and, as a positive control, concanavalin A at a 
concentration of 1.25 µg/ml were incubated with the samples at 37°C and 5 % CO2. Each 
condition was analysed in triplicate individually for every animal. After 48 h, [
3
H]-thymidine 
was added to a final decay rate of 685.19 Bq/ml culture supernatant and incubated with the 
cells for 16 h. For quantification of [
3
H]-thymidine incorporation, cells were lysed and then 
transferred to a Filter Mat A using the Filter Mate cell harvester. Filter mats were washed six 
times with water and dried at 80°C for 90 min. A MeltiLex scintillator sheet was melted onto 
each filter mat. The mats were cooled to room temperature and radioactive decay was 
measured using the MicroBeta TriLux luminescence counter. 
 
2.2.6 Animal experiments 
2.2.6.1 Immunization with MOG35-55 peptide and treatment with LPS 
For the induction of EAE, MOG35-55 peptide mixed with CFA was used. Mice were 
anaesthetized using a combination narcotic of 8 % ketamine and 4 % xylazine hydrochloride, 
in sterile 0.9 % NaCl. The animals were injected with 100 µl of MOG35-55 immunization paste 
(50 % MOG35-55 peptide, 50 % CFA), mixed and incubated at 4°C for 90 min prior to 
injection) subcutaneously in two different sites. Two hundred µl of pertussis toxin solution 
were applied intraperitoneal (i.p.), and mice were observed while recovering from narcosis. 
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Forty-eight hours after immunization with MOG35-55 immunization paste, the animals were 
injected with a second bolus of 200 µl pertussis toxin solution. Lipopolysaccharide (LPS) was 
injected i.p. 24 h after immunization with MOG35-55 immunization paste at a concentration of 
5 µg/g body weight. Controls were injected with 0.9 % NaCl solution. 
 
2.2.6.2 Clinical scores of EAE 
Beginning on day 10 following immunization with MOG35-55 peptide, mice were observed 
daily to evaluate EAE disease progression. Scores were assigned following the parameters 
stated in Table 19. With a score of 4 and above, mice were offered powdered food and water 
at the bottom of the cage, with a score of 5 and above, mice were additionally kept on cotton 
mats to avoid sores. Upon reaching a score of 7 or higher or after losing more than 20 % of 
their original body weight, mice were euthanized. EAE experiments were approved by the 
LAVES (reference number 3392 42502-04-13/1227). 
 
Table 19: Clinical scores for EAE 
Score Clinical signs 
0 No clinical signs 
1 Reduced tail tonicity 
2 Flaccid tail paresis 
3 Loss of righting reflex 
4 Kinetic ataxia 
5 Mild paresis of hind legs 
6 Full paresis of one hind leg or partial paresis of both hind legs 
7 Paraplegia with full paresis of both hind legs 




2.2.6.3 Surgery for myocardial infarction 
Myocardial infarction was surgically introduced into STAT1-F77A knockin mice on a 
C57BL/6N background. Surgery was performed on healthy young adult animals at the age of 
8-12 weeks. Three days before surgery, the drinking water of the animals was supplemented 
with 2 mg/ml metamizol to provide basic analgesia and to prevent avoidance of metamizol 
supplemented water after surgery. Mice were anaesthetized using 10 µl/g body weight 
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narcotic solution (5 % Cepetor, 10 % midazolam, 10 % fentanyl, in 0.9 % NaCl) i.p. and fixed 
in the supine position. Through a small incision of the trachea, a tube was inserted to provide 
artificial respiration. Respiration was set at 150 µl volume and 150 strokes/min. The skin on 
the chest was dissected with a lateral cut, the pectoral muscles were detached to expose the rib 
cage and the 4
th
 intercostal space was spread to expose the heart. The infarction was 
introduced by ligation of the left anterior descending artery using Ethilon 9-0 BV-4 5.0 mm 
3/8c EH7448G surgical silk. Whitening of the cardiac apex was observed to control proper 
occlusion of the coronary vessel. After successful introduction of the infarction, retractors 
were removed and the skin was sutured using Prolene 6-0 C-1 13 mm 3/8c 8889H surgical 
silk. Narcotic antagonist (5 % Revertor, 10 % Flumazenil, in sterile 0.9 % NaCl) was injected 
i.p. at a dose of 10 µl/g body weight. Mice were given a buprenorphine solution (1 % 
Temgesic in sterile 0.9 % NaCl) at a dose of 15 µl/g body weight and left on a pre-warmed 
plate at 37°C until fully awake. Sham-operated mice underwent the same surgery but the 
suture around the coronary vessel was removed without occlusion of the left anterior 
descending artery. After surgery, gavage of metamizol through drinking water was continued. 
If analgesia was not sufficient, the mice were given buprenorphine (10 µl/g body weight) i.p. 
twice per day. Myocardial infarction experiments were approved by the LAVES (reference 
number 3392 42502-04-13/1226). 
 
2.2.6.4 Echocardiographical assessment 
Transthoracic echocardiography was performed ≤ 7 days before myocardial infarction (MI) 
surgery and 3 days after surgery for the acute phase testing and at 1 week and 4 weeks after 
surgery for the long-term observation cohort. Echocardiography was performed under 1.5 % 
isoflurane narcosis using the Vevo x2100 system equipped with a 30 MHz centre frequency 
ultrasound transducer. The long axis was visualized in B mode only, the short axis in B- and 
M-mode. Heart rates varied in the range of 320-450 bpm, respiration rates ranged from 100-
150 per minute. Data analysis was performed using the Vevo 2100 software. In the long axis, 
the diastolic and systolic length was determined (Ls and Ld). In the short axis, left ventricular 
inner diameter (LVIDs and LVIDd), anterior and posterior wall thickness and left ventricular 
interior area (Areas and Aread) were measured in systole and diastole. In addition, the left 
ventricular exterior area was measured in systole only. From these data, fractional area 
shortening (FAS), fractional shortening (FS), ejection fraction (EF), end-diastolic (Vold) and 
end-systolic volume (Vols) were calculated. 
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Table 20: Endpoint calculation of echocardiography data 
Measurement Calculation 
FAS (Aread – Areas) / Aread * 100 
FS (LVIDd – LVIDs) / LVIDd * 100 
Vols (5 / 6) * (Areas * Ls) 
Vold (5 / 6) * (Aread * Ld) 
EF (Vold – Vols) / Vold * 100 
 
2.2.7 Classical histology 
2.2.7.1 Paraffin embedding of tissue and organs 
In order to prepare murine tissue and organs for histological and immunohistological analysis, 
organs were embedded in paraffin. Mice were sacrificed through cervical dislocation under 
isoflurane narcosis. Organs of interest were surgically removed and washed in PBS before 
being perfused for 96 h in 4 % formaldehyde solution at 4°C. Organs and tissue were 
transferred to pure PBS for 16 h and dehydrated using consecutive ascending concentrations 
of ethanol, pure xylene and finally paraffin. Paraffin perfused organs were cast in blocks 
using the EG1160 tissue embedder. To perform histological analysis, paraffin blocks were cut 
using the SM 2000 R microtome, stretched using a water bath at 45°C and dried at 50°C. 
Sections were of 5 µm in thickness. 
 
2.2.7.2 H&E staining of paraffin embedded sections of murine heart 
To gain an overall impression of tissue conditions, haemalum and eosin (H&E) staining was 
performed on paraffin embedded sections. For this purpose, tissue samples were first de-
paraffinized and re-hydrated by incubation in xylene for twice 15 min and descending 
concentrations of ethanol (99 %, 96 %, 70 %, desalted H2O) twice for 2 min each. Slides were 
stained with filtered Mayer’s haemalum solution for 10 min and blued using running tapwater 
for 10 min. The slides were counterstained in 0.1 % eosin solution for 2 min, washed twice in 
desalted water and dehydrated using ascending concentrations of ethanol (70 %, 96 %, 99 %) 
twice for 2 min each followed by two 15 min incubation steps in xylene. The samples were 
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2.2.8 Immune staining techniques 
2.2.8.1 Fluorescence-activated cell sorting analysis 
When performing fluorescence-activated cell sorting (FACS) analysis, cells of spleen, lymph 
nodes or circulating leukocytes were stained after producing a single cell suspension. If 
nothing else is stated, 5 x 10
5
 cells were used for analysis. The cells were centrifuged at 185 x 
g for 8 min and 4°C and washed once with FACS buffer. They were stained after 
resuspension in 100 µl antibody mastermix (FACS buffer with antibodies) for 15 min at 4°C 
while being protected from light. Cells were washed again once using FACS buffer and were 
resuspended in 1 ml FACS buffer before analysis. Staining of nuclear forkhead box P3 
(FoxP3) was performed using, the PE anti-mouse/rat/human FOXP3 Flow kit according to the 
manufacturer’s recommendations. After having been stained for extracellular markers, the 
cells were incubated for 30 min with 400 µl Fix-Perm solution, protected from light 
throughout the entire staining. Cells were washed once in FACS buffer. Blocking was 
performed for 15 min in 2 % rat serum in perm buffer. One µl of FoxP3 antibody was then 
directly added and incubated with the cells for 30 min. Cells were washed twice in perm 
buffer and resuspended in 200 µl FACS buffer. 
Sorting was performed using the FACSCalibur cell sorter. For analysis, the software 
CellQuestPro was used. A minimum of 30,000 cells was sorted for quantitative analysis. Four 
different reaction mixes staining for different leukocyte subsets were used for detection. One 
mix was targeted to identify different T cell-subsets and contained CD4 PE e610 (1:500), 
CD8 PE/Cy7 (1:333), CD44 PE (1:333), and CD62L (1:200). In a second reaction, myeloid 
cell subsets were identified using CD11b FITC (1:200), Ly-6C APC/Cy7 (1:500), 
CCR2 AF700 (1:20), and Ly-6G PE (1:1,000). The third staining was performed to identify 
NK and NKT cells using TCRβ FITC (1:200), CD4 PE (1:1,000), and NK-1.1 APC/Cy7 
(1:250), and in the fourth reaction, regulatory T cells were quantified using CD25 FITC 
(1:200), CD4 PE/Cy5 (1:500) and the PE anti-mouse/rat/human FOXP3 Flow kit. 
 
2.2.8.2 Immune staining using HRP-reaction 
Immune staining for the detection of the protein localisation in tissue sections was performed 
using a peroxidase reaction. The tissue sections were de-paraffinized and re-hydrated by 
incubation in xylene twice for 15 min followed by a series of descending concentrations of 
ethanol (99 %, 96 %, 70 %, desalted H2O) twice for 2 min each. Slides were boiled in citrate 
buffer (8.13 mM sodium citrate, pH 6.0) for 15 min, left to cool on ice and rinsed with 
double-distilled H2O and PBS. A peroxidase block was performed using 3 % H2O2 in PBS for 
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20 min at 4°C. The tissue was blocked in 10 % FBS in PBS supplemented with 0.05 % Triton 
X-100 and incubated with the primary antibody in 10 % FBS in PBS for 16 h at 4°C. The 
antibody was removed and the tissue rinsed three times with PBS before the biotinylated 
secondary antibody diluted 1:200 in 10 % FBS in PBS was applied for 1 h at room 
temperature. After rinsing the slide four times with PBS, it was incubated with streptavidin-
peroxidase diluted 1:1,000 in PBS for 1 h. Slides were developed using DAB. The 2.5 % 
stock solution of DAB was diluted 1:250 in PBS supplemented with 0.012 % H2O2 and 
incubated with the tissue until the chromatic reaction was clearly visible. The reaction was 
stopped by rinsing off the DAB with double-distilled H2O. Nuclei were counterstained with 
Mayer’s haemalum solution for 10 min and blued using running tap water for 10 min. The 
slides were washed twice in desalted water and dehydrated using ascending concentrations of 
ethanol (70 %, 96 %, 99 %) twice for 2 min each and two 15 min incubation steps in xylene. 
The samples were mounted using Entellan and analysed using light microscopy. Dilutions of 
primary antibodies were as follows: anti-phosphotyrosine-STAT1; 1:200, anti-
myeloperoxidase (MPO); 1:200, anti-CD68; 1:75, and anti-CD3 1:200. 
 
2.2.8.3 Evaluation of staining intensity 
Ventricle myocardial infiltration was assessed using two independent measures, the 
distribution of cells staining positive and the density of these cells within the positive area. 
Both measures were scored on a scale from 0-4. The criteria applied for scoring the 
distribution are listed in Table 21. The criteria applied for scoring the density are listed 
inTable 22. For the evaluation of the H&E stained hearts, only the distribution criteria were 
applied. 
 
Table 21: Criteria for distribution scores 
Score Characteristics 
0 No specific staining 
1 Less than half of the left ventricle 
2 50 % to 90 % of the left ventricle 
3 Entire left ventricle but little or no infiltration of the septum or 
right ventricle 
4 Entire left ventricle and strong infiltration of the right ventricle or 
the septum 
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Table 22: Criteria for density scores 
Score Characteristics 
0 No specific staining 
1 Single cells at low density 
2 Small accumulations, moderate density 
3 Many or large accumulations 
4 High, even density of positively stained cells 
 
2.2.9 Statistical analysis 
For statistical analysis, IBM SPSS and SigmaPlot were used. Means and standard deviations 
or standard errors were calculated from the data. Between-group differences were assessed 





3.1 N-terminus-mediated intradimeric interactions are dispensable for 
protomer exchange kinetics of STAT1 
It is known that STAT1 dimers need to undergo a conformational change from a parallel to an 
antiparallel alignment to be prone to inactivating dephosphorylation (Zhong et al., 2005). 
Mertens and colleagues have proposed a mechanism in which intradimeric N-terminal 
interactions facilitate the rotation of dimer partners from one of the conformational states to 
the other (Mertens et al., 2006) (Figure 2, model 1). Here, experimental data support an 
alternative mechanism to achieve conformational reorientation, namely, conversion of parallel 
to antiparallel STAT1 dimers is achieved through dissociation and re-association of STAT1 
protomers (Wenta et al., 2008) (Figure 2, model 2). Kinetics of the dissociation of dimers and 
tetramers were investigated using EMSA technique, utilising native and GFP-tagged STAT1 
protein derived from transfected U3A cells. Furthermore, the question as to whether N-
terminal interactions – especially those facilitated by the phenylalanine residue at position 77 
– are essential for this process has been addressed. 
 
Figure 2: Proposed mechanisms for STAT1 conformational change. Model 1 by Mertens et al,. 2006 
suggested that the transition between two conformational states is facilitated through reciprocal N-
terminal interactions. Model 2 is based on the dissociation and reassociation of STAT1 dimers. High-
affinity DNA binding (dimeric as well as tetrameric) is only possible in the parallel form. N = N-





3.1.1 DNA-binding kinetics do not differ among native STAT1 and GFP-tagged STAT1 
In order to assess the exchange kinetics of STAT1 protomers, an experimental system was 
established. The vectors pcDNA3.1, coding for full-length native STAT1, and pEGFP-N1, 
encoding a GFP-tagged STAT1 fusion protein, were utilized to introduce two different 
versions of the STAT1 gene into the STAT1-deficient cell line U3A. These two constructs 
differ in weight which makes it possible to distinguish them in EMSA readouts and in their 
ability of subcellular trafficking (Meyer et al., 2007). First, we evaluated whether they also 




Figure 3: Native STAT1 and STAT1-GFP both favour tetrameric binding to tandem GAS sites. 
EMSA confirmed the identity of recombinant STAT1 proteins interpreted to be the untagged (lane 1, 
lane 2 and lane 5) and the GFP-tagged variant (lane 3 and lane 4) using supershift reactions with 
either anti-STAT1 (lane 1 and lane 3) or anti-STAT3 (lane 2 and lane 4) antibody. Lane 5 shows the 
result of a competition experiment with unlabelled GAS elements added in 750-fold excess. The 
asterisk indicates an unspecific band. 
 
Protein extracts derived from U3A cells transfected with a construct carrying either the 
native STAT1 gene or the gene for STAT1 with a GFP-tag were incubated with the [
33
P]-
labelled 2xGAS probe and analysed by means of EMSA (Figure 3). Both STAT1 proteins 
bound to the probe specifically as dimeric and tetrameric complexes, as shown in lane 2 and 
lane 4 for native STAT1 and GFP-tagged STAT1, respectively. For both variants, the slower 
migrating complex corresponding to the tetrameric form was favoured over the dimeric 
complex, as indicated by stronger signal intensity in the autoradiograms. The specificity of the 




significantly shifted the dimer and tetramer band (lane 1 and 3), whereas an antibody directed 
against STAT3 was unable to cause this effect (lane 2 and 4). Co-incubation with a 750-fold 
molar excess of an unlabelled 2xGAS oligonucleotide rapidly weakened the signal for dimeric 
STAT1 bound to the probe, while leaving the signal intensity for the tetramer almost 
unaffected. This highlights the higher stability of tetrameric complexes bound to DNA as 
compared to dimeric complexes – an effect highly dependent on reciprocal interactions 
between the STAT1 amino-termini (Vinkemeier et al., 1996; Begitt et al., 2014). 
 
 
Figure 4: Competition assay showing the dissociation kinetics of STAT1 dimers from single GAS 
elements. (A) Protein extracts from U3A cells transfected with plasmids coding for either wildtype or 
GFP-tagged STAT1 were incubated with [
33
P]-labelled M67 for 15 min and subsequently co-
incubated with a 750-fold molar excess of unlabelled M67 duplex for the indicated times. The asterisk 
indicates an unspecific band. (B) Densitometry of three independent experiments showing the results 
from the competition assay in A. Error bars represent the standard deviation. Asterisks indicate 
statistically significant differences. 
 
In order to compare the DNA-release kinetics of the two STAT1 variants, a competition 
with the untagged M67 oligonucleotide was performed (Figure 4). Protein extracts from 
IFNγ-treated U3A cells which had been transiently transfected with a plasmid coding for 
either native or GFP-tagged STAT1 were incubated on ice for 15 min with the radioactively 
labelled M67 probe which contained a single GAS element. A 750-fold molar excess of non-
labelled M67 oligonucleotide was added 0, 5 and 10 min before the samples were loaded onto 
the non-denaturing polyacrylamide gel. As seen in lanes 6-8 of Figure 4A, DNA binding of 
native STAT1 was reduced with time owing to competition from unlabelled DNA. The same 
effect was observed for the STAT1-GFP molecule (lanes 3-5). Quantitative assessment of 




relatively rapidly and that the dissociation kinetics of the native and the GFP-tagged STAT1 
variants are comparable (Figure 4B). 
 
3.1.2 Native and GFP-tagged STAT1 form hetero-tetrameric complexes ex vivo 
Given the observation that native and GFP-tagged STAT1 both bind to DNA with similar 
kinetics, the next step was to observe whether the two variants were able to interact in order to 
form hetero-tetramers. Extracts from IFNγ-treated U3A cells expressing either recombinant 
GFP-tagged or untagged STAT1 were incubated with radioactively labelled 2xGAS probes. 
As a control, each of the protein variants was incubated with the DNA probe separately for 
20 min on ice and the resulting samples were then combined immediately before being loaded 
onto the gel (Figure 5, lane 5). In this setting, the two homo-tetramers can be clearly 
distinguished. To allow interchange of dimers, a separate reaction was set up where the [
33
P]-
labelled 2xGAS probe was incubated with a mix of both extracts for 20 min before being 
loaded onto the gel (Figure 5, lane 6). In this setting of co-incubating the extracts with the 
probe, both bands corresponding to the homo-tetramers in lane 5 appeared again. 
Additionally, a third band appeared between the two homo-tetramers which was interpreted as 




Figure 5: Native STAT1 and STAT1-GFP can form hetero-tetramers. Extracts from U3A cells 
expressing native or GFP-tagged STAT1 were incubated with the [
33
P]-labelled 2xGAS probe either 





To validate the identity of the additional band, a co-incubation of the extracts before 
loading with varying portions of both STAT1 variants was performed (Figure 6). Lane 1 and 
2 correspond to lane 5 and 6 from Figure 5. In lanes 3 and 4, the amount of extracts from cells 
transfected to produce native STAT1 exceeded the extracts from lane 5 and 6 by the factor 5, 
while this relation was reversed for GFP-tagged STAT1. It becomes clear that, in lane 4, there 
is almost no signal from the band representing the STAT1-GFP homo-tetramer, whereas in 
lane 6, the signal from the native STAT1 homo-tetramer band was markedly reduced 
compared with the corresponding band in lane 2 and 5. This strong reduction in the signal 
intensity indicated that the newly formed tetrameric complex is indeed a hetero-tetramer 
consisting of two STAT1-GFP/STAT1-GFP and STAT1/STAT1 homodimers, respectively. 
 
 
Figure 6: STAT1 hetero-tetramers consisting of two homodimers are formed on tandem GAS sites.  
Extracts from U3A cells expressing either recombinant, untagged or GFP-tagged STAT1 were co-
incubated at ratios of 1:1, 1:5 and 5:1 with [
33
P]-2xGAS elements before loading on a non-denaturing 
EMSA gel. Lanes with odd numbers show the results for extracts that were incubated separately, while 
lanes with even numbers correspond to the co-incubated extracts. Asterisks indicate unspecific bands. 
 
3.1.3 The rate of protomer exchange is reduced through binding to DNA 
To this point, the data demonstrated the presence of a STAT1/STAT1-GFP heterotetramer 
only with a 1:1 stoichiometry. This complex most probably consisted of two homo-dimers 
since no additional bands representing a 1:3 or 3:1 stoichiometry were observed. In order to 
validate the conditions under which complexes with a 1:3 and 3:1 stoichiometry were formed, 
extracts from IFNγ-treated U3A cells transfected with either variant were incubated separately 
in the presence of DNA (Figure 7, lane 1). Alternatively, lysates containing the two variants 
were mixed in the absence of [
33
P]-2xGAS, which was only added immediately before the 




45 min at room temperature, before the DNA-bound STAT1 complexes were 
electrophoretically separated by EMSA. When free exchange of STAT1 molecules was 
allowed in the absence of co-incubating DNA, this resulted in the occurrence of several 
additional bands not detected in the presence of the 2xGAS probe. This observation showed 
that not only dimers but also single tyrosine-phosphorylated protomers can interchange 
between different dimer pairs in solution, unless STAT1 is bound to high-affinity DNA-
binding sites present in the incubation mix.  
 
 
Figure 7: Untagged and GFP-tagged STAT1 form hetero-tetramers with 3:1 and 1:3 stoichiometry 
when unbound to DNA. Co-incubation of extracts from reconstituted U3A cells expressing either 
untagged or GFP-tagged STAT1 at room temperature for 45 min before addition of [
33
P]-2xGAS  
probe resulted in the appearance of the predicted bands with 3:1 and 1:3 stoichiometry (lane 2). No 
such bands were detected in the presence of binding to GAS elements. The asterisk indicates an 
unspecific band. 
 
The kinetics of the promoter exchange was then investigated. Protein extracts from 
reconstituted U3A cells containing either recombinant untagged or GFP-tagged STAT1 were 
co-incubated with the 2xGAS DNA probe for different durations of time (Figure 8). A 
comparison of lane 1 with lane 2 and 3 in Figure 8A shows that longer co-incubation of the 
STAT1 isoforms in the absence of DNA resulted in increased interchange of dimers and 
protomers of STAT1. This demonstrates that binding of STAT1 to DNA hinders the 






Figure 8: Binding of STAT1 to DNA hinders the exchange of protomers. (A) [
33
P]-labelled 2xGAS 
was incubated with mixed extracts from U3A cells expressing either untagged STAT1 or STAT1-GFP 
for the indicated durations of up to 20 min (lane 1-3). Lane 4 and 5 display the results of [
33
P]-2xGAS 
incubation with only one of the STAT1 variants. The asterisk indicates an unspecific band. (B) 
Densitometry from three independent experiments showing the tetramer signal in relation to the 
combined signal of dimers and tetramers. Error bars represent the standard deviation. Asterisks 
indicate statistically significant differences.  
 
Furthermore, densitometric analysis of three independent experiments verified the 
impression that increasing incubation time of STAT1 with DNA favoured the formation of 
tetrameric complexes over the binding as a dimer. In summary, these data highlight the 
significance of DNA binding in the dissociation and re-association of dimers and the 
stabilization of tetrameric STAT1 complexes. 
 
3.1.4 The exchange of STAT1 protomers is a process independent of intradimeric N-
terminal interactions 
To allow for inactivation of tyrosine-phosphorylated STAT1 dimers, a conformational change 
from a parallel to an antiparallel alignment is necessary (Zhong et al., 2005). A mechanistic 
model had been proposed by Mertens and colleagues that required intradimeric interactions 
between the N-termini of the partner protomers to break the phosphotyrosine-SH2 binding 
(Mertens et al., 2006). As a tool to study N-terminal interactions, the STAT1-F77A mutant 
was created. By exchange of the phenylalanine at position 77 to alanine, reciprocal N-domain-
mediated binding between two dimers was critically weakened (Meyer et al., 2004). Further 
insights into the dynamics of protomer exchange were expected from studying the phenotype 
of the STAT1-F77A mutant. Since the STAT1-F77A mutant had been shown to display more 




2004), protein extracts used in further experiments were tested by means of Western blotting 
technique to adjust for equal amounts of tyrosine-phosphorylated STAT1 (Figure 9B). 
 
 
Figure 9: Protomer exchange kinetics of dimers does not differ between the wildtype STAT1 and 
the F77A mutant. (A) Protein extracts of U3A cells that had been transfected with the native or GFP-
tagged form of WT or F77A mutant STAT1 were co-incubated for the indicated durations. The probe 
used for binding STAT1 was [
33
P]-M67 containing a single GAS site. The asterisk indicates an 
unspecific band. (B) No evidence of gross structural alterations in the STAT1-F77A mutant was 
detected as judged from Western blotting results. Lysates from IFNγ-pre-treated, reconstituted U3A 
cells expressing either the untagged form of STAT1α with a molecular weight of 91 kDa or the GFP-
tagged variant with the molecular weight of 118 kDa were tested in isolation or as a mixture using a 
STAT1-phospho-tyrosine-specific antibody (top). The result from stripping-off bound 
immunoreactivity and exposure of the membrane with a pan-STAT1 antibody is shown at the bottom. 
(C) Densitometric analysis of three independent experiments performed as demonstrated in (A). 
Shown is the proportion of heterodimers among all dimers that were detected. Error bars represent 
the standard deviation. Asterisks indicate statistically significant differences.  
 
Protein extracts from transfected U3A cells expressing the untagged or the GFP-
conjugated isoform of wildtype or F77A mutant STAT1 were co-incubated for 0, 15 or 
30 min before addition of the M67 DNA probe (Figure 9A). Lanes 6-8 depict a representative 
result for wildtype STAT1. In line with the above mentioned observations, an increase in 
STAT1 hetero-dimers with increasing times of co-incubation before addition of the probe was 




the wildtype molecule. The readouts from three independently conducted EMSAs were 
quantified using densitometry analysis. The results shown in Figure 9C confirmed that there 
was no significant difference in the intradimeric protomer exchange kinetics between the 
wildtype protein and the F77A mutant when binding to a DNA probe carrying a single GAS 
motif was studied. 
Subsequently, the differences in the DNA-association kinetics between the wildtype and 
the F77A mutant were tested by means of EMSA using the 2xGAS probe (Figure 10A). Lanes 
7-9 show the results for the wildtype. Lane 7 corresponds to completely separate incubation of 
the wildtype and the GFP-tagged variant, lane 8 displays the co-incubation of the two 
isoforms in the presence of GAS, and lane 9 depicts co-incubation of the two STAT1 variants 
in the absence of GAS elements which were added immediately before loading onto the gel. 
Again, the results confirmed the conclusion from the previous experiments. Lanes 10-12 show 
the respective results for the STAT1-F77A mutant. The slight retardation in the migration of 
the tetramer band of native STAT1 carrying the F77A mutation probably results from a less 
compact form of the homo-tetramer due to its lack of tetramer stabilization through N-
terminal interactions (Vinkemeier et al., 1996; Meyer et al., 2004).  
As for the wildtype molecule, little to no signal was detectable for recombined isoforms 
other than the two homo-tetramers, upon incubation of the two STAT1 variants with the 
2xGAS probe separately (Figure 10A, lane 10). Upon incubation of the two isoforms together 
with the DNA probe for the entire duration of the experiment, all five different compositions 
of the tetramer are observed (lane 11). When the protein extracts were mixed and co-
incubated before addition of the DNA, again all five species appeared (lane 12). The main 
difference between the result of the incubation of the mixed protein extracts with and without 
the probe is the higher concentration of hetero-tetramers with 3:1 and 1:3 stoichiometry which 
corroborated the earlier observation that dimers within a tetramer are exchanged at a faster 
rate than protomers and that exchange rates for dimers and monomers dramatically drop as 
soon as they are bound to DNA.  
In Figure 10B, the results from the corresponding densitometric analysis are displayed. The 
quantitation of the EMSA results showed the relative amount of GFP-tagged and untagged 
STAT1 isoforms in the tetramers formed under conditions of co-incubation with protein 
extracts and/or GAS elements. This analysis underlines the initial observation demonstrating 




protein and its F77A mutant. This finding supported the conclusion that reciprocal N-terminal 
interactions are dispensable for the exchange of protomers. 
 
 
Figure 10: Amino-terminal interactions are dispensable for monomer exchange of STAT1. (A) 
EMSA experiment comparing the intratetrameric and intradimeric subunit exchange kinetics of 
wildtype STAT1 (lane 7-9) with its F77A mutant (lane 10-12). The asterisk indicates an unspecific 
band. Unconjugated wildtype STAT1 homo-tetramers run slightly faster than STAT1-F77A homo-
tetramers probably due to a more condensed structure facilitated through tetramer stabilization. (B) 
Densitometry analysis of the proportions of each variant at the indicated stoichiometric ratio from 







3.2 Gene expression of ezrin is weakly induced by STAT1 
3.2.1 Unique GAS motif in the promoter region of the human ezrin gene was identified 
Ezrin, radixin and moesin constitute the ERM protein family, a class of cytoskeletal proteins 
with the main function of linking transmembrane proteins to the actin cortex. While recent 
studies have focused on the role of ERM proteins on leukocyte recruitment (e.g. Killock et al., 
2009; Wang et al., 2014), less is known about the regulation of their gene expression.  
An in silico search revealed the presence of a unique STAT-binding element in the 
promoter of the human ezrin (EZR) gene approximately 500 bases upstream of the first exon 
(Table 23). This motif consists of two GAS elements located in tandem orientation which are 
separated by only one base pair. Each element closely resembles the consensus STAT-binding 
site, termed GAS sequence (TTC[N]3-4GAA), which is usually located in the vicinity of the 
transcriptional start site (Decker et al. 1997). 
 
Table 23: GAS motifs surrounding the transcription-start site (TSS) in the promoter of the human 











GCAGGCGCCGGGTGAGGCGTGCGGCGGCCGGGGTC      
   
Exon 1, IFNγ-activated site motif  
Predicted TSS using the data base Berkeley Drosophila Genome Project (BDGP) neural network 
prediction tool (http://www.fruitfly.org/seq_tools/promoter.html) 
 
Given that the IFNγ/STAT1 axis is a signalling pathway highly relevant to a plethora of 
immunological processes, STAT1 may be a candidate for regulating ezrin signalling in 
leukocytes. Although in the mouse genome a similar tandem GAS motif cannot be found in 
the Ezr gene promoter (Table 24), three optimal and two non-optimal GAS motifs were 




first intron. This finding warranted further research efforts to investigate the IFNγ/STAT1 
signalling pathway as a putative mediator of Ezr gene transcription in mice. 
 
Table 24: GAS motifs surrounding the TSS of the murine EZR gene sequence. Gene sequence was 






























Exon 1, IFNγ-activated site motif, non-optimal IFNγ-activated site motif  
Predicted TSS using BDGP neural network prediction tool 
 
 
3.2.2 STAT1 readily binds to the tandem GAS motif as a dimer but poorly as a tetramer 
To evaluate whether the identified sequence was in fact an IFNγ-activated site, gel shift 
assays were applied using a radioactively labelled probe that contained the native sequence 
with the tandem GAS motif from the human EZR promoter region. Protein extracts from 
IFNγ-treated U3A cells expressing wildtype human STAT1 were incubated with this probe 
and tested for specific DNA-binding activity (Figure 11A). The autoradiograms showed a 




while tetrameric complexes were not detectable. The identity of the band was determined 
through a supershift reaction using an antibody recognizing STAT1 and, as a negative control, 
STAT3 (Figure 11A, lane 1 and 2). 
Whether STAT1 preferentially bound to the first or the second GAS motif of the tandem 
sequence was then tested. In this study, four different mutant versions of the probe that were 
termed EZR M1 to EZR M4 were designed. The annealed oligonucleotide termed EZR M1 
had an altered first GAS motif and would, therefore, not support STAT1 binding at that site, 
while for EZR M2 the second GAS motif was altered in the same way. The probe EZR M3 
incorporated the mutated sites of both EZR M1 and EZR M2 and was expected not to bind 
STAT1, and in EZR M4, the GAA of the first and the TTC of the second motif were altered 
and, therefore, presented with two half-sites. As demonstrated in Figure 11A, lanes 4 to 7, it 
appeared that there was no preference towards the first or second motif of the tandem GAS 
element shown by similar signal intensity of the dimer band in lane 4 and 5. The complex 
formed was specific since no binding was detected for EZR M3 mutated at both sites (lane 6). 
EZR M4, however, still showed some, though reduced binding of STAT1 showing that either 
an intact half site could support the dimer binding or that the dimer could span a longer 
distance on the DNA with reduced binding affinity. 
The tandem GAS element found in the EZR promoter region was different from previously 
reported tandem GAS motifs. For example, the gene CCL2 was reported to have a one-and-a-
half GAS motif that consisted of a full-length GAS motif and another half-site located at 
10 bp distance from the GAS site. This sequence has been discussed to be better at facilitating 
tetramer stabilization and contributes to the stronger sensitivity of CCL2 gene transcription in 
response to different phosphorylation levels of STAT1 (Hüntelmann et al. 2014). 
In order to confirm that the GAS element found in the EZR promoter did not support 
tetramer binding, a probe was designed that spanned a larger sequence surrounding the GAS 
motif which was termed EZR long. This probe was tested with extracts of U3A cells 
expressing wildtype STAT1 or a mutant of STAT1 with point mutations in positions 92 and 
96 which had been shown to provide significantly stronger stabilization of STAT1 tetramers 
(Staab et al., 2015). When testing this probe a prominent signal resembling binding as a 
tetramer was detected for the STAT1-DE92/96RR (Figure 11B, lane 4), while the 
corresponding signal for the wildtype molecule was hardly detectable (lane 2). In contrast, 
binding of dimeric STAT1 to the probe ERZ long was found for both STAT1 variants. Thus, 








Figure 11: EMSA showing STAT1 binding to tandem GAS elements in the human EZR promoter. 
(A) Native (N) and mutant versions (probes 1-4) of the tandem GAS motif found in the human EZR 
promoter were incubated with protein extracts of STAT1-expressing U3A cells treated with IFNγ and 
Na3VO4. Probes used were native EZR short (N) (5’-TTTTTAATTCCTAGAATTTCAGAGAATC-3’), 
EZR M1 (1) (5’-TTTTTAATAGCTACTATTTCAGAGAATC-3’), EZR M2 (2) (5’-TTTTTAATTCCTA 
GAATTAGAGACTAATC-3’), EZR M3 (3) (5’-TTTTTAATAGCTACTATTAGAGACTAATC-3’), EZR 
M4 (4) (5’-TTTTTAATTCCTAGTATTACAGAGAAATC-3’). αS1 = STAT1-specific antibody, αS3 = 
STAT3-specific antibody. (B) Extracts from U3A cells reconstituted with either wildtype STAT1 or the 
DE92/96RR double mutant that had been pre-treated with IFNγ/Na3VO4 (lane 2 and 4) or left 
untreated (lane 1 and 3) were tested with the probe EZR long (5’-TTTTCAAACAAAAAAA 
CTTAATTCCTAGAATTTCAGAGAAATCCCATGGAGCTTTTT-3’). Asterisks mark unspecific bands.  
 
 
3.2.3 STAT1 associates to the EZR promoter in Jurkat cells 
After showing that tyrosine-phosphorylated STAT1 binds to the GAS elements in the 
promoter of the EZR gene, the next step was to evaluate whether this association was also 
present in living cells. To this end, we used extracts from Jurkat cells which are a well-studied 
cell line derived from a T cell leukaemia (Gillis and Watson, 1980). Analysis of STAT1 
binding to the EZR promoter using the ChIP technique revealed that, after stimulation of cells 
with IFNγ, the respective DNA segment can be precipitated using an antibody targeted to 




association of STAT1 to the IRF1 promoter was included as a positive control. This result 
showed that STAT1 is recruited to the EZR promoter in IFNγ-treated Jurkat cells. 
 
 
Figure 12: ChIP analysis of STAT1 association to the EZR promoter in IFNγ-treated Jurkat cells. 
Shown is a representative result of a ChIP assay with an anti-STAT1 antibody used for the pulldown 
including the corresponding input (cross-linked and pre-cleared sample before pulldown). The 
experiment was performed in Jurkat cells treated with recombinant IFNγ for 45 min (+) and in 
untreated Jurkat cells (-). For evaluation, the precipitated fragments were amplified using 
conventional PCR and then visualized by means of agarose gel electrophoresis. IRF1 was analysed as 
a positive control. 
 
 
3.2.4 IFNγ-activated STAT1 induces EZR gene transcription 
Since IFNγ-activated STAT1 is recruited to the promoter of the EZR gene, whether this 
process had an effect on gene transcription was of interest. As a measure for endogenous gene 
expression, quantitative PCR (qPCR) was used on reversely transcribed RNA isolates. Jurkat 
cells were chosen as the suitable system since, in this cell line, the ChIP experiments 
described above had identified the association of STAT1 to the EZR promoter. HL-60 cells, a 
myeloid progenitor leukaemia cell line (Collins et al., 1977), were used as a control to 
confirm the results obtained in Jurkat cells. The data showed that in Jurkat cells, ezr 
expression increased slightly after 6 h of incubation with IFNγ. This trend continued and was 
even more pronounced after 10 h incubation and led to a roughly three-fold induction (Figure 
13A). Control experiments with known targets of IFNγ-induced STAT1 signalling, namely 
irf1 and stat1, confirmed that the experimental conditions were suitable to induce STAT1-
dependent gene transcription but also showed that the induction of the EZR gene was 
comparably mild (Figure 13B and 13C). Similar results were obtained from HL-60 cells. 
Expression of the EZR gene was mildly induced by IFNγ after 6 h and 10 h of incubation 
(Figure 13D). Control analysis of irf1 and stat1 was again in line with the results from Jurkat 





Figure 13: Real-time PCR results from Jurkat cells and HL-60 cells treated with IFNγ for 2 h, 6 h, 
and 10 h, respectively. (A-C) Jurkat cells, (D-F) HL-60 cells. Expression of ezrin (A,D), irf1 (B,E) and 
stat1 (C,F). Evaluation was performed using the ΔΔCT method. Shown are representative results. 
Asterisks indicate statistically significant differences. Error bars represent standard error of the mean. 
 
In order to evaluate whether the observed gene induction was specific for IFNγ-activated 
STAT1 signalling, transcription of the EZR gene was analysed also in IFNα-treated cells 
(Figure 14A). It was shown that IFNα was less potent in inducing EZR gene transcription in 
Jurkat cells as compared to IFNγ. Analysis of stat1, irf1 and ifit1 – an IFNα target gene – 
confirmed adequate stimulation of Jurkat cells (Figure 14B-D). 
These data support the hypothesis that EZR is a target gene of IFNγ-dependent STAT1 
signalling. The relatively mild induction of the protein might be attributed to the fact that 
ezrin is a cytoskeletal protein of which only limited induction is needed. This contrasts to 
other STAT1-target genes with a much larger increase from baseline expression to cytokine-





Figure 14: Real-time PCR results of Jurkat cells treated with IFNα and IFNγ showing induction of 
the EZR gene. Expression levels for ezrin (A), stat1 (B), irf1 (C), and ifit1 (D) are shown in 
unstimulated controls (Ctr) as compared to cells stimulated for 6 h with either IFNα or IFNγ. Gene 
induction was analysed using the ΔΔCT method. Shown are representative results. Asterisks indicate 
statistically significant differences. Error bars represent standard error of the mean. 
 
 
3.2.5 No evidence of IFNγ-induced ezrin expression in leukaemia cell lines  
Whether stimulation of leukaemia cell lines with IFNγ resulted in increased translation of 
ezrin was then tested. For this purpose, protein lysates were produced using a protocol of 
fractionated extraction from Jurkat cells and HL-60 cells pre-treated with IFNα or IFNγ, 
which were subsequently analysed by means of Western blotting. Stimulation with interferons 
had no impact on ezrin expression after 4 h, 8 h or 24 h of treatment, as shown by 
immunoblotting using an antibody directed against ezrin (Figure 15A and 15E). Quantitation 
from three experiments confirmed this finding (Figure 15B and 15F). Similar results were 
obtained using a pan-ERM antibody which detected both ezrin and moesin expression 
confirming that protein levels of ezrin were unchanged when related to the house-keeping 
enzyme GAPDH. In addition, no significant differences were seen for moesin expression 






Figure 15: Expression of ezrin and moesin in Jurkat and HL-60 cells treated with IFNα or IFNγ. 
(A) Expression of ezrin in relation to STAT1-phosphorylation levels after 4 h, 8 h and 24 h of IFNα or 
IFNγ treatment in HL-60 cells. (B) Densitometric quantitation of the ezrin signal in (A). (C) 
Expression of ERM proteins in relation to STAT1 expression after 4 h, 8 h and 24 h of IFNα and IFNγ 
treatment in HL-60 cells. Ezrin and moesin differ in their molecular weight (approximately by 5 kDa) 
and can, therefore, be distinguished, while radixin expression is absent in leukocytes. (D) 
Densitometric quantitation of the moesin signal in (C). (E) Expression of ezrin in relation to the 
STAT1-phosphorylation level after 4 h, 8 h and 24 h of IFNα or IFNγ treatment in Jurkat cells. (F) 
Densitometric quantitation of the ezrin signal in (E). (G) Expression of ERM proteins in relation to 
STAT1 expression after 4 h, 8 h and 24 h of IFNα and IFNγ treatment in Jurkat cells. (H) 
Densitometric quantitation of the moesin signal in (G). Shown are representative blots. 
Quantifications show the means of three independent experiments. Error bars represent standard 
error of the mean. All membranes were first exposed to an antibody against the respective ERM 






Figure 16: Expression and phosphorylation of ezrin and moesin in HL-60 cells treated with IFNα 
or IFNγ. (A) Phosphorylation levels of ezrin and moesin in relation to STAT1 expression after 10 min, 
1 h, 4 h, 8 h and 24 h of treatment with IFNα as compared with the untreated control. (B) 
Densitometric quantitation of the signal for phosphorylated moesin in (A). Due to low signal 
intensities, levels of phospho-ezrin were not quantified. (C) Expression of ezrin in relation to 
phosphorylated STAT1 after indicated times of treatment with IFNα. (D) Densitometric quantitation of 
the ezrin signal in (C). (E) Expression of ERM proteins after the indicated times of treatment with 
IFNα. (F) Densitometric quantitation of the moesin signal in (E). (G) Phosphorylation levels of ezrin 




as compared with the untreated control. (H) Densitometric quantitation of the signal for 
phosphorylated moesin in (G). (I) Expression of ezrin in relation to phosphorylated STAT1 in IFNγ-
treated cells, as described above. (J) Densitometric quantitation of the ezrin signal in (I). (K) 
Expression of ERM proteins in cells treated with IFNγ. (L) Densitometric quantitation of the moesin 
signal in (K). Shown are representative blots. Quantitations show means of three independent 
experiments, and error bars represent standard error of the mean. The membranes in (A), (C), (G) and 
(I) were first exposed to an antibody against the respective ERM protein, and, subsequently, the same 
membrane was additionally developed for STAT immunoreactivity. 
 
To test whether interferon signalling might have an effect on the phosphorylation levels of 
ezrin and/or moesin, an antibody targeted to all ERM proteins in their phosphorylated state 
was used. The respective Western blotting data (Figure 16A and 16G) including their 
densitometric analysis (Figure 16B and 16H) did not reveal significant differences in the 
phosphorylation level of moesin for any of the tested treatment durations ranging from 10 min 
to 24 h. Ezrin phosphorylation levels were barely detectable and, therefore, not quantified. 
The data obtained for ezrin and moesin (Figure 16C-F and 16I-L) confirmed the results 
demonstrated in Figure 15. In summary, the data showed that, despite being weakly activated 
on the transcriptional level in response to IFNγ signalling, ezrin production was not increased 
at the protein level in two widely used leukocyte-like cell lines. 
 
3.2.6 Ex vivo analysis of STAT1-deficient and STAT1-F77A mutant mice does not show 
decreased ezrin protein expression 
Since no ezrin induction on the protein level had been observed in IFNγ-treated cells, whether 
baseline ezrin expression was dependent on STAT1 signalling was tested. For this evaluation, 
bone marrows extracted from mice carrying a deletion of major parts of the STAT1 gene 
(referred to as STAT1-KO) and mice carrying a point mutation at position 77 which strongly 
impairs IFNγ signal transduction (referred to as STAT1-F77A) were compared to those of 
wildtype mice.  
Figure 17A and 17C shows the baseline expression of ezrin and moesin in bone marrow of 
three individual animals of each genotype. The blot as well as the corresponding quantitation 
of ezrin and moesin expression (Figure 17B and 17D) showed no differences between the 
three genotypes.  
To gain a deeper insight into the regulation of ezrin and moesin in murine bone marrow, 
the isolated cells were incubated with IFNα or IFNγ for 45 min and the whole cell proteins 
were isolated and analysed by means of Western blotting technique. Again, no significant 




18A and 18B). Analysis of the phosphorylation levels of ezrin and moesin did not reveal a 
marked difference between the genotypes, neither did the treatment conditions (Figure 18C 
and 18D). Figure 18 E and F show the expression and quantitation of ezrin protein expression 
after stimulation again detecting no differences among the genotypes.  
 
 
Figure 17: Ex vivo analysis of baseline expression of ezrin and moesin in bone marrow cells from 
wildtype, STAT1-deficient and STAT1-F77A mice. (A) Expression of ezrin at baseline in protein 
extracts derived from bone marrow obtained from three individual mice of each genotype (B) 
Densitometric quantitation of the moesin signal in (A). (C) Expression of the ERM proteins in relation 
to STAT1 in protein extracts derived from murine bone marrow obtained from three individual 
animals of each genotype. (D) Densitometric quantitation of the moesin signal in (C). Error bars 
represent standard error of the mean. In (C), first, immunoreactivity for ERM protein was detected, 
and in a second step the same membrane was developed for STAT immunoreactivity. 
 
To test the hypothesis that in the absence of STAT1-dependent signalling, STAT3-
dependent signalling becomes upregulated, STAT3 and p-STAT3 were detected in the bone 
marrow protein extracts of all three genotypes. Analysis of the phosphorylation level of 
STAT3 revealed an induction by IFNγ and to a limited extent also by IFNα. The induction, as 
well as, the baseline phosphorylation appeared to be slightly more pronounced in the F77A 






Figure 18: Phosphorylation levels of ezrin and moesin in bone marrow from wildtype, STAT1-
deficient and STAT1-F77A knockin mice treated ex vivo with interferons. (A) Expression of the 
ERM proteins in bone marrow cells treated for 0 min (untr) or 45 min with IFNα or IFNγ. (B) 
Densitometric quantitation of the moesin signal in (A). (C) Phosphorylation levels of ezrin and moesin 
bone marrow cells treated for 45 min with either IFNα or IFNγ. Signal for STAT3 was very weak. (D) 
Densitometric quantitation of the phospho-ezrin signal in (C). (E) Expression of ezrin in bone marrow 
cells treated for 45 min with IFNα or IFNγ. (F) Densitometric quantitation of the ezrin signal in (E). 
(G) Phosphorylation levels of STAT3 in bone marrow cells treated for 45 min with IFNα or IFNγ. (H) 
Densitometric quantitation of phospho-STAT3. Shown are representative blots. Quantitation shows 
means of three independent experiments. Error bars represent standard error of the mean. First, 
immunoreactivity for ERM protein was detected in (A), (C) and (E) and in a second step the same 




The data obtained from the two mouse models of impaired IFNγ/STAT1 signalling were in 
line with the results from Jurkat cells and HL-60 cells which did not show a significant 
change in ezrin expression upon cytokine stimulation. A mild but consistent and robust 
induction of EZR gene transcription by IFNγ signalling in both cell lines tested was shown. 
However, an increased production of ezrin at the protein level was neither detected in human 
cell lines nor in murine bone marrow cells. 
 
3.3 Assessment of the role of IFNγ-dependent STAT1 signalling in 
myocardial infarction 
Upon myocardial infarction, functional cardiac tissue is not only lost due to ischemia-related 
tissue necrosis but also by an accompanying inflammatory reaction (Bonaventura et al., 
2016). Inhibiting the recruitment of inflammatory cells to the myocardium is hypothesized to 
be a promising approach to favour repair and reduce injury. With respect to the role of STAT1 
in the context of cardiac ischemia, it was shown that STAT1 signalling favours apoptosis over 
autophagy, as demonstrated in an ischemia/reperfusion model using the Langendorff heart 
(McCormick et al., 2012). Since this model ignores the role of the immune reaction, the focus 
of this project was set on an in vivo model of myocardial infarction where cardiac function as 
well as the immune response can be monitored. 
 
3.3.1 General characteristics of the study cohort and infarct survival 
Mice carrying the STAT1-F77A mutation on a C57Bl/6N background as well as wildtype 
control mice were performed surgery on to induce myocardial infarction by ligating the left 
anterior descending artery. Table 25 summarizes the general characteristics of the study 
cohort. Mice were divided into a group that was sacrificed three days after surgery to analyse 
the hearts during the acute phase of inflammation and a second cohort that was kept for 
4 weeks after surgery to acquire data on survival and cardiac remodelling. Echocardiography 
was performed before and 3 days, 1 week and 4 weeks after surgery to monitor cardiac 
function and remodelling. Additionally, samples were taken on day 3 for histological and 
biochemistry analyses to evaluate cardiac inflammation during the acute phase of myocardial 








MI/Sham MI Survival/Death 
Total ♀ ♂ Total ♀ ♂ 
Total 125/23 59/11 66/12 117/8 56/3 61/5 
WT 50/8 23/4 27/4 47/3 22/1 25/2 
WT/F77A 28/7 14/3 14/4 25/3 13/1 12/2 
F77A/F77A 47/8 22/4 25/4 45/2 21/1 24/1 
 
All animals which survived the MI-surgery were observed for at least three days before 
being sacrificed in order to collect cardiac tissue for further analysis. Within the first 48 h 
after myocardial infarction, the mice lost a mean 9 % of their body weight but started to gain 
weight again and were only 5.2 % below their pre-surgery body weight on day 3. This 
observation was similar in wildtype, heterozygous and STAT1-F77A knockin mice and did 
not differ significantly between males and females. The overall survival rate of the surgery 
during the first three days was 88 % without significant differences among the genotypes. 
Females displayed a slightly higher survival rate (92.5 %) than males (84.8 %) which was in 
line with studies using different models of myocardial infarction, heart failure and 
atherosclerosis which describe beneficial effects of oestrogen (Piro et al. 2010). 
In the cohort for the 4 week follow-up, only homozygous animals were included. The 
higher mortality of males as compared to females was confirmed. Data on the weight loss 
after surgery confirmed the observation that after an initial weight loss of about 10 % of the 
original body weight within the first day after surgery, mice started gaining weight again until 
reaching a weight gain of roughly 7 % of the pre-surgery weight at 4 weeks post-infarction. 
No significant differences between the genotypes were observed with respect to changes in 
body weight. 
During the chronic follow-up, a high number of animals (in total 40 % of the study cohort) 
died or had to be euthanized. The mortality was non-significantly higher in the wildtype as 
compared with the STAT1-F77A knockin cohort (47.8 % 4-week-survival in the wildtype 
group as compared to 72.7 % 4-week-survival in the knockin group). The analysis of these 
data for males and females separately, showed that the effect disappeared for female animals 




19 presents the Kaplan-Meier survival curves of the animals included in the study cohort up to 
4-weeks after myocardial infarction. The data showed that while survival rates in females are 




 day after 
myocardial infarction. This drop in survival was significantly more pronounced in wildtype 
animals than in the STAT1-F77A knockin mice. Therefore, loss of the IFNγ-STAT1 axis was 
considered to be beneficial in male mice undergoing myocardial-infarction surgery. 
 
 
Figure 19: Kaplan-Meier survival analysis of mice subjected to experimental myocardial infarction. 
Shown are the survival rates for all animals in the study group included in the 4-week analysis. 
Animals of both sexes (A) as well as exclusively female (B) and male (C) mice were evaluated. Asterisk 
indicates statistically a significant difference. 
 
 
3.3.2 H&E staining did not reveal differences in the size of the infarcted area 
In order to assess the extent of inflammation of the ventricular wall during myocardial 
infarction, mice were sacrificed 3 days after MI surgery, and their explanted hearts were 
immediately fixed and embedded in paraffin. To allow for an estimation of the position of the 
sections used for staining, sections of 5 µm thickness were produced in a serial manner. 
Sections taken roughly 1.2 mm, 1.6 mm, 2.0 mm and 2.4 mm from the apex of the heart, 
corresponding to the entire region of the infarcted area, were subjected to H&E staining. 
Figure 20 shows representative sections of MI and sham-operated hearts of each genotype at 
~1.6 mm from the cardiac apex. All samples except the sham-operated hearts showed 
pronounced accumulation of invading leukocytes after myocardial infarction, as can be 
concluded from the presence of numerous cells with a small cytoplasmic rim and haemalum-
stained nuclei.  
In order to quantify the extent of the inflamed area of the cardiac muscle, the angle for 
distribution of inflammatory foci over the entire circumference of the left ventricle was 




between wildtype, STAT1-F77A knockin and heterozygous mice, as judged from the 
measurement of the circumference affected by infiltrates. 
 
 
Figure 20: H&E staining of acute myocardial infarction. Shown are representative slides of hearts 
3 days after MI or sham operation of each genotype. Strong infiltration of the left ventricular 
myocardium is visible in all three genotypes after infarction but not in the hearts of sham-operated 
animals. Arrowheads mark representative areas of infiltration. LV: left ventricle, RV: right ventricle. 
Images are montages of 15 to 20 individual  images. 
 
To take into account the severity of the inflammation and not only the distribution, a score 
between 0 (no inflammation) and 4 (very severe inflammation) was assigned to the H&E-
stained MI samples at each of the aforementioned positions (Figure 21B). Again, there was no 
significant difference in the score assigned to the infarcted sections between the different 
genotypes. Figure 21C shows the results of the consecutive ranking of the extent of 
inflammation. There appeared to be a mild tendency of the STAT1-F77A samples towards a 
score at a slightly higher rank than the wildtype counterparts but the effect was below the 
level of significance and is not supported by the data of the heterozygous animals which 
received the lowest mean rank. These data showed that wildtype and STAT1-F77A knockin 
mice did not differ with respect to the severity and distribution of inflammatory foci in their 






Figure 21: Evaluation of the extent of inflammation according to H&E staining of sections of 
paraffin-embedded cardiac tissue three days after myocardial infarction. (A) The distribution of 
inflammatory infiltrates was assessed by determining the angle from the centre of the left ventricle in 
which areas of pronounced accumulation of small cells (assumed to be leukocytes) were located. The 
angle was determined for sections in the middle of the infarcted area. The mean was calculated for 
each genotype. Error bars represent standard error of the mean. (B) An arbitrary score was assigned 
to each infarcted heart in serial section near the apex (1, ~1.2 mm from apex), in the middle of the 
infarcted area (2, ~1.6 mm from the apex), in the upper part of the infarcted area (3, ~2 mm from the 
apex) and at the top part of the infarcted area (4, ~2.4 mm from the apex). The score “0” was 
assigned to sections without inflamed areas, “1” for small, restricted areas of inflammation of less 
than half the left ventricular wall, “2” for distribution of inflammatory foci over up to 90 % of the left 
ventricular wall, “3” for entire left ventricle with little or no involvement of septum and right ventricle 
and “4” for involvement of septum and right ventricle. Error bars represent standard error of the 
mean. (C) Scatter blot of the consecutive ranks assigned to each MI heart. Largest infarction was 
ranked highest. Each point corresponds to one heart at the respective position. Numbers indicate that 
several samples were assigned the same rank. For wildtype, 7 cases were analysed, and for 
heterozygous and knockin 8 animals were included. 
 
 
3.3.3 Mice carrying the STAT1-F77A mutant are protected from adverse cardiac 
remodelling 
In the acute phase after myocardial infarction, immune cells are recruited to ischemic areas of 
the heart during a first inflammatory phase (reviewed in Bonaventura et al., 2016). This 
inflammatory reaction begins within the first hours after the insult and is resolved after a few 
days. It has been noted that the inflammatory environment extends beyond the ischemic tissue 




by inflammatory cells, anti-inflammatory signalling starts to facilitate clearing of the 
inflammation. Following survival of myocardial infarction, patients often suffer from heart 
failure due to post-infarction left ventricular remodelling (reviewed in Galli and Lombardi, 
2016). During this process, fibrotic scar formation of the previously hypoxic tissue is 
accompanied by an alteration in matrix composition as well as the absence of contracting 
cardiomyocytes in this area. As a consequence, the left ventricle is often dilated resulting in a 
permanently reduced ejection fraction. 
 
 
Figure 22: Increase in left ventricular diameter after myocardial infarction. The diameter of the left 
ventricular lumen was measured in diastole (A) and systole (B) in wildtype and STAT1-F77A-
expressing mice using echocardiographic images obtained in B mode. For all mice analysed, pre-
infarction data were acquired. Mice were analysed either during the acute phase (analysis on day 3 
after infarction) or kept for monitoring cardiac remodelling (analysis 1 week and 4 weeks after 
infarction). Shown are only the data acquired from female mice. The numbers of mice included in this 
experiment is indicated inside the columns. Asterisks indicate statistically significant differences. 
Error bars represent standard error of the mean. 
 
In order to evaluate the adaption of the cardiac tissue in the absence of IFNγ signalling, 
echocardiography was performed on mice, three days, one week and four weeks after ligation 
of the left anterior descending coronary artery and compared with the measurement obtained 
before surgery (mice of the day-3 cohort were analysed before and 3 days after surgery, mice 
of the 4-week cohort were analysed before and 1 week after and 4 weeks after surgery). Based 






Figure 23: Increased left ventricular cross-sectional area due to myocardial infarction. The cross-
sectional area of the left ventricular lumen and the epicardial area were measured using 
echocardiographic images obtained in B mode. (A) Left ventricular cross-sectional area of the lumen 
in diastole. (B) Measurements obtained in systole. (C) End-systolic epicardial cross-sectional area. 
For all mice analysed, pre-infarction data were acquired. Mice were analysed either during the acute 
phase (analysis on day 3 after infarction) or kept for monitoring cardiac remodelling (analysis 1 week 
and 4 weeks after infarction). Shown are only the data acquired from female animals. The numbers of 
mice included are indicated inside the columns. Asterisks indicate statistically significant differences. 
Error bars represent standard error of the mean. 
 
Analysis of the entire cohort showed no differences in cardiac remodelling, shape or 
performance between the wildtype and the STAT1-F77A knockin mouse. Variance of all 
measurements was high. Separation of the data obtained from male and female mice and 
separate analysis of these produced a drop in variance. In females carrying the STAT1-F77A 
knockin allele, the increase in both diastolic and systolic left ventricular diameter was 
attenuated during short-term follow-up (Figure 22). Similar differences between female 




sections 3 days and 1 week following ligation of the coronary artery (Figure 23). In male 
mice, no difference was found among the genotypes (data not shown). 
 
 
Figure 24: Increase in end-diastolic and end-systolic volume after myocardial infarction. The end-
systolic volume (A) and end-diastolic volume (B) were calculated from the echocardiographic data 
obtained in B mode. For all mice analysed, pre-infarction data were acquired. Mice were analysed 
either during the acute phase on day 3 after infarction or kept for monitoring cardiac remodelling at 
1 week and 4 weeks following myocardial infarction. Shown are only the data acquired from female 
mice. Numbers of mice included are indicated inside the columns. Asterisks indicate statistically 
significant differences. Error bars represent standard error of the mean. 
 
Based on the anatomical measurements of left ventricular dimensions, end-diastolic and 
end-systolic volumes were computed (Figure 24). Following myocardial infarction, the left 
ventricle started to dilate massively, almost tripling its original volume by week 4 in the 
wildtype animals. In line with the above-mentioned data, enlargement of the left ventricle was 
reduced in the F77A knockin mice during the early phase on day 3 and week 1 and continued 
as a – however non-significant – trend up to week 4. Therefore, lack in IFNγ-responsiveness 






Figure 25: The reduced cardiac function after myocardial infarction is blunted in mice with 
impaired STAT1 tetramer stabilization. Fractional area shortening (A), fractional shortening (B) and 
ejection fraction (C) were computed from the echocardiographic data obtained in B mode. For all 
mice analysed, pre-infarction data were acquired. Mice were analysed either during the acute phase 
on day 3 after infarction or kept for monitoring cardiac remodelling on week 1 and week 4 after 
coronary ligation. Shown are only the data acquired from female mice. The numbers of mice included 
are indicated inside the columns. Asterisks indicate statistically significant differences. Error bars 
represent standard error of the mean. 
 
In order to test the significance of these findings, fractional area shortening, fractional 
shortening and the ejection fraction were calculated (Figure 25). In response to the insult, 
cardiac function was markedly reduced as indicated by a pronounced and immediate drop in 
all three measurements. In STAT1-F77A female mice, cardiac function was ameliorated in 
comparison with the wildtype, 1 week after MI surgery. This trend was seen on a non-
significant level on day 3 and week 4 after experimental infarction. Again, no significant 
differences were observed from the analysis of male mice. The lack of significant differences 
among the male cohorts might be attributed to the poor overall survival rates, as described 




wildtype group, suggesting that animals with the highest impact of the infarction were not 
included in our analysis. Overall, the data revealed that the IFNγ-irresponsive STAT1-F77A 
mutant mouse line displayed ameliorated cardiac dilation and blunted remodelling resulting in 
better cardiac performance. This finding suggested that the absence of a functional 
IFNγ/STAT1-dependent signal response was not only protective due to its direct non-
transcriptional effect on apoptosis and autophagy (McCormick et al. 2012) but also due to 
other transcriptionally related mechanisms. 
 
3.3.4 STAT1 expression is reduced in hearts of STAT1-F77A knockin mice compared 
with the wildtype on day 3 following myocardial infarction 
Given the beneficial effects of the STAT1-F77A mutation in cardiac function during the acute 
phase of myocardial infarction, STAT1 regulation was then investigated at the molecular 
level. To this end, protein was extracted from the infarcted area of hearts that had been 
obtained and snap frozen 3 days after myocardial infarction. These lysates were compared 
with protein extracts isolated from unaffected areas of the basal parts of the ventricles and 
atria, as demonstrated by means of Western blotting. Figure 26A and 26B shows 
representative Western blots of protein samples from infarcted hearts of mice homo- and 
heterozygous for the STAT1-F77A mutation as compared with the wildtype. The 
phosphorylation levels of STAT1 and STAT3 as well as pan-STAT3 did not differ 
significantly between the three genotypes (Figure 26C, 26D and 26F). However, a 
significantly lower expression of STAT1 in the infarcted areas of the hearts of the STAT1-
F77A knockin mice was detected. This observation is in line with the overall reduced 
expression of STAT1 in the non-infarcted areas (Figure 26E). The expression of STAT3 is 
favoured in the myocardium of STAT1-F77A mice, as demonstrated by the increased ratio of 







Figure 26: Expression and phosphorylation of STAT1 and STAT3 in heart tissue from STAT1-
F77A knockin mice on day 3 after myocardial infarction. (A) Representative Western blots of 
phosphorylated (p)-STAT1, STAT1 and GAPDH. (B) Representative western blots of p-STAT3, STAT3 
and GAPDH. Densitometry analysis of phosphorylated STAT1 (C), phosphorylated STAT3 (D), and 
pan-STAT1 all normalized to GAPDH expression (E), as well as pan-STAT3 (F), phospho-STAT3 to 
phospho-STAT1 (G), and pan-STAT3 to pan-STAT1 (H). Data show means of four independent 
experiments. Only the α-form of STAT1 and STAT3 were evaluated. Asterisks indicate statistically 




3.3.5 Immune histochemistry shows an accumulation of cells expressing tyrosine-
phosphorylated STAT1 in the inflammatory infiltrate 
After assessment of the expression and activation of STAT1 and STAT3 using Western 
blotting, immunohistochemical staining was performed. Slides (5 µm) of paraffin-embedded 
hearts obtained 3 days after myocardial infarction from wildtype C57BL/6N mice as well as 
mice heterozygous and homozygous for the STAT1-F77A allele were stained for tyrosine-
phosphorylated STAT1. Figure 27A shows representative images taken from hearts of 
myocardial infarction- and sham-operated animals from each genotype three days after 
surgery. Following sham operation, no phospho-STAT1-positive cells were observed in the 
cardiac muscle. However, following myocardial infarction, cells scattered throughout the 
infarcted area stained positively for tyrosine-phosphorylated STAT1. There was a tendency 
for phospho-STAT1-positive cells to be distributed at a low density over the infarcted area 
and to form clusters with a higher density distributed randomly within the infarcted area. 
Outside the inflammatory infiltrate, only few cells that were stained for phospho-STAT1, 
indicating that there is an association of STAT1 activation with the acutely infarcted area. 
The accumulation of cells which stained positively for p-STAT1 was quantified using a 
score, considering two factors: their distribution over the ventricular wall and septum and, in 
addition, the density of phospho-STAT1-positive cells within this area. A score of “4” 
indicates the widest distribution and highest density, while “0” represents the absence of 
positive immunoreactivity. Figure 27B and 28C show the results of these quantifications. 
Among the different genotypes, there was a marked difference in the distribution of the 
phospho-STAT1-positive cells, showing that, in the STAT1-F77A knockin mice, STAT1 
phosphorylation was less restricted to confined areas. With respect to the density of 
p-STAT1-positive cells, there were no significant differences between the genotypes. This 
indicates that more cells staining positively for p-STAT1 were present in the infarcted area of 
cardiac sections obtained from STAT1-F77A knockin mice. These cells were distributed over 
a larger area of the myocardium but did not show stronger accumulation to confined regions 





Figure 27: Staining of tyrosine-phosphorylated STAT1 in heart sections on day 3 after myocardial 
infarction or sham operation. (A) Representative microscopic fields of view of the left ventricular 
wall of sham-operated animals (top) or the infarcted area of MI-operated animals (middle and 
bottom) of all three genotypes are shown. In the infarcted areas, p-STAT1-positive cells are 
accumulated in clusters (arrowheads) with moderate accumulation outside these areas. The bottom 
row shows a higher magnification of p-STAT1 areas with staining of p-STAT1-expressing cells. (B) 
Arbitrary quantification of the distribution of clusters of p-STAT1-positive cells over the ventricular 
wall and septum. (C) Arbitrary quantification of the density of p-STAT1-positive cells within the 
infarcted area. Asterisks indicate statistically significant differences. Error bars represent standard 




3.3.6 No evidence of altered recruitment of neutrophils, monocytes or T cells to areas of 
myocardial infarction was observed in STAT1-F77A mutant mice 
A hallmark of ischemic injury of the cardiac muscle is an inflammatory reaction based on the 
recruitment of different immune cells. The main effectors in this context are neutrophil 
granulocytes, monocytes/macrophages, and T cells (Bonaventura et al. 2016). Whether the 
recruitment of one or all of these subsets was impaired in the absence of IFNγ signaling was 
considered. FACS analysis of the lymphatic organs was performed to quantify baseline 
populations of inflammatory cell types in wildtype and STAT1-F77A knockin mice. For this 
purpose, the populations of B cells, T cells, neutrophils and monocytes were analysed in 
blood, spleen, lymph nodes and thymus in 9-week-old females. The analysis revealed a mild 
increase in regulatory T cells in spleen and lymph nodes (Figure 28). None of the other cell 
types showed significant differences with respect to their population size. 
 
 
Figure 28: Analysis of the relative numbers of regulatory T cells in lymph node and spleen of the 
STAT1-F77A mouse line. A: Analysis of regulatory T cell populations in lymph nodes (A) and spleen 
(B) of STAT1-F77A knockin mice as compared to wildtype controls. Asterisks indicate statistically 
significant differences. Error bars represent standard error of the mean. 
 
Figure 29 shows the typical expression patterns of two chemotactic cytokines in 
reconstituted U3A cells lacking endogenous STAT1 expression. The two STAT1-target genes 
CCL2 and CXCL10 display structurally different GAS elements in their promoter in which 
with the gene encoding CCL2 has a one-and-a-half GAS motif, while CXCL10 has one single 
GAS element. Both genes were induced less efficiently in the mutant despite almost normal 
expression levels at baseline. While CCL2 showed a reduced induction approximately by a 






Figure 29: Reduced activation of two known IFNγ-target genes by STAT1-F77A in reconstituted 
U3A cells. Shown are representative qPCRs of cDNA samples obtained from wildtype or STAT1-F77A 
expressing U3A cells. Untreated cells are compared with 6 h of IFNγ treatment for the induction of the 
ccl2 (A), cxcl10 (B) and, as control stat1 (C) transcript. Asterisks indicate statistically significant 
differences. Error bars represent standard error of the mean. 
 
Immunohistochemical staining using a horseradish-peroxidase-based method was utilised 
to identify different subsets of inflammatory cells during the acute phase of myocardial 
infarction. Staining for myeloperoxidase (MPO) was used as a marker for infiltrating 
neutrophils. The results identified neutrophils as the most prevalent cell type in the 
inflammatory infiltrates (Figure 30A). Quantification of the extent of myocardial infiltration 
by neutrophils revealed no significant differences in the overall area of infiltrates between the 
genotypes but a reduction in neutrophil density in animals carrying one but not two STAT1-
F77A alleles (Figure 30B and 30C). 
In order to assess the presence of monocytes and macrophages, CD68 expression was 
detected (Figure 31). Compared with the population of neutrophils at the site of inflammation, 
CD68-positive cells made up a markedly smaller proportion of the inflammatory infiltrate 
(Figure 31A). However, when quantifying the distribution and density of monocytes and 
macrophages, no difference was detected between the genotypes (Figure 31B and 31C). 
As the last subset, the infiltration of T cells was assessed through staining for CD3. 
Analysis revealed that this subset constitutes the smallest portion among the three subsets 
(Figure 32A). Again, quantification revealed that the cells were distributed equally between 
the genotypes (Figure 32B and 32C). In summary, immunohistochemical staining for the most 
prominent leukocyte subsets of the inflammatory infiltrate in the acute phase after myocardial 
infarction identified a small, yet non-significant reduction in the portion of neutrophils in 
mice homozygous for the STAT1-F77A mutation as compared to wildtype animals. This 
trend was support by a significantly lower density of neutrophils in the heterozygous mice 





Figure 30: Staining of myeloperoxidase (MPO) on day 3 following myocardial infarction or sham 
operation. (A) Shown are representative fields of view of the left ventricular wall of sham-operated 
animals (top) and MI-operated animals (bottom) of all three genotypes investigated. Arbitrary 
quantification of MPO-positive cells with respect to their distribution over the ventricular wall and 
septum (B) the density of MPO-positively stained cells (C). Asterisks indicate statistically significant 







Figure 31: Staining of CD68 following ligation of the left ascending coronary artery or sham 
operation on day 3. (A) Shown are representative fields of view of the left ventricular wall of sham-
operated (top) or MI-operated animals (bottom) of all three genotypes investigated. Single CD68-
positive cells were found in the inflammatory infiltrates (arrowheads) but not in the mock-operated 
ventricular wall. Arbitrary quantification of CD68-positive cells with respect to their distribution over 
the ventricular wall and septum (B) and the density of CD68-positively stained cells (C). Error bars 








Figure 32: Expression of CD3 in infarcted heart tissue on day 3 follow-up. (A) Representative fields 
of view of the left ventricular wall of sham-operated animals (top) and mice subjected to myocardial 
infarction (bottom) of all three genotypes are shown. CD3-positive cells were found in the 
inflammatory infiltrate (arrowheads) but not in the ventricular wall of sham-operated animals. 
Arbitrary quantification of the distribution of CD3-positive cells over the ventricular wall and septum 
(B) and the density of CD3-positive cells within the infarcted area (C). 
 
 
3.4 STAT1 deficiency delays onset of EAE upon challenge with 
lipopolysaccharide 
A plethora of studies has been published that show that STAT1 and STAT3 are main factors 
in the determination of T cell fate (Ma et al. 2016). Defects in these pathways have been 
associated with dysfunction of the immune system including immunodeficiency and 
autoimmunity. Within the context of experimental autoimmune encephalomyelitis (EAE), 




higher rate of so-called atypical EAE (Bettelli et al. 2004; Peters et al. 2015). Studies on the 
impact of LPS on the onset and progression of EAE are rare and, depending on the exact time 
point of LPS application, a delay or exacerbation of the disease have been reported (Buenafe 
and Bourdette 2007; Park et al. 2015). 
 
3.4.1 STAT1 knockout mice are protected upon LPS challenge 
In this project, we aimed to discover the effect of a combination of MOG35-55 peptide-induced 
EAE and LPS-mediated activation of TLR4. Wildtype and STAT1-deficient mice both on a 
C57BL/6 genetic background were immunized following the standard protocol. Pertussis 
toxin was given at the time of immunization and 48 h later to increase the effectiveness of the 
challenge with the antigen. Half the mice cohort were given LPS i.p. (5 mg/kg body weight) 
24 h after immunization. Following this protocol, the onset of EAE is expected between day 
10 and day 12 after immunization. 
 
 
Figure 33: Survival before onset of EAE upon LPS challenge. Shown is the percentage of animals 
surviving the period between immunization with MOG35-55 peptide and 10 days after immunization. 
Injection with LPS was performed i.p. on day 1 after immunization. Control animals were injected 
with an equal volume of 0.9 % NaCl solution. Asterisks indicate statistically significant differences. 
Error bars represent standard error of the mean. 
 
The mean weight at the time of LPS challenge was 21.4 g, and the mean age at MOG35-55 
immunization was 11.3 weeks. Sixteen out of 66 animals, that had been immunized, died 
before the onset of EAE. Most of these animals belonged to the groups challenged with 
5 mg/kg bodyweight LPS. This mortality was significantly higher in the wildtype than in the 
STAT1-deficient animals (Figure 33). The decreased sensitivity towards LPS challenge is in 




decreased mortality in the knockin model compared with their wildtype littermates (Begitt et 
al. 2014).  
 
3.4.2 Onset of clinical symptoms of EAE is delayed in STAT1 knockout mice injected 
with LPS 
The mean onset of EAE was 10 to 12 days after immunization with MOG35-55 peptide and 
progressed usually as an ascending flaccid paresis of tail and limbs. Disease severity was 
rated using a scale from 0-10, where 0 corresponds to no symptoms, 7 to complete paresis of 
the hindlimbs, and 10 to death. 
Figure 34 shows the mean onset and progression of EAE in STAT1-KO as compared to 
wildtype C57BL/6N mice that had been injected with LPS or with 0.9 % NaCl used as a 
control. In line with the literature, disease severity was mildly but not significantly increased 
in STAT1-deficient mice as compared to wildtype mice. Injection of LPS 24 h after 
immunization with MOG35-55 peptide resulted in a delay of disease onset by several days. This 
effect was even more pronounced in the group of STAT1-deficient mice injected with LPS 
(Figure 35). In terms of the disease severity, there were differences among the various 
treatment conditions: the NaCl-treated STAT1 knockout animals showed the most severe 
symptoms, while the LPS-treated wildtype animals presented with the mildest symptoms. The 
high variance is attributed to the high mortality rate upon LPS injection, which reduced the 
sample size of the cohort. In summary, the LPS-induced delay in the onset of EAE symptoms 






Figure 34: Clinical scores in STAT1-deficient and wildtype mice treated with and without LPS 
injection. (A) Combined scores of all four experimental conditions. Clinical scores of EAE 
progression rated on a 10-point scale in wildtype mice injected with NaCl solution (B), in STAT1 
knockout mice injected with NaCl solution (C), in wildtype mice injected with LPS (D), and in 





Figure 35: Mean date of EAE onset. Comparison between the four groups of wildtype (WT) and 
STAT1 knockout (KO) mice challenged with and without LPS after immunization for the induction of 




3.4.3 Cells from STAT1 knockout mice show increased proliferation upon MOG35-55 
peptide stimulation 
EAE symptoms develop through the destruction of the myelin sheath of axons after invasion 
of the CNS by autoreactive immune cells. In order to provoke such a response, clonal 
expansion of antigen-specific CD4
+
 T cells in the lymphatic organs is necessary (Rangachari 
and Kuchroo, 2013). To assess the proliferative capacity of immune cells derived from 
wildtype and STAT1-deficient mice, an ex vivo proliferation assay with MOG35-55 peptide was 
performed. Spleens and lymph nodes were extracted from mice of both genotypes which had 
been immunized with MOG35-55 peptide and then challenged with LPS or left untreated on 
day 10 and day 17 after immunization. Single cell suspensions produced from spleen and 
lymph nodes were incubated with either MOG35-55 peptide as a specific stimulus or 
concanavalin A as an unspecific stimulus for two days before addition of [
3
H]-labelled 
thymidine for 16 h to evaluate proliferation through the readout of incorporated radioactivity. 
Figure 36A shows the results of this proliferation assay for spleen-derived cells obtained 
10 days after immunization. For the cell isolates from wildtype animals, there were only 
minor differences between LPS-challenged and unchallenged cells. When comparing cells 
from wildtype carriers with cells derived from STAT1 knockout animals and treated under the 
same conditions, a markedly higher proliferation rate in response to MOG35-55 peptide as well 
as concanavalin A was observed in the unchallenged cells. In contrast, cells obtained after 




concanavalin A response remained strong. Similar results were obtained for cell isolates 




Figure 36: Relative proliferation rates of cells derived from lymphatic organs challenged with 
MOG35-55 peptide or concanavalin A.  Spleen (A) and lymph node (LN) cells (B) extracted on day 10, 
as well as spleen cells (C) and lymph node (D) cells extracted on day 17 were stimulated with 
MOG35-55 peptide, concanavalin A (Con A) or left untreated. Proliferation was measured by 
incorporation of [
3
H]-labelled thymidine for 16 h. Asterisks indicate statistically significant 
differences. Error bars represent standard error of the mean. 
 
Although LPS markedly delayed the onset of EAE in both wildtype and knockout mice, 
the reduced proliferation capacity in response to a specific antigen was more pronounced in 
the KO animals, while, in the wildtype animals, it remained at a similar level to that in the 
group of the untreated controls. The KO mice which had not been injected with LPS showed 
enhanced proliferation in response to the specific as well as the unspecific stimulus. Given the 
considerable differences between the cells derived from STAT1-deficient mice with and 
without LPS injection, a second proliferation assay was performed using cells obtained 17 
days after MOG35-55 immunization. This time point was chosen since LPS delayed the onset of 
disease symptoms by about 1 week. Figure 36C shows the respective data of cells derived 
from the spleen. No significant differences were observed among the two conditions. These 




lymph node derived cells (Figure 36D). This indicates that the impact of LPS stimulation on 
lymphocyte proliferation was transient and in line with the in vivo observation that LPS 
injection delayed but did not reduce the severity in EAE in STAT1-deficient mice. 
 
3.4.4 STAT1 knockout cells produce increased amounts of IL-17A and IFNγ 
A major mediator of the development of EAE is the population of CD4
+
 T cells which can 
develop towards different cell fates such as Th1, Th2, Th17 and regulatory T cells in response 
to signalling peptides (Bonelli et al., 2014). For the model of EAE in mice, Th1 cells  and 
Th17 cells have been identified as the major actors in disease progression (Rangachari and 
Kuchroo, 2013). In order to identify whether the proliferative expansion of cells shown in 
Figure 36 was attributed to Th1 or Th17 cells, the secretion of marker cytokines of both cell 
lineages was quantified in the culture supernatant using ELISA technique. Figure 37 shows 
the results for the secretion of IL-17A, the marker cytokine of Th17 cells. Only low amounts 
of IL-17A were detected in the supernatants of cultured cells from spleen and lymph nodes of 
wildtype animals on day 10 (Figure 37A and 37B). The STAT1 knockout cells obtained from 
mice which had been immunized but not treated with LPS produced significantly higher 
amounts of IL-17A under MOG35-55 peptide or concanavalin A stimulation than cells from 
wildtype mice. This suggested stronger proliferation of Th17 cells and was in line with the 
more severe progression of EAE in this group. Cells derived from STAT1-deficient mice 
following injection with LPS secreted only low amounts of IL-17A in response to MOG35-55 
peptide and concanavalin A.  
ELISA analysis was repeated for cells derived from spleen and lymph nodes of STAT1-
KO animals sacrificed on day 17 after immunization (Figure 37C and 37D). In line with the 
observations made in the proliferation assays described above (Figure 36C and 36D), the 
differences between the LPS-treated and non-treated conditions disappeared at this later time 
point. 
ELISA analysis was subsequently performed under similar experimental conditions to 
identify IFNγ concentration in the ex vivo culture supernatant as a readout of Th1 proliferation 
(Figure 38). In the cells derived from untreated wildtype spleen, there was a marked secretion 
of IFNγ in response to MOG35-55 peptide stimulation that exceeded the response to 
concanavalin A supporting the notion that Th1 cells are the main actors of EAE in this context 
(Figure 38A). In the cells derived from the LPS treated animals, the secretion of IFNγ 




secretion of IFNγ in the cells derived from STAT1 knockout animals treated with MOG35-55 
peptide – the condition that showed the highest proliferation and also highest secretion of IL-
17A. Again, this effect was reversed in the cells derived from animals that had been injected 
with LPS. Data of the cells derived from lymph nodes confirmed these observations, although 
secreted levels of IFNγ were much lower in the supernatants of these cultured cells and in 
some cases below the level of detection (Figure 38 B). 
 
 
Figure 37: IL-17A concentrations in the supernatants of spleen and lymph node cells from 
MOG35-55-immunised mice in the presence or absence of LPS challenge. Spleen cells (A, C) and 
lymph node cells (B, D) obtained on day 10 (A, B) or day 17 (C, D) after MOG35-55 immunization of 
mice in the absence or presence of LPS injection were stimulated ex vivo with MOG35-55 peptide, 
concanavalin A (Con A) or left untreated. Production of IL-17A was measured using ELISA technique. 
n.d. marks measurements below the detection level. Asterisks indicate statistically significant 
differences. Error bars represent standard error of the mean.  
 
The results of the later time point on day 17 post-immunization were in line with the 
previous observation that at this point, the differences between the STAT1-deficient animals 
injected with LPS or saline disappeared (Figure 38 C and D). In summary, the secreted 
cytokine patterns supported the observations made from the proliferation assays and the 






Figure 38: Dysregulated IFNγ production in the supernatants of primary cells from lymphatic 
organs of STAT1 knockout animal cells immunized with MOG35-55 peptide in the presence or 
absence of LPS co-stimulation. Spleen cells (A, C) and lymph node cells (B, D) obtained on day 10 
(A, B) or day 17 (C, D) after MOG35-55 immunization of mice in the absence (controls) or presence of 
LPS challenge. IFNγ concentrations in the supernatants of primary cells were detected using ELISA 
technique. n.d. marks measurements below the detection level. Asterisks indicate statistically 









Since the 1990s, STAT1 regulation has been under investigation as to its function in 
immunological processes (Shuai et al., 1992; Larner et al., 1993). Numerous studies have 
highlighted the essential role of the STAT1 transcription factor in defending viral, bacterial 
and parasite pathogens, and mutations in this protein have been shown to affect susceptibility 
to a catalogue of pathogens in mammals (Zhang et al., 2008). From crystallographic data, it is 
known that STAT1 can form a DNA-bound parallel dimer conformation as well as an anti-
parallel conformation not bound to DNA (Chen et al., 1998; Mao et al., 2005). Reciprocal 
interactions between N-terminal domain dimers are required for stabilization of tetrameric 
complexes. To characterize the physiological consequences of impaired tetramer stability in 
an organismic context, a genetic knockin mouse line carrying the STAT1-F77A mutant allele 
has been described (Begitt et al., 2014). The phenotype of this mouse line shows decreased 
stabilization of tetramers, loss of cooperative DNA binding and an overall failure to induce 
IFNγ-regulated target genes. In this project, the impact of abolished STAT1 cooperative DNA 
binding was studied in a murine model of ischemic injury and the impact of a complete loss of 
STAT1-dependent signalling was analysed in the context of autoimmunity. Both pathological 
conditions are characterized by a pronounced inflammatory reaction which induces loss of 
functional tissue. The role of STAT1 in the regulation of rearrangements of the actin 
cytoskeleton in leukocytes through the ERM proteins will be discussed as a possible 
mechanism of leukocyte recruitment. The results underscore the fact that the STAT1-F77A 
mutant is a valuable tool for the understanding of STAT1 signal transduction and, in 
particular, for the study of the molecular mechanisms of the conformational transition from 
the parallel to the anti-parallel conformation. 
The proposed mechanism of STAT1-dimer conformational shift, which is in line with data 
from the Vinkemeier laboratory (Wenta et al., 2008), relies on the constant dissociation and 
re-association of protomers as opposed to the hypothesis of N-terminal interactions 
facilitating the conversion between the two conformational states of the STAT1 dimer 
(Mertens et al., 2006). An experimental set-up using EMSA was established to study the 
recombination between full-length untagged STAT1 and the GFP-tagged fusion protein 
thereof. The assay proved helpful in identifying inter-molecular interactions since it allowed 
for the identification of the two STAT1 variants based on an electrophoretic separation due to 
their different molecular weights (Figure 3). Both STAT1 variants demonstrated similar 




the carboxy-terminal fusion to GFP neither augments nor impairs the dissociation of tyrosine-
phosphorylated STAT1 dimers from their target sequence on DNA (Figure 4). Co-incubation 
experiments with untagged and GFP-tagged STAT1 showed that the two variants were able to 
form functional heterotetramers in the presence of specific GAS binding sites – a prerequisite 
to render them helpful in the study of the kinetics of the exchange of protomers (Figure 5 and 
Figure 7). 
However, incubation of STAT1 dimers with DNA was shown to significantly slow down 
the kinetics of the protomer exchange which led to the notion that DNA binding protects from 
monomer exchange (Figure 9). Regarding the tetramer, the exchange of dimers was observed 
in the absence of DNA binding (Figure 7). It is worthy of note that reciprocal amino-terminal 
interactions facilitated by the critical phenylalanine residue in position 77 are dispensable for 
the dissociation into promoters, as shown by the fact that a STAT1 mutant carrying a 
mutation to alanine in this critical residue also showed dissociation (Figure 9 and Figure 10). 
Therefore, in contrast to its pivotal role in tetramer stabilization and cooperative DNA 
binding, no indication was found that the phenylalanine in position 77 was needed for the 
transition between the STAT1 conformational states or the exchange of protomers. 
The data on the kinetics of the protomer exchange (Figure 9) when compared with the 
DNA binding kinetics (Figure 4) show that while the association and release from DNA 
occurs rather rapidly the in vitro half-life of phosphorylated STAT1 dimers at room 
temperature exceeds 10 min. The structure of the phosphorylated STAT1 dimer was shown to 
be relatively stable even in the absence of DNA. High-affinity binding to its known target 
sequence further decelerates the exchange kinetics of STAT1 monomers. Furthermore, the 
results show that reciprocal interactions of the amino-termini of two adjacent monomers are 
not necessary for the formation of new dimer combinations. 
As an alternative model for the reciprocal amino-terminal interactions facilitating the 
transition between the two conformational states of the STAT1 dimer (Mertens et al., 2006), a 
different mechanism had been proposed (Wenta et al., 2008). From the literature, it seems 
well established that the phosphorylation status of the critical tyrosine residue 701 is 
important for dimer orientation. While phosphorylated STAT1 preferentially acquires the 
parallel conformation, the absence of tyrosine phosphorylation stabilizes the more condensed 
anti-parallel conformation. Wenta and colleagues estimated a half-life of 20-40 min for each 
STAT1 dimer conformation which is of the same order of magnitude identified for the half-




that conformational change might be achieved by dissociation and re-association in different 
conformational states. 
The acquired data cannot exclude the possibility that the phosphorylated STAT1 dimer is 
constantly oscillating between the two different conformational states at a rate much faster 
than the kinetics identified for the exchange of protomers and that this oscillation might be 
supported by amino-terminal interactions. However, this putative oscillation cannot be the 
rate limiting step in the dimer dissociation kinetics nor the main determinant of dimer 
stability. 
The physiological significance of these observations remains to be evaluated. It is assumed 
that the anti-parallel STAT1 dimer is the substrate for the inactivating STAT1-specific 
phosphatase, since binding of STAT1 to DNA hinders dephosphorylation (Meyer et al., 2003; 
Mertens et al., 2006). The conformational change from the parallel to the anti-parallel state is 
a prerequisite for STAT1 inactivation. Mutant isoforms of STAT1 such as F77A which are 
discussed to specifically hinder the alignment in the anti-parallel orientation have been found 
to be associated with prolonged tyrosine phosphorylation (Zhong et al., 2005; Mertens et al., 
2006). 
A study using single-molecule microscopy has shown that phosphorylated STAT1 
associates to the DNA in a way that alternates short binding events of up to 5 sec with distinct 
saltatory movements (Speil et al., 2011). This process was interpreted as a series of 
intermitting events of retardation and immobilization by putative STAT1-binding sites. These 
data support the observation from this study that DNA-dimer interactions of STAT1 are less 
stable and characterised by a shorter half-life than intradimer interactions. Therefore, the 
dimer dissociation kinetics could be the rate limiting step in the STAT1 activation cycle. 
The findings support the hypothesis that constant dissociation and re-association of 
phospho-STAT1 dimers occurs. However, the kinetics of the protomer exchange appears to 
be relatively slow in comparison with the fast release of dimers from DNA suggesting that the 
dissociation kinetics is the rate limiting step in the STAT1-mediated transcriptional response 
within the nucleus. The results from this thesis clearly demonstrate that high-affinity binding 
to DNA hinders monomer exchange and that intradimeric interactions between the N-termini 
are dispensable for the protomer exchange.  
The focus of this project was then directed towards the regulation of the expression of the 




components of the JAK/STAT pathway as mediators in actin cytoskeleton rearrangements 
during inflammatory processes and one way to induce stimulus-dependent cytoskeletal 
alterations is by ezrin signalling. Up to now, the focus of most of these studies had been on 
immediate changes, mostly via Rho kinase signalling. In macrophages, IFNγ was shown to 
increase the fraction of filamentous actin and Rac1-GTP which enhances the phagocytosis of 
bacteria (Frausto-Del-Río et al., 2012). Another study demonstrated that acquisition of an M1 
or M2 type by macrophages is linked to the reorganization of the cytoskeleton. In vitro 
differentiation experiments have revealed that M1 macrophages, as induced by IFNγ and LPS, 
are round and flat in shape, while M2 macrophages, as induced by IL-4 and IL-13, are 
elongated and show a more polarized phenotype. When being grown on a surface that 
strongly favours an elongated cell shape, the M2 lineage was favoured even in the presence of 
LPS and IFNγ stimuli showing that cell shape and cytoskeletal structure help determine 
macrophage cell fate (McWhorter et al., 2013). In T cells, signalling induced by CXCL12 and 
CCL21 triggers dephosphorylation of ERM proteins and increases motility of the cells. 
Surprisingly, knockdown of JAK1 and JAK2 inhibited ERM phosphorylation and impaired 
chemokine-induced migration suggesting that JAK/STAT signalling can influence ERM 
metabolism (Pérez-Rivero et al., 2013). 
Unlike the moesin and radixin gene, the gene encoding ezrin carries a GAS motif near the 
transcription start site (Table 23 and Table 24). In humans, this GAS motif possesses a unique 
structure since two optimal STAT1-binding sites are located approximately 500 bp upstream 
of the transcription start site in tandem orientation, separated by only 1 bp. With these 
characteristics, the GAS motif of the EZR gene markedly differs from the one-and-a-half GAS 
site of the CCL2 gene which has been suspected of being more sensitive to changes in STAT1 
phosphorylation levels and could therefore be affected to a higher degree than most STAT1-
target genes by just minor increases in STAT1 phosphorylation (Hüntelmann et al., 2014).  
The EMSA experiments performed in this project using the motif from the human EZR 
gene support the conclusion that this sequence can only be occupied by a single STAT1 
homodimer (Figure 11). No preference for either of the two GAS elements aligned in tandem 
orientation was observed. This finding suggests that the putative GAS elements in the 
promoter of the human EZR gene are a target sequence for STAT1 homodimers which can 
only bind one dimer specifically most probably for steric reasons. Since most STAT1-target 
genes contain only one GAS motif in the vicinity of the TSS (Decker et al., 1997), the role of 




ChIP experiments in Jurkat cells revealed that STAT1 binds to the EZR promoter in these 
cells (Figure 12). Since this human cell line was derived from a T cell leukaemia (Gillis and 
Watson, 1980), the binding of STAT1 to the EZR promoter not only suggests a role in gene 
regulation but might also indicate that this is of relevance in T cell function. However, since 
ezrin expression and activation have been found in connection with carcinogenesis 
(Leiphrakpam et al., 2014), induction of the EZR promoter might also be due to the 
transformed nature of this cell line. 
Real-time PCR of reversely transcribed RNA extracted from Jurkat as well as HL-60 cells 
consistently revealed a significant increase in ezr mRNA expression by the factor 2.5 in 
response to IFNγ treatment (Figure 13 and Figure 14). This effect was less pronounced in 
response to stimulation with IFNα. Both interferons induce the phosphorylation of the STAT1 
homodimer but in response to IFNα, a fraction of the STAT1 monomers becomes also 
sequestered into ISGF-3 (Horvath, 2000). Since no ISRE-binding site has been identified for 
the EZR promoter, the reduced induction below the level of significance in response to IFNα 
is in line with the hypothesis that EZR is an exclusive target gene of IFNγ-mediated STAT1 
signalling. The observation that the induction of ezrin transcription is relatively mild might be 
attributed to the fact that ezrin is a cytoskeletal protein which only needs induction by a low 
magnitude and is moderately expressed at baseline. In contrast, most other IFNγ-regulated 
genes are cytokines, transcription factors and effectors of immune response which are close to 
silent at baseline and induced at high magnitudes to protect the tissue from infections by 
pathogenic agents. 
Surprisingly, the induction of ezrin expression was not observed on the protein level, 
neither in leukaemia-derived tumour cell lines nor in bone marrow lysates obtained from 
wildtype mice, STAT1-deficient mice and mice which expressed the STAT1-F77A mutant 
(Figure 15, Figure 16, Figure 17, and Figure 18). This suggests that STAT1-induced changes 
in the protein expression of ezrin are below the detection level or that a different mechanism 
counteracts the weak induction of ezr mRNA production. A candidate for this effect would be 
the protease calpain. In response to extracellular stimuli, calpain actively cleaves ezrin in a 
Ca
2+
-dependent manner (Yao et al., 1993). Calpain inhibition resulted in massive 
overexpression of ezrin and mild overexpression of radixin and moesin in NIH-3T3 cells. By 
overexpressing these ERM proteins, calpain inhibition led to an impairment in the 
cytoskeletal rearrangements necessary in cell spreading (Potter et al., 1998). Studies in the 




mRNA and intracellular protein levels of calpain expression (Deshpande et al., 1995). 
Therefore, increase in calpain expression may be a possible mechanism to counterbalance 
STAT1-induced ezrin transcription. 
Besides the regulation of ezrin on the transcriptional level, whether IFNα- or IFNγ-induced 
signalling could evoke phosphorylation of ERM proteins was evaluated. Threonine 
phosphorylation of the ERM proteins has been shown to regulate their activation status. The 
Rho kinases, a family of small GTPases, were described to phosphorylate ezrin at Thr567, 
radixin at Thr564, and moesin at Thr558. Phosphorylation of this conserved residue reduces 
head-to-tail associations of the amino-terminal and the carboxy-terminal domains (Matsui et 
al., 1998). Interactions of ERM proteins and small GTPases have been implicated in a variety 
of ERM-dependent mechanisms including polarization, adhesion, migration and T cell 
homing (Okamoto et al., 1999; Menager et al., 1999; Denker and Barber, 2002; Cernuda-
Morollón et al., 2010; Ishihara et al. 2015). IFNγ-activated signalling mediates internalization 
of tight-junction proteins in a RhoA/ROCK-dependent manner, thereby impairing epithelial 
barrier integrity (Youakim and Ahdieh, 1999; Utech et al., 2005). Therefore, phosphorylation 
of ERM protein in response to interferon treatment was monitored. 
In HL-60 cells, ERM phosphorylation levels were comparatively low and showed no 
induction by interferon treatment over different durations of time ranging from 10 min to 24 h 
(Figure 16). In protein lysates obtained from murine bone marrow, phosphorylation of ezrin 
and moesin was readily detectable. Treatment of single cell suspensions derived from murine 
bone marrow with IFNα or IFNγ for 45 min, produced no significant changes in 
phosphorylation levels of ERM proteins (Figure 18). Therefore, the observations do not 
support the hypothesis that interferon-induced signalling directly affects ERM 
phosphorylation.  
The STAT1-F77A mutant included in these experiments was linked to poor induction of 
IFNγ-mediated gene expression due to a lack in tetramer stabilization which is pivotal for 
cooperative DNA binding of STAT1 (Meyer et al., 2004; Begitt et al., 2014). This mutation 
has impact on the susceptibility towards infectious disease, as the STAT1-F77A mouse is 
protected from vesicular stomatitis virus but showed higher mortality upon infection with 
Listeria monocytogenes. These data are in line with the notion that most genes which are 
upregulated as a response to viral infection are mediated by type I interferons via the ISGF-3 
and that lack in binding cooperativity has little impact on ISGF-3 association to ISRE-binding 




so far only been studied in infectious diseases. Here, for this project, its phenotype in the 
context of myocardial infarction was evaluated.  
Over the last two decades, STAT proteins have been attributed a role in myocardial 
infarction and ischemia/reperfusion injury (Fuchs et al., 2003; Hilfiker-Kleiner et al., 2004; 
Boengler et al., 2008; Fischer and Hilfiker-Kleiner, 2007; Fischer and Hilfiker-Kleiner, 2008; 
Hilfiker-Kleiner et al., 2010; McCormick et al., 2012; Knight et al., 2012). Ischemia has been 
shown to promote apoptosis in an IFNγ/STAT1-dependent manner by inducing the expression 
of caspase 1 in cultured neonatal cardiomyocytes as well as in the murine heart using the 
Langendorff perfusion method (Stephanou et al., 2000). For the promotion of apoptosis in 
cardiomyocytes, the most important role was attributed to the STAT1 C-terminal domain 
since expression of a truncated mutant lacking the last 60 amino acids resulted in decreased 
rates of apoptosis. This effect was not found to be directly regulated via STAT1 
transcriptional activity, because lack of the DNA-binding domain did not impair the pro-
apoptotic actions of a STAT1 mutant (Stephanou et al., 2002). STAT1 and STAT3 have both 
been shown to become phosphorylated in response to ischemic injury to the myocardium. 
Different antioxidant agents which are known to be cardioprotective were shown to inhibit 
STAT1 activation (McCormick et al., 2006; Scarabelli et al., 2009). Given the function of 
STAT3 in mitochondrial respiration (Wegrzyn et al., 2009; Carbognin et al., 2016) STAT3 is 
known to have cardioprotective effects under pressure overload as well as during 
ischemia/reperfusion injury (Fuchs et al., 2003; Hilfiker-Kleiner et al., 2004; Boengler et al., 
2008; Fischer and Hilfiker-Kleiner, 2007; Fischer and Hilfiker-Kleiner, 2008; Heusch et al., 
2011). A lack of STAT3 expression in cardiomyocytes resulted in impaired cell survival upon 
inflammatory stimuli and the spontaneous development of fibrosis and cardiac dysfunction 
during the process of aging (Jacoby et al., 2003). These effects are partially attributed to its 
transcriptional pro-survival and anti-ROS actions. In recent years, some non-canonical 
interactions of STAT3 with the NF-κB signalling pathway and with complex I of the 
mitochondrial electron-transport chain have been identified. These interactions have been 
shown to further reduce damage to cardiomyocytes by limiting damage by reactive oxygen 
species (ROS) (Zouein et al., 2015). Therefore, the current notion is that, in cardiomyocytes, 
STAT1 increases the cell damage by promoting apoptosis while STAT3 mediates pro-survival 
signalling. 
The human heart consists of approximately four to five billion cardiomyocytes 




regenerative capacity. Upon myocardial infarction, functional cardiomyocytes are lost due to 
necrotic cell death as well as apoptosis. Tissue inflammation has been a main feature of 
ischemic injury of the heart and induces a pro-apoptotic environment often with damaging 
effects to the post-infarction myocardium. If a substantial amount of cardiomyocytes is lost, 
only defective healing marked by collagen deposition and scar formation but no functional 
healing by cardiomyocyte proliferation occurs (Scarabelli and Gottlieb, 2004; Frangogiannis, 
2012; Bonaventura et al., 2016). Post-infarction cardiac repair is orchestrated in three phases. 
The first phase is characterised by massive invasion of the cardiac muscle by inflammatory 
cells. This leads to the clearance of the infarcted tissue of cell debris and dead cells and 
initiates reparative signalling pathways. During the second, proliferative phase, vascular cells 
and myofibroblasts are recruited by growth factors mainly secreted by macrophages. As a 
result, the structural integrity of the heart becomes restored by the synthesis of extracellular 
matrix proteins. During the third and final phase, many of the effector cells become quiescent 
or undergo apoptosis to avoid excess extracellular matrix deposition. The newly formed 
collagen is crosslinked to ensure structural integrity therefore completing the scar 
(Frangogiannis, 2012; Bonaventura et al., 2016). 
Upon necrosis of the myocardium, damage-associated molecular patterns induce an 
activation of the innate immune system (Kono and Rock, 2008). The induction of damage-
associated signalling was shown for several factors released during tissue necrosis, such as 
high mobility group box 1 (HMGB1), galectin-9 and heat-shock proteins. These factors 
induced maturation of dendritic cells, cytokine production, differentiation of Th1 cells and 
induction of receptor of advanced glycation end products (RAGE) signalling (Basu, 2000; 
Scaffidi et al., 2002; Dai et al., 2005). This pro-inflammatory environment leads to the 
recruitment of immune cells to the ischemic heart. The main effectors of this inflammatory 
response were identified as being neutrophil granulocytes, monocytes/macrophages, 
lymphocytes, mast cells, myofibroblasts, platelets and vascular cells (Bonaventura et al., 
2016). Platelets are the first cells to become activated and localize to the infarcted area. Upon 
binding to adhesion or matrix proteins, they become activated and release a variety of 
chemotactic factors (Gawaz 2004). Binding of neutrophils with cardiomyocytes induced the 
intracellular generation of reactive oxygen species in both interaction partners (Entman et al., 
1992). Adhesion molecules have received some attention in the context of the recruitment of 
inflammatory cells to the myocardium. Neutralizing antibodies against CD11a, CD11c, 
CD18, ICAM-1 and P-selectin were shown to reduce the infiltrate as well as the infarction 




promising findings from cell-adhesion inhibition in animal models into humans by 
administration of neutralizing antibodies against integrins to patients during the first hours 
after myocardial infarction did not result in detectable beneficial effects (Christia and 
Frangogiannis, 2013). 
Since the role of STAT1 upon myocardial ischemia has mainly be assessed in ex vivo 
models, in this project an in vivo model was applied to evaluate how STAT1-dependent 
signalling is involved in myocardial infarction and post-infarction remodelling. Ligation of 
the left anterior descending artery was performed on mice carrying the F77A knockin 
mutation in the Stat1 gene. During the first 96 h after the induction of myocardial infarction, 
no differences between wildtype and knockin mice were observed with respect to weight loss 
or sickness behaviour. Mortality during the first 4 days after infarction was below 10 %. 
However, between day 4 and day 7, survival of wildtype mice dropped from 87 % to 52 %, 
while survival rates of the STAT1-F77A knockin mice decreased from 95 % to 77 % (Figure 
19). In the study cohort, this effect was almost completely attributed to the male sex, while 
mortality rates of female mice were equally low in the two genotypes. In the male mice, the 
carriers of the STAT1-F77A mutant were protected from death during the follow-up period 
after myocardial infarction. The timing of the marked drop in survival, which is usually more 
pronounced in males than in females, is due to left ventricular rupture or heart failure - a 





after infarction (Scherrer-Crosbie et al., 2001; Gao et al., 2005; Xiang et al., 2009; Sauvé et 
al., 2010). A mouse model of ischemia/reperfusion injury in mice deficient for the IFNγ-
induced gene Ccl2 resulted in attenuated and delayed cardiac remodelling which was caused 
by reduced recruitment of macrophages and myofibroblasts (Dewald et al., 2005). Diminished 
recruitment of macrophages to sites of inflammation was also described for a genetic 
knockout model of the gene encoding the CCL2 receptor (Kurihara et al., 1997). Since the 
STAT1-F77A mutant does not induce transcription of the CCL2 gene as efficiently as the 
wildtype (Figure 29), a reduced recruitment of macrophages to the infarcted hearts of the 
knockin mouse was expected. Another cytokine, which is usually induced via IFNγ-dependent 
STAT1 signalling, is CXCL10. In the STAT1-F77A knockin model, cxcl10 is only induced 
by IFNα, while IFNγ fails to induce gene transcription (Begitt et al. 2014, Figure 29). 
Ischemia/reperfusion injury of the heart in the CXCL10-deficient mouse was characterized by 
increased numbers of neutrophils in the early acute phase 24-72 h post-infarction and 
enhanced density of macrophages in the late acute phase 3-7 days after the infarction. This 




remodelling leading to poor cardiac function (Bujak et al., 2009). Since both cytokines are 
less inducible in the STAT1-F77A knockin mouse model and one has proven beneficial while 
the other mediates adverse effects during post-infarction remodelling, the outcome of 
myocardial infarction in the STAT1-F77A mouse was difficult to predict. However, since 
both cytokines mediate the recruitment of different cellular subsets to the inflamed region, an 
overall reduced recruitment of immune cells resulting in attenuated post-infarction 
remodelling was expected. 
Ligation of the left anterior descending artery was rapidly followed by massive infiltration 
of the myocardium with several leukocytes subsets. The extent of this infiltration did not 
differ among the wildtype and the homozygous STAT1-F77A knockin mouse line (Figure 20, 
Figure 21, Figure 27, and Figure 30-32) In the STAT1-F77A knockin mouse line, a higher 
number of cells staining positively for activated STAT1 was observed. This observation is in 
line with the in vitro data showing that the STAT1-F77A mutant displays prolonged and 
increased rates of phosphorylation compared with the wildtype molecule (Meyer et al., 2004). 
Cells stained positively for tyrosine-phosphorylated STAT1 were found at similar densities in 
the hearts of wildtype and knockin mice during the acute phase of myocardial infarction, 
although, in the transgenic mouse line, these cells were distributed over a larger area. The 
cells recruited during the acute phase are mainly neutrophils, monocytes/macrophages, and T 
cells, as demonstrated by means of immunohistochemistry. Massive infiltration of the 
myocardium with neutrophils was detected during the acute phase as well as a moderate 
infiltration with macrophages and T cells (Figure 30, Figure 31, and Figure 32). Neutrophil 
infiltration was pronounced in all genotypes and was significantly reduced in heterozygous 
mice, but not in homozygous mice carrying the STAT1-F77A mutation as compared to their 
wildtype littermates.  
Protein lysates of the hearts revealed increased expression levels of STAT1 and STAT3 in 
the infarcted areas compared with lysates obtained from non-infarcted areas (Figure 26). 
While phosphorylation levels of STAT1 appeared to be fairly equal among the genotypes, 
there was a higher expression of STAT1 in the infarcted myocardium of wildtype mice as 
compared with the hetero- and homozygous STAT1-F77A knockin mice. Since the STAT1-
F77A mutant fails to activate STAT1-driven IFNγ target genes, STAT3-mediated signalling 
may be preferred in this mouse line. Corroborating this hypothesis, it was found that the ratio 




to wildtype and heterozygous animals, while the corresponding ratios of their phosphorylated 
forms were similar among the three genotypes.  
Clinical studies in humans after myocardial infarction have identified ejection fraction, 
end-systolic volume and end-diastolic volume to be valid and strong predictors of post-
infarction survival. Elevated end-systolic volume proved to be the most accurate predictor for 
post-infarction death from cardiac dysfunction-related causes (White et al., 1987). To some 
extent, post-infarction cardiac remodelling and scar formation can be seen as beneficial since 
it helps to restore and maintain cardiac output. Continued maladaptive cardiac remodelling, 
however, was linked to the progression of heart failure (Cohn et al., 2000).  
When analysing for the effects of the STAT1-F77A knockin on post-infarction cardiac 
remodelling by means of echocardiography, the transgenic mouse line showed attenuated 
cardiac dilation in females (Figure 22-25). Analysis of the heterozygous genotype before and 
three days after myocardial infarction did not contradict the observed effect but was not 
identified clearly as showing a gene-dose effect or mimicking the results of the wildtype or 
the mutant (data not shown). The striking difference among the sexes was unexpected but 
could be attributed to the reduction in cohort size due to the high mortality rate during the first 
week after surgery. It is possible that, preferentially those animals of the study cohort which 
had the most severely affected heart function died. Corroborating the data from the pure 
anatomical measurements including the end-systolic and end-diastolic volume, hearts of 
STAT1-F77A mice showed an ameliorated cardiac performance during the course of cardiac 
remodelling (Figure 25). After MI injury, fractional area shortening, fractional shortening and 
ejection fraction were reduced in both wildtype and homozygous mutant mice. However, the 
drop was less pronounced in the IFNγ-irresponsive STAT1-F77A mutant.  
All findings were most pronounced at week 1 after MI injury and had partially faded to 
being non-significant when the data obtained 4 weeks after the insult were analysed. Since 
only few female mice died during the follow-up, this result might indicate that the functional 
effect is transient. In the CCL2 knockout mouse, cardiac remodelling was delayed which 
resulted in a more favourable outcome with regard to cardiac performance (Dewald et al., 
2005). Since CCL2 induction by the STAT1-F77A mutant is impaired, the observed effect 
could be attributed to a similar one mediated by fewer macrophages and a lower recruitment 
of myofibroblasts. However, this hypothesis must remain controversial since no reduction in 
macrophage recruitment was observed for the knockin mice in the early phase after 




heterozygous mice suggest that these animals may be protected from neutrophil-induced ROS 
generation (Entman et al., 1992). This favours higher rates of cardiomyocyte survival and 
improved cardiac function as a permanent effect. Although the exact mechanism remains to 
be identified, the data clearly show beneficial effects of impaired IFNγ-dependent signalling 
during the early phase after MI injury. 
Cellular effects in myocardial infarction are the consequence of hypoxia-induced organ 
damage and are mainly mediated by processes of innate immunity including the recruitment 
of neutrophils and macrophages and the induction of extracellular matrix deposition 
(Bonaventura et al., 2016). In contrast, autoimmunity is a process resulting from the 
recognition of self-antigens by B or T lymphocytes. STAT1 and STAT3 and their 
downstream signalling effectors, have been attributed some functions during the development 
of several autoimmune diseases including multiple sclerosis (MS) and systemic lupus 
erythematosus (Feng et al., 2002; Ding et al., 2016). Therefore, the study was aimed at 
evaluating the clinical consequences of interactions between the innate immunity as activated 
by LPS challenge and factors of the adaptive immunity as induced by experimental 
autoimmune encephalomyelitis. 
In this study, mice were injected with 5 mg/kg body weight LPS during the induction 
phase of EAE. This injection resulted in the development of severe symptoms of systemic 
inflammation and was accompanied by weight loss and general signs of fatigue. Interestingly, 
mortality was particularly high in the group of LPS-injected wildtype mice which express all 
components of intact IFNγ-dependent signalling (Figure 33). The results showed that the 
STAT1 genotype is a strong predictor of mortality in the sense that the STAT1 knockout mice 
are protected upon LPS treatment. This is in line with a report that mice deficient for STAT1, 
STAT4 or TYK2 are protected from LPS-induced sepsis-related death (Kamezaki et al., 
2004). 
Lipopolysaccharide is a bacterial substance that induces signalling via the toll-like 
receptor 4. The toll-like receptors (TLRs) are a class of pattern recognition receptors and part 
of the innate immune system which poses a first line defence mechanism in the recognition of 
characteristic structures displayed by microbial pathogens (Kawai and Akira, 2010). Although 
most studies on TLR4 have focused on its role in innate immunity, LPS-dependent TLR4 
signalling was identified as promoter of the development of Th17 cells but not Th1 or Th2 




Besides the direct effect of LPS in acute inflammation, mice injected with it displayed their 
first symptoms of EAE later than mice not co-treated with it (Figure 35). Wildtype mice that 
had received an LPS injection prior to disease development showed a higher variability in 
their disease onset with a mean delay of approximately one week. This effect is in line with a 
report of a delay of 5 days in EAE onset in mice in response to LPS treatment three days prior 
to EAE induction (Buenafe and Bourdette, 2007). In this study, the delay in onset was 
attributed to the induction of TNFα, TGFβ, IFNβ and SOCS3 in response to the TLR4 
stimulus. This delay could also be reported for the STAT1-deficient mice but with a more 
consistent delay in disease onset of 1 week. The knockout mice developed slightly more 
pronounced disease symptoms regardless of whether they had been treated with LPS or not 
(Figure 34). However, this exacerbated disease progression was not as pronounced as had 
been reported earlier by the laboratory group of Bettelli (Bettelli et al., 2004). Most studies 
indicate protective and beneficial effects due to LPS treatment (e.g. Raziuddin and Morrison, 
1982; Buenafe and Bourdette, 2007; Ellestad et al., 2009; Li et al., 2010), whereas there are 
some which name detrimental effects of LPS (e.g. Nogai et al., 2005). However, the protocols 
used in these studies vary widely with respect to the dose as well as the time point of LPS 
administration. In general, gavage of LPS to mice prior to the induction of EAE delayed or 
attenuated disease development.  
One proposed mechanism of LPS action was the induction of IL-10 production by 
dendritic cells which has proven to be inhibitory to disease progression (Zhou et al., 2014). 
An earlier study showed that mice which produce transgenic IL-10 under the control of the 
H2 promoter are protected from EAE induction (Cua et al., 1999). However, this notion might 
be problematic since LPS-induced IL-10 production is, at least in part, considered to result 
from type I interferon signalling (Iyer et al., 2010). High IL-10 production has been reported 
for the STAT1 knockout as well as the T-bet-STAT1 double knockout mice (Bettelli et al., 
2004). 
Experimental autoimmune encephalomyelitis is an inducible model of a neurodegenerative 
disease mimicking the main features of multiple sclerosis (MS). Most commonly, EAE is 
induced in rodent models such as mouse and rat but also protocols for EAE induction in non-
human primates are utilised (Hart et al., 2015). Multiple sclerosis is among the most common 
causes of neurological disability in young adults with higher prevalence in females than in 
males. Owing to demyelination and axon loss, patients develop physical and mental disability. 




roughly half of whom live in Europe (Kingwell et al., 2013; Grigoriadis and van Pesch, 2015). 
According to disease progression, MS is categorized as the relapsing-remitting MS, which can 
develop into the secondary progressive form, or the primary progressive form of MS. Patients 
suffering from relapsing-remitting MS alternate between periods of severe disease symptoms 
and periods of almost complete recovery. In some cases, the disease course develops into the 
secondary progressive form with no recovery. Patients suffering from the primary progressive 
form do not go into remission (Kieseier and Hartung, 2003).  
On the immunological level, MS is a disease mediated by dysfunction of parts of the 
innate, as well as, the adaptive immune system. Infiltration of the CNS, mainly the white 
matter by Th1 and Th17 cells, is a characteristic feature of the disease. Release of 
inflammatory cytokines activates macrophages and microglia which leads to the production of 
reactive oxygen and nitrogen species. In this pro-inflammatory environment, axons are 
demyelinated and degenerate leading to neurological disease symptoms (Grigoriadis and van 
Pesch, 2015). In the model of MOG35-55 peptide-induced EAE, dendritic cells pick up the 
peptide, migrate to the lymph nodes and cross-present the antigen to naïve T cells (Slavin et 
al., 2001). Symptoms are caused by the demyelination of axons of CNS neurons evoked by 
invasion of the CNS by autoreactive T cells, and the onset of disease is preceded by the 
activation and proliferation of T cells in the lymphatic organs (Soulika et al., 2009). 
Several studies in mice have reported that impairment of the IFNγ-STAT1 axis, including 
genetic knockout of the genes encoding for STAT1, IFNγ or the ligand-binding chain of 
IFNGR, do not ameliorate EAE development and progression but rather augments disease 
severity, susceptibility and mortality (Ferber et al., 1996; Krakowski and Owens, 1996; 
Willenborg et al., 1996; Bettelli et al., 2004). Differences in numbers and function of 
regulatory T cells have been suggested as an underlying mechanism for the EAE progression 
in these transgenic models. In 129Sv mice, reduced numbers of regulatory T cells, as defined 
by the co-expression of CD4 and CD25, have been reported in STAT1-deficient mice as 
compared to a wildtype background (Nishibori et al., 2004). Furthermore, STAT1-deficient 
regulatory T cells were reported to lack the ability to inhibit growth. This observation 
contradicts our analysis of decreased numbers of regulatory T cells in the IFNγ-irresponsive 
STAT1 knockin mouse line, as shown in Figure 28. Some studies have reported that FoxP3-
positive induced regulatory T (iTreg) cells are less frequent in STAT1- and in IRF1-deficient 
mice and that IFNγ-signalling is either a suppressor or inducer of Treg development (Wang et 




STAT1-F77A knockin mouse line support studies showing that defective IFNγ signaling is 
linked to increased iTreg differentiation. 
A different mechanism to explain the protective effect of IFNγ-dependent signalling in 
EAE was the induction of iNOS which leads to increased levels of reactive nitrogen species 
(Willenborg et al., 1999). The inhibitory effect of increased NO production resulting from 
IFNγ- or concanavalin A-induced signalling has been repeatedly reported (Albina et al., 1991; 
Krenger et al., 1996; Zettl et al., 1997). This mechanism was identified as specific for Th1 
activation: IFNγ which was released from Th1 cells inhibited exacerbated Th1 activation 
resulting from NO production by APCs (van der Veen et al., 2000). Deficiency in iNOS 
expression was shown to hinder remission during the course of EAE. Overall, lack of iNOS 
was shown to augment EAE progression in mice (Fenyk-Melody et al., 1998; Sahrbacher et 
al., 1998). Furthermore, IFNγ-dependent signalling has been seen to regulate activation-
induced cell death in T lymphocytes (Refaeli et al., 2002).  
In an adoptive transfer model of EAE, Th1 recipient mice displayed a chemokine profile of 
high CXCL9, CXCL10 and CXCL11 expression, while Th17 recipients secreted CXCL1 and 
CXCL2. Although the cytokine profiles were distinct, clinical disease progression was similar 
in Th1- and Th17-mediated disease (Kroenke et al., 2008). In IFNγ knockout mice, the 
recruitment of inflammatory cells to the CNS is mainly mediated by CXCL2 and CCL1, not 
by CCL5 and CCL2 as in the wildtype (Tran et al., 2000). In an experimental autoimmune 
uveitis model, a similar pattern of recruitment of immune cells via the Th2 and Th17  
cytokines CCL1, CXCL2, CCL11, CCL17 and CCL22 instead of the Th1-dependent 
cytokines CCL5, CXCL9, and CXCL10 was observed for the IFNγ knockout mouse (Su et 
al., 2007). Here, the differential expression of cytokines led to an increased recruitment of 
neutrophil and eosinophil granulocytes and a reduced recruitment of lymphocytes and 
monocytes.  
In vitro proliferation assays using cell isolates derived from spleen and lymph nodes of 
MOG35-55 peptide-immunized mice shortly before the predicted onset of initial disease 
symptoms demonstrated a striking difference among the cells of wildtype and STAT1-
deficient mice (Figure 36). While MOG35-55 peptide and concanavalin A both readily induced 
proliferation in cells from wildtype lymph nodes, cells derived from STAT1 knockout mice 
showed an even stronger increase in proliferation in response to either stimulus. This 
observation is in line with the notion that disease symptoms were augmented by the STAT1 




findings, T cells from STAT1 knockout mice have been reported to be hyperproliferative 
(Bettelli et al., 2004). Increased proliferation of activated CD4
+
 T cells characterised by high 
expression of CD44 and low expression of CD62L has been previously reported for IFNγ-
deficient mice (Chu et al., 2000). In this model, the effect was, in part, attributed to failure of 
APCs to induce apoptosis.  
Pre-treatment of mice with LPS showed little effect on the proliferation of cells of the 
wildtype genotype (Figure 36). However, the analysis of the impact of LPS on proliferation in 
the knockout genotype, revealed that the proliferation rate in response to MOG35-55 peptide 
was critically impaired while the response to concanavalin A appeared to be unchanged. 
These findings indicate that LPS has little effect on the induction of proliferation of T cells in 
spleen and lymph nodes of wildtype animals, whereas it impairs proliferation in cells from 
STAT1 knockout mice. MHC class II molecules are under transcriptional control of STAT1. 
A study using early life exposure of mice to LPS showed a protective effect of this treatment 
on EAE severity which was mainly attributed to reduced expression of MHC class II 
molecules on antigen presenting cells (Ellestad et al., 2009). Since it had been shown that 
STAT1 signalling in APCs limits T cell proliferation, the observations can be explained by an 
impaired antigen presentation after LPS treatment with an overall impaired effect on growth 
inhibition in the STAT1 knockout (van der Veen et al., 2000). 
Reports on the mechanisms underlying the onset and progression of EAE have attributed 
major roles to CD4
+
 lymphocytes and, in particular, Th1 and Th17 cells (Rangachari and 
Kuchroo, 2013; Bonelli et al., 2014). Th1 and Th17 cells are characterised by the secretion of 
marker cytokines which are IFNγ in the case of Th1 cells and IL-17A in Th17 cells 
(Mosmann et al., 1986; Park et al., 2005). Assessment of the release of these cytokines in 
supernatants of ex vivo cultures of spleen and lymph node cells led to the notion that cells 
from immunized STAT1-deficient mice readily released large amounts of both cytokines in 
response to MOG35-55 peptide encounter (Figure 37 and Figure 38). This observation was 
surprising since IFNγ-dependent signalling is mainly transduced via the transcription factor 
STAT1, and the gene encoding T-bet, TBX21, is a known STAT1-target gene and the master-
regulator of Th1 differentiation (Lighvani et al., 2001; Afkarian et al., 2002; Villarino et al., 
2010). The expectation in this context was that the Th17 lineage would be preferred in the 
absence of IFNγ/STAT1-dependent signal transduction (Harrington et al., 2005). 
Furthermore, it has been reported that lack of STAT1-mediated signalling usually pushes a 




maturation. Disturbances of the balance between STAT1- and STAT3-dependent signal 
pathways have been linked to altered lineage decision as a response to typical Th1 or Th17 
inducing cytokines (Qing and Stark, 2004; Yang et al., 2007; Peters et al., 2015; Wan et al., 
2015). However, although T-bet is regulated by IFNγ-dependent STAT1 signalling, it can be 
upregulated in T cell subsets in the absence of IFNγ signalling and even in the combined 
knockdown of IFNγ and IL-12. In the context of T cell fate, IFNγ-producing and IL-17A-
producing T cells developed as well as T cells expressing both cytokines (Yeh et al., 2011). A 
study on Th17 cells showed that commitment towards this lineage was not permanent. Upon 
treatment of Th17 cells with Th1- or Th2-inducing factors, the production of Th1 and Th2 
marker cytokines could still be induced (Stritesky et al., 2008). IL-23 has been identified as an 
agent which pushes the development of IL-17A and IFNγ double positive cells from Th17 
cells. Knockout of STAT1, STAT4 or TBX21 did not reduce the size of this T cell population 
(Duhen et al., 2013). Similar to its effect in leukocyte proliferation, LPS treatment abrogated 
the release of IL-17A and IFNγ by the cultured cells. This effect was similar in the two 
genotypes and in line with the observation of delayed onset of disease symptoms after 
treatment with LPS. Therefore, the strong induction of cytokine production in the STAT1 
knockout can, in part, be explained by the strong proliferation. Additionally, Th17 cells that 
acquire the double positive phenotype of IL-17A and IFNγ-producing cells can also 
contribute to the high secretion of both cytokines. 
In summary, this project underscores the protomer exchange kinetics as a critical step in 
the STAT1 activation/inactivation cycle and describes this process as an alternative 
mechanism for the conformational change between the parallel and anti-parallel dimer 
conformation. Furthermore, it was shown that DNA binding of STAT1 not only hinders 
dephosphorylation but also the exchange of STAT1 protomers. The gene encoding the 
cytoskeletal protein ezrin was identified as a STAT1-regulated target gene since binding of 
tyrosine-phosphorylated STAT1 to the EZR promoter induced a weak transcriptional 
response. This effect could not be found at the level of protein expression which might 
indicate a counteracting mechanism. The phenotype of the STAT1-F77A mutant was further 
characterised by showing that this mutant was proficient in facilitating normal monomer 
exchange kinetics. Moreover, this mutant, similar to the complete functional knockout of 
STAT1, displayed no reduced expression levels of ezrin or moesin, supporting the notion that 
STAT1 is dispensable for the baseline expression of the two ERM proteins. In the context of 
inflammation following myocardial infarction, STAT1-F77A knockin males showed 




dilation and had a less impaired cardiac function when compared with their wildtype 
littermates. Analysis of the inflammatory infiltrate revealed a minor increase in cells 
expressing activated STAT1, while slightly fewer neutrophil granulocytes were recruited 
during the acute phase in heterozygous STAT1-F77A knockin mice. Analysis of the role of 
STAT1 in autoimmunity using EAE as the model of choice, revealed hyperproliferation and 
increased production of Th1 and Th17 marker cytokines in the STAT1 knockout context. 
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